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Abstract 
Viral aerosol survivability, transmission, and sampling were studied size-selectively in an 
environmental chamber, which simulated a typical indoor environment featuring a complex flow 
field and low viral aerosol concentration. MS2, HAdV-1, AIV, SIV, TGEV, and aMPV were 
tested as surrogates for common human viruses. Live virus titer, total virus concentration, and 
fluorescence intensity were measured to calculate virus relative recovery and survival. 
 
Because of the low viral aerosol concentration in the chamber, long-term sampling had to be 
conducted for virus quantification. Long-term sampling performance of the eight-stage non-
viable Andersen cascade impactor was tested first. All six viruses were sampled for one and six 
hours at 25 ˚C and 50% RH. The six-hour samples did not show much higher live virus titers than 
the one-hour samples, suggesting significant inactivation in the impactor. The six-hour tests did 
collect much higher total virus concentrations that resulted from PCR analysis. Impactor plate 
overloading which caused a decrease in sampling efficiency was observed in the six-hour tests. 
 
Due to higher survivability and lower uncertainty, MS2, HAdV-1, and AIV were further tested at 
different temperatures and humidities. All three viruses had lower inactivation rates at 25 ˚C than 
at 30 ˚C, but the effect was not significant for HAdV-1. Absolute humidity (AH) was found to be 
a better predictor of survival than relative humidity (RH). Using AH also removed the significant 
interaction between temperature and humidity, which exists when RH is used. MS2 and HAdV-1 
had the lowest inactivation rates at low AH, and AIV had the lowest inactivation rate at high AH 
for the AH range from 8.8 to 15.2 g/m
3
, which is common in most indoor environments. Future 
tests are recommended at more extreme humidity levels. 
 
In the UVGI tests, the survival of MS2, HAdV-1 and AIV was significantly reduced by UVGI, 
showing the good potential of this technology for indoor air disinfection. The inactivation 
damaged the nucleic acid, which reduced live virus titer and total virus concentration by similar 
rates. Based on relative recovery, virus inactivation rates due to UVGI were calculated for the 
three viruses. To quantify the virus susceptibility, a transient numerical simulation was conducted 
iii 
 
with Lagrangian particle tracking and log-linear inactivation kinetics. The average susceptibility 
of MS2 was 0.057 cm
2
/mJ with the range for one standard error to be [0.022, 0.098] cm
2
/mJ. For 
HAdV-1, the susceptibility was 0.056 [0.035, 0.079] cm
2
/mJ, and for AIV, it was 0.132 [0.031, 
0.278] cm
2
/mJ. The result suggests that virus susceptibility to UVGI may be similar for air and 
water environments. Tests for different irradiance and dose levels are recommended to further 
investigate the inactivation kinetics and verify the numerical model. 
 
In the HVAC filter tests, the overall filtration efficiencies for fluorescein and for total virus were 
similar, but the filtration efficiency for total virus was significantly higher than that for 
fluorescein at about 1 µm particle diameter. This result suggests that using fluorescein may not 
accurately predict the filtration behavior of viruses for the small particles. For the chemical-free 
filters tested, no significant inactivation of MS2 was found in the filtration process. 
 
More than 95% of the aerosol mass collected was smaller than 4.7 µm, with the mass median 
diameter of about 1.5 µm. The particle size distribution was affected by suspension medium but 
not virus. If the nucleic acid was not damaged during a test, the physical loss of virus was better 
predicted by total virus (PCR) rather than fluorescein, and their difference could be larger for 
larger viruses. In the nebulizer fluid, no significant virus inactivation was found after the one-
hour tests with 20 psi (138 kPa) compressed air, or after the six-hour tests with 10 psi (69 kPa) 
compressed air. The evaporation effect was more obvious for longer test duration or greater 
compressed air pressure. The nebulization rate of fluorescein was higher than that of virus. 
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1 Introduction 
1.1 Transmission of viral aerosol 
It has been reported that nearly 60% of human disease infections are caused by viruses (Sattar 
1987). An important reason for viruses’ strong infectivity is their potential to survive and reach 
new hosts by different routes after being shed into the environment outside of cells (Sobsey 2003). 
One of the major transmission routes is by aerosol. Viral aerosol is the specific type of aerosol 
that carries infectious viruses. When viruses are encased in an aerosol particle, their infectivity is 
enhanced due to shielding from damaging effects including desiccation and radiation (Tyrrell 
1967). Many researchers have found that viral aerosols are capable of traveling up to thousands of 
kilometers, and maintaining their infectivity for up to several days (Donaldson 1975; Ijaz 1985; 
Li 2008). 
 
Several disease outbreaks have suggested the importance of the aerosol transmission route. The 
most famous ones are the 1960s outbreaks of smallpox (Wehrle 1970), the 1990s epidemics of 
classical swine fever (CSF) in Europe (Dewulf 2000; Weesendorp 2008), and the severe acute 
respiratory syndrome (SARS) epidemic in the early 2000s (CDC 2003; Olsen 2003; Public Health 
Agency of Canada 2003; Christian 2004; Yu 2004; Tseng 2005a). Other smaller cases have also 
shown the possibility of aerosol transmission of influenza, adenovirus, Norwalk-like virus (NLV), 
small pox, measles, and mumps (Moser 1979; Marks 2000; Tseng 2005a; Blachere 2009; Yao 
2009; Yee 2009; Goyal 2011; Yang 2011). Serious study of viral aerosol transmission and 
infection started in the 1930s (Sattar 1987). Since then the aerosol transmission capacity of many 
viruses has been tested and proven in experiment. These viruses include adenovirus (Li 2008), 
CSF virus (Weesendorp 2008), coronavirus (Ijaz 1985), Ebola virus (Jaxx 1994), influenza virus 
(Andrews 1941; Hood 1963; Mubareka 2009; Munster 2009; van Hoeven 2009), Newcastle 
disease virus (NDV) (Hopkins 1971), porcine reproductive and respiratory syndrome virus 
(PRRSV) (Kristensen 2004), and severe acute respiratory syndrome (SARS) virus (Booth 2005; 
Chu 2005). 
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Virus transmission in the air includes two modes based on particle size or travelling distance. The 
aerosol mode is for particles smaller than 5 µm in diameter and capable of traveling indefinitely 
long distances in the air (Ijaz 1987; Bridges 2003; Blachere 2009; Memarzadeh 2012). Because 
they are usually dried-out residues of droplets, these particles are called droplet nuclei by some 
researchers (Bridges 2003; Stetzenbach 2004; Wong 2004; Atkinson 2009). Due to the small 
sizes, gravitational force is less dominant than diffusion and advection for their motion. In some 
other studies, the name of droplet nuclei was also used for particles between 5 and 10 µm (Tang 
2006; Xie 2007). However, these larger particles are more involved in shorter range transmissions 
(Mubareka 2009). 
 
It has been reported that particles smaller than 10 µm can be inhaled and retained in the human 
respiratory system. The smaller the particles, the deeper in the system they can reach. Generally, 
particles smaller than 5 µm can reach the lower respiratory tract in lungs, and particles greater 
than 5 μm can be more likely trapped in the upper respiratory tract in nose and throat (Stuart 1973; 
Ijaz 1987; Hinds 1999; Tellier 2006; Shen 2008; Verreault 2008; Atkinson 2009). Possibly due to 
the deep deposition, past studies found that the doses needed by aerosol route infections were 
several orders of magnitude lower than those for nasal route infections (Couch 1966; Ijaz 1987; 
Tellier 2006; Weber 2008). 
 
The other mode of virus transmission in the air is the large droplet mode for particles usually 
much larger than 10 µm in diameter (Weber 2008; Mubareka 2009). These particles usually fall 
to the ground quickly due to the more dominating gravitational effect. They usually travel only a 
few meters in front of the generation point, and cannot easily reach the lower respiratory tract 
(Hatch 1964; Hinds 1999). Viruses travelling in the air in either transmission mode may finally 
deposit on surfaces, potentially causing indirect infection. In fact, for the cases of disease 
infection, it is usually difficult to distinguish each transmission mode (CDC 2003; Munster 2009). 
 
1.2 Objectives and outline of thesis 
Because of the enhanced infectivity and the capability of traveling over long distances while 
being difficult to detect or predict, viral aerosol transmission has become an important focus of 
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research. However, possibly due to the great variety of viruses, the uncertainty of measurement, 
or the differences in test methods, even though a large number of studies have been conducted, 
the data still do not provide conclusive results in many aspects. This study thus aims to contribute 
to the database, and more importantly to uncover unknown or ignored facts related to viral 
aerosol survivability, transmission, and sampling. With this goal in mind, tests were designed to 
size-selectively study different viruses with different temperatures and humidities, with 
ultraviolet germicidal irradiation (UVGI), and with the filters designed for common heating, 
ventilation, and air conditioning (HVAC) systems. All the tests were conducted in an 
environmental chamber with relatively low viral aerosol concentration to simulate a common 
indoor situation. 
 
Particle size is a significant factor for viral aerosol transmission, since it affects the amount of 
virus carried by each particle, the route of travel, and the deposition in the human respiratory 
system. It was recently suggested that more tests are needed to study the particle size effect on 
viral aerosol survival and transmission (Yang 2011). In this study, the Andersen cascade impactor 
(ACI) was used to sample viral aerosols size-selectively. Before studying viral aerosol 
survivability and transmission, the performance of the ACI was first tested for its long-term 
sampling capability. The tests estimated the inactivation of collected viruses in the ACI, and 
determined the suitable sampling duration and other parameters for the rest of the viral aerosol 
tests. 
 
In the second task, viral aerosols were tested under different temperatures and humidities. Not 
only the virus survival under different conditions was studied, the effects of the relative humidity 
and the absolute humidity were also compared. 
 
Viral aerosols were then tested with two UVGI lamps. The inactivation effect of UVGI was 
assessed and compared for the test viruses. To further investigate the UVGI effect, a numerical 
model containing flow field simulation, particle tracking, and UVGI irradiance field simulation 
was developed. With the numerical model, susceptibilities of the test viruses to UVGI were 
quantified and compared with the published data. 
 
4 
 
In the last part of this thesis, viral aerosols were tested with two chemical-free HVAC filters of 
different minimum efficiency reporting values (MERV) using a test duct installed in the 
environmental chamber. Even though the performance of the test filters at their designed 
operating condition could not be evaluated due to the non-standard test condition, the tests could 
still determine whether the filtration efficiency for viruses could be predicted using fluorescein or 
typical particle counters. If the answer is yes, the current filter test standard or data could be 
relied on to predict filter performance for viruses as well, and tedious viral aerosol tests would be 
unnecessary in the future for this purpose. 
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2 Test facility and instruments 
2.1 The environmental chamber 
2.1.1 Background 
In a lab environment, viral aerosol tests can be conducted in a rotating drum, a wind tunnel, or an 
environmental chamber. The rotating drum utilizes slow rotational motion (usually several 
revolutions per minute) to keep viral aerosol suspended and minimize physical loss (Harper 1961; 
Verreault 2008). Temperature and humidity are usually controlled in it as well. In a wind tunnel, 
air flow is one-directional, and is usually strictly controlled. These features make it an ideal 
facility for testing the performance of filters or samplers for viral aerosols (Farnsworth 2006). 
The environmental chamber is either a scaled or a full-size model of an indoor environment, such 
as an office, a hospital ward, or a barn. The temperature, humidity, and ventilation rate can 
usually be adjusted. Various instruments can be placed inside to expand its functionality, or to 
closely simulate a specific situation. Compared with rotating drums and wind tunnels, the aerosol 
concentration in the chamber can be much lower due to the larger volume for aerosol dissipation. 
This means a much larger volume of air may need to be sampled for viral aerosol detection or 
titration. The complex flow field and low concentration both make the environmental chamber an 
ideal test facility to simulate viral aerosol survivability, transmission, and sampling in the field. 
 
2.1.2 Structure and specifications 
Originally built as a half-scale room, the inside of the environmental chamber is 1.95 m (width) 
by 1.95 m (depth) by 1.45 m (height) (FIGURE 2.1.1). Its interior was painted white for better 
illumination. 
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FIGURE 2.1.1 The empty environmental chamber shown without access door, supply air diffuser, return 
air grille, lamps, and other interior components. 
 
A door made of acrylic glass is located on the front wall of the chamber, and is 1.09 m (height) by 
0.57 m (width) (FIGURE 2.1.2). During testing, the door was sealed with rubber gaskets and 
fastened by three clamps. A pressure tap was placed on the door to monitor the negative pressure 
in the chamber during a test to prevent the escape of viral aerosol to the surrounding laboratory 
space. The negative pressure was measured with a Magnehelic differential pressure gauge 
(Dwyer Instruments, Inc., Michigan City, IN) with a range of 0-0.5 inch water (0-124 Pa) and a 
resolution of 0.01 inch water (2.5 Pa). In order to safely manipulate the instruments in the 
chamber during a test, two glove ports with Hypalon gloves were placed on the door. An access 
window between the two gloves was used to retrieve the nebulizer and impactors from the 
chamber after each test when the chamber interior had not been disinfected. The operation of the 
small window strictly followed the requirement for a biosafety level-2 (BSL-2) cabinet in that the 
inward velocity of at least 75 ft/min (0.38 m/s) must be maintained when the window was open. 
A test indicated that the minimum velocity was reached when the negative pressure in the 
chamber was above 0.16 inch water (40 Pa) before the window was opened. For the actual 
operations with the fan running at its maximum speed, the negative pressure was about 0.36 inch 
water (90 Pa). 
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FIGURE 2.1.2 Schematic drawing (left) and photo (right) of the chamber door with two glove ports, an 
access window, and a static pressure tap. 
 
 
FIGURE 2.1.3 Top view of the chamber, showing the main dimensions and positions of round supply 
diffuser, square return grille, recessed light, and two UVGI lamps. 
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The chamber ceiling was built with foam boards covered in plastic sheeting which provided 
thermal insulation (FIGURE 2.1.3). A round supply diffuser (10 in or 25.4 cm diameter) and a 
square return grille (11 in or 27.9 cm side length) were placed on the centerline of the ceiling. A 
recessed light (5 in or 12.7 cm diffuser diameter) was installed to illuminate the chamber interior. 
The light fixture was thermally insulated, and its diffuser was vapor proof. Two linear fluorescent 
UVGI lamps using G25T8 tubes (General Electric) with 1 in (2.5 cm) diameter and 
approximately 17 in (43.2 cm) length were installed for viral aerosol inactivation tests and for 
chamber disinfection after each test as recommended by several studies (Hocking 2000; Booth 
2005; Sze To 2009). The switches for the recessed light and the two UVGI lamps were placed 
outside the chamber. 
 
 
FIGURE 2.1.4 The chamber air handling unit (AHU) for air circulation and conditioning. 
 
In the air handling unit (AHU), PVC pipe and insulated flexible ducts of 6 in (15.2 cm) inside 
diameter (ID) were used to connect a variable speed fan, four HEPA filters, and other air 
conditioning equipment (FIGURE 2.1.4). The fan could provide a maximum volumetric flow rate 
of about 150 ft
3
/min (4250 l/min) to the chamber. The instantaneous chamber air flow rate was 
measured with a nozzle flow meter, which was calibrated using a duct traversing method shortly 
before the viral aerosol tests (ASHRAE 2009). The air flow rate was calculated from the pressure 
drop in the nozzle, which was measured with a Magnehelic differential pressure gauge (Dwyer 
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Instruments, Inc., Michigan City, IN) with a range of 0-5 inch water (0-1244 Pa) and a resolution 
of 0.1 inch water (24.9 Pa). Four HEPA filters in the AHU were placed on top of the chamber, 
and used to capture the viral aerosol generated in the chamber. Two of the HEPA filters were for 
supply and return air. A pre-filter was placed immediately upstream of the return air HEPA filter 
to collect large particles. The other two HEPA filters were used for make-up and breather air 
respectively. During the aerosol tests, these two HEPA filters were sealed otherwise the by-pass 
flow would cause an unknown offset in the measurement of the chamber air flow rate by the 
nozzle flow meter. A certification test was conducted for the four HEPA filters before the viral 
aerosol tests, and no leakage was detected. 
 
 
FIGURE 2.1.5 The piping and equipment for glycol solution for heat exchangers. 
 
To change the temperature of the supply air, heat exchanger coils were installed in the AHU 
(FIGURE 2.1.5). The chamber walls and floor were constructed using plate heat exchangers 
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attached to aluminum plates that formed all the interior surfaces of the chamber except the ceiling. 
The working fluid for all the heat exchangers was a 50% ethylene glycol solution in water. A 
water heater and a water chiller were used to adjust the temperature of the working fluid. Two 
water pumps circulated the working fluid through the heater and chiller separately. Eight ball 
valves on the control panel were used to change the passages for hot and cold flows. Before the 
viral aerosol tests began, the working fluid was replaced, and new filters were installed. The heat 
exchanger coil in the AHU could operate in combination with the downstream electrical heater 
(FIGURE 2.1.4) to dry the air when needed. The electrical heater also provided more precise 
temperature control than using the heat exchanger coil alone. 
 
Type T thermocouples (TFE-T-20, Omega Engineering, Inc., Stamford, CT) were installed on the 
interior surfaces of the walls, ceiling, floor, the UVGI lamps, and at various locations in the AHU 
to monitor temperature. A hygrometer (HX94C, Omega Engineering, Inc., Stamford, CT) was 
installed downstream of the return air HEPA filter to measure both temperature and relative 
humidity. Before the viral aerosol tests began, the thermocouples were calibrated using an ice 
bath. The hygrometer accuracy was checked using saturated salt solutions in a temperature 
controlled container, since it was purchased new with valid factory calibration. The temperature 
and humidity measured by the hygrometer were taken as the average values in the chamber 
environment, and were referred to when the test condition was being monitored. The electrical 
signals from the thermocouples and the hygrometer were picked up by a multimeter (2700, 
Keithley Instruments, Inc., Cleveland, OH) through a multimeter card (7706, Keithley 
Instruments, Inc., Cleveland, OH). The signals were first processed by the multimeter, and then 
transferred to a computer data logging program (Excelinx-1A, Version C04, Keithley Instruments, 
Inc., Cleveland, OH). 
 
2.2 The Collison nebulizer 
In this study, viral aerosols were generated from virus suspensions using a 6-jet modified MRE 
Collison nebulizer (BGI, Inc., Waltham, MA) (FIGURE 2.2.1). The Collison nebulizer was first 
introduced by W. E. Collison as the “inhaler” at a meeting of the British Medical Association in 
1932 (Collison 1935). Detailed descriptions can be found in several publications (May 1973; Ijaz 
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1987; First 1998). The Collison nebulizer generates aerosol from liquid using compressed air. 
During operation, only a small portion of the fluid jets coming out of the nozzles is carried out by 
the compressed air as aerosol; the rest flows back to the jar (May 1973). Depending on the 
composition of the liquid medium, the liquid evaporates over time, causing the solution to 
become more and more concentrated (Chen 2001a; Finley 2001). Evaporation can also lower the 
nebulizer fluid temperature by 5-10 ˚C below ambient due to latent heat (May 1973; Placke 1990). 
The changes in concentration and temperature could gradually change the size distribution of the 
output aerosol, which would be significant for long-term operation (Phipps 1990; Chen 2001a; 
Hogan 2005). The fluid viscosity and compressed air pressure, however, were not found to 
significantly affect aerosol size distribution. Increasing fluid viscosity decreases the recirculation 
rate of the liquid in the jar. Increasing the compressed air pressure increases fluid consumption 
rate, but a small decrease in aerosol concentration at the nebulizer outlet has been observed (May 
1973). 
 
 
FIGURE 2.2.1 The 6-jet Collison nebulizer used in this study. 
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2.3 The Andersen impactor 
2.3.1 The Andersen impactor 
Impactors are among the most common viral aerosol samplers which also include impingers, 
filters, cyclones, and electrostatic precipitators (Grinshpun 1997; Agranovski 2005; Tseng 2005a; 
Verreault 2008; Fabian 2009). In a previous study, the eight-stage non-viable Andersen cascade 
impactor (ACI) (Thermo Scientific, Franklin, MA) (FIGURE 2.3.1) and the micro-orifice 
uniform deposit impactor (MOUDI) (MSP Co., Shoreview, MN) were compared. Both impactors 
were capable of size-selectively sampling viral aerosols, but the ACI achieved higher relative 
recoveries than the MOUDI (Appert 2012). Therefore, the ACI was further tested in the current 
study, and was used to investigate viral aerosol survivability and transmission. The ACI collected 
size-selective samples on eight 80 mm aluminum plates. At its standard sampling flow rate of 1 
ft
3
/min (28.3 l/min), the size range spanned from 0.4 to 10 µm, covering that of droplet nuclei and 
simulating particle deposition in the human respiratory system (TABLE 2.3.1). 
 
 
FIGURE 2.3.1 The eight-stage non-viable Andersen cascade impactor (ACI) used in this study. 
 
TABLE 2.3.1 Size ranges of the Andersen impactor stages at the standard sampling flow rate. 
Impactor stage 0 1 2 3 4 5 6 7 
Lower limit (µm) 9.0 5.8 4.7 3.3 2.1 1.1 0.7 0.4 
Upper limit (µm) 10.0 9.0 5.8 4.7 3.3 2.1 1.1 0.7 
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The ACI has been discussed in several publications (Andersen 1958; Liu 1986; Lodge 1986; 
Hinds 1999; Verreault 2008). In an ACI stage, aerosol is first accelerated in nozzles upstream of 
the collection plate. As the air flow direction is abruptly changed due to the presence of the plate, 
particles which are too large to follow the streamlines impact on the plate and are retained on it. 
With a number of impactor stages arranged in series, size-selective sampling is achieved. In the 
ACI, each following impactor stage in the downstream direction has smaller nozzles, gradually 
increasing the momentum of particles so that smaller particles can be collected. The sampling 
efficiencies of impactors for viral aerosols were generally satisfactory in previous studies 
(Verreault 2008). In dry impactors, the impaction force and desiccation may significantly 
inactivate collected viruses. As a result, an impactor with aqueous medium on the collection 
plates has been used for viral aerosols (Booth 2005). With the development of quantitative PCR, 
however, the inactivated viruses can also be detected and quantified. For long-term sampling, the 
collection plate may be overloaded, resulting in increased particle bounce and decreased sampling 
efficiency (Agranovski 2005). 
 
2.4 Other equipment and test setup 
Most of the test equipment was placed inside the chamber for the viral aerosol tests (FIGURES 
2.4.1-2.4.2). The nebulizer and up to two ACIs were secured on a cart close to the chamber door 
for easy access. The compressed air for the nebulizer was dried, filtered, and regulated outside the 
chamber. Flexible Tygon tubing was attached to the nebulizer outlet for controlling the aerosol 
injection position and direction. For aerosol sampling, a 0.75 HP (0.55 kW) vacuum pump (NT10, 
Oerlikon Leybold Vacuum, Cologne, Germany) was used to draw air through up to two ACIs in 
this study. One mass flow meter (4100, TSI, Inc., Shoreview, MN) was used to monitor the 
sampling flow rate through each ACI. All of the mass flow meters were calibrated regularly 
during the study with a bubble meter (Sensidyne Gilian Gilibrator). Flexible Tygon tubing was 
attached to the inlet of each ACI to control the sampling position and direction. Neutralizers were 
not attached to either the nebulizer or the impactors, since their effect on virus inactivation was 
not known, and might not remain constant over time. One ultrasonic humidifier (Vicks V-
5100NS) and one warm mist humidifier (Duracraft DWM250) were placed on the chamber floor 
to adjust humidity. The vacuum pump, the mass flow meters, and the humidifiers could be turned 
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on or off individually using a power strip with individual switches in the chamber accessible 
through the glove ports. 
 
 
FIGURE 2.4.1 Chamber floor plan with cart, vacuum pump, and two humidifiers. 
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FIGURE 2.4.2 Schematic drawing of the test setup in the environmental chamber. 
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3 Test method and procedure 
3.1 Virus growth and titration 
3.1.1 Challenge Viruses 
Viruses are the smallest infectious agents with size range from about 20 to 300 nm. They usually 
consist of a nucleic acid genome surrounded by a protein coat, and some of them have an outer 
layer called an envelope. Viruses can multiply and are only active within specific host cells (Cox 
1995; Tseng 2005b; Verreault 2008). Six viruses were tested in this study: bacteriophage MS2, 
human adenovirus serotype-1 (HAdV-1), avian influenza virus (AIV), swine influenza virus 
(SIV), avian metapneumovirus (aMPV), and transmissible gastroenteritis virus (TGEV). 
 
Bacteriophage MS2 has often been used as a general surrogate for animal and human viruses for 
its innocuousness and fast analysis (Harstad 1965; Hatch 1969; Trouwborst 1972; Comelis 1982; 
Yahya 1993; van Voorthuizen 2001; Thurston-Enriquez 2003; Cho 2005; Tseng 2005a; Eninger 
2008; Verreault 2008; Lee 2009; Woo 2010; Appert 2012). MS2 is a non-enveloped, single-
stranded RNA (ssRNA) coliphage with a small (25 to 30 nm) round icosahedral capsid. It has no 
tail, and is similar to many pathogenic viruses such as enterovirus, calicivirus, rotavirus, 
poliovirus, rhinovirus, and foot-and-mouth disease (FMD) virus (Cho 2005; Verreault 2008). 
Compared with the five animal viruses tested in this study, the titer of the MS2 stock was about 
5-log higher, which was an advantage for better detection and lower uncertainty. However, as no 
surrogate is perfect, extrapolation of the MS2 results should be made carefully (Tseng 2005a; 
Appert 2012).  
 
HAdV-1 is a non-enveloped virus with a diameter of about 70-100 nm (Kennedy 2009). It is the 
only DNA (double-stranded) virus tested in this study. DNA viruses are usually more stable than 
RNA viruses (Memarzadeh 2012). 
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AIV and SIV are both influenza A viruses. Influenza A viruses are spherical and enveloped 
ssRNA viruses with a diameter of about 80-120 nm. They infect and cause respiratory diseases in 
humans and other animal hosts including birds, horses, whales, and mink (Lamb 1983). Influenza 
A viruses are generally host specific, and rarely cross species barriers. However, pigs are 
postulated to act as a “mixing vessel” for the interspecies transmission of influenza A viruses, 
including human and avian strains, via the process called genetic reassortment (Kida 1994; 
Scholtissek 1994, 1998). Due to the physical and genetic similarities, the avian and swine strains 
could be used as surrogates for human strains (Lamb 1983). The avian strain has also been 
reported to be hardier than human or swine strains (Mitchell 1968, 1972). 
 
The aMPV is responsible for causing respiratory diseases in turkeys and humans. The virus is 
typically spherical with a diameter range from 150 to 200 nm, but is also sometimes non-
spherical with dimensions from 70 to 600 nm. It is an ssRNA virus enveloped with spikes, and 
used as the surrogate for human metapneumovirus and human respiratory syncytial virus (Juhasz 
1994; Dani 1999; Jones 2000; Broor 2007). 
 
TGEV is a coronavirus, which is named for its surface spikes (Spaan 1988; Cavanagh 1994). It is 
an enveloped and spherical ssRNA virus with a diameter range from about 100 to 150 nm 
(including the surface spikes) (Risco 1996). The Purdue strain for pigs used in this study causes 
gastrointestinal infections in pigs (Tajima 1970; Escors 2001), and shares physical and genetic 
similarities to human strains (Lamb 1983; Jackwood 2006). It has been used as a conservative 
surrogate for human severe acute respiratory syndrome (SARS) coronavirus (Casanova 2010). 
 
3.1.2 Preparation of virus stocks 
The host cell and preparation procedure depend on virus type. Classified by virus stock 
preparation method, the six viruses can be divided into two groups: MS2 and the other five 
animal viruses. For MS2, the virus stock preparation procedure was the same as that in Appert 
2012 and Zuo 2013. Briefly, 0.1 ml of MS2 (15597-B1, ATCC) and 1 ml of a log-phase culture 
of E. coli C-3000 (700891, ATCC) were mixed in top agar tubes at 48 ˚C. The mixture was then 
poured on trypticase soy agar (TSA) plates. The top agar was allowed to solidify before the plates 
were inverted and incubated at 37 ˚C for 24 hours. After plaques were confluent (within 24 hours 
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of incubation), 5 ml of tryptic soy broth (TSB) was added to each plate. After 2 hours at room 
temperature, the solution was aspirated, centrifuged at 2500 xg for 15 min, and sterile-filtered. 
The final stock was stored at -80 ˚C in 50 ml aliquots until use. 
 
The procedure of stock preparation was similar for the five animal viruses, but the host cells were 
different: HAdV-1 (VR-1, ATCC) was propagated in 24-hour old A-549 human lung carcinoma 
epithelial cells (CCL-185, ATCC), AIV (2007 Maryland H9N9 strain for chicken) and SIV (2010 
Minnesota H3N2 strain for pigs) were propagated in Madin-Darby canine kidney (MDCK) cells 
(CCL-34, ATCC), aMPV was propagated in Vero cells, and the Purdue strain of TGEV was 
propagated in swine testicular (ST) cells. All these cells were grown in Eagle’s minimum 
essential medium (MEM) (Mediatech, Herndon, VA) supplemented with 8% fetal calf serum, 150 
IU/ml penicillin, 150 µg/ml streptomycin, 50 µg/ml neomycin, and 1 µg/ml fungizone. Cells were 
washed three times with Hanks’ balanced salt solution (pH 7.3) before virus inoculation. After 
inoculation, the virus was allowed to adsorb to the host cells at 37 ˚C for 1 hour. MEM without 
fetal calf serum was added to the cells before the cells were incubated at 37 ˚C and 5% CO2 with 
humidity control. After 4-5 days, when the virus-induced cytopathic effects (CPE) appeared, the 
cells were first processed with three freeze-thaw cycles (−80/+25 ˚C) and then the viruses were 
harvested from the infected cells. Cell debris was removed by centrifugation at 2000 xg for 20 
min. The supernatant was then divided into 50 ml aliquots and stored at -80 ˚C before being 
tested. 
 
3.1.3 Cell-culture based titration for live virus titers 
The live virus titers of MS2 in virus stock and aerosol samples were determined by the double 
agar layer (DAL) procedure (Appert 2012). Briefly, top agar tubes (0.7% TSA) were prepared 
and held in a 48 ˚C water bath. Then, 0.1 ml MS2 sample and 1 ml of log-phase culture of E. coli 
C-3000 (13706, ATCC) were inoculated into each tube. Serial 10-fold dilutions (-1 to -10) of 
each sample were prepared in TSB, and were then added to prepared top agar tubes along with 
the log-phase E. coli. After being gently mixed, and poured onto 1.5% TSA bottom agar plates, 
the top agar was allowed to solidify, then inverted and incubated at 37 ˚C for 24 h. After 
incubation, DAL plates were examined for the appearance of plaques, and the results were 
expressed in plaque forming units per 100 µl (PFU/100 µl) of the sample. The lower detection 
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limit of this method was 1 PFU/100 µl. For any sample below the detection limit, 0.1 PFU/100 µl 
was used when needed. 
 
For titration of the five animal viruses, 100 µl from each sample was taken for serial 10-fold 
dilutions (-1 to -6) in Eagle’s MEM with 8% fetal bovine serum. The dilutions were then added to 
the cell monolayers in 96-well microtiter plates (Nunc, New York) using four wells per dilution. 
The cells were the same as with virus stock preparation. The inoculated cells in plates were 
incubated at 37 ˚C and 5% CO2, and were examined daily with a microscope for five consecutive 
days for the appearance of virus-induced CPE. Virus titers expressed in TCID50/100 µl were 
calculated by the Karber method (Karber 1931). The lower detection limit was 1 TCID50/100 µl. 
If no virus was detected in any sample, 0.1 TCID50/100 µl was used when needed. 
 
3.1.4 Real-time quantitative PCR for total virus concentrations 
A major weakness of some traditional viral aerosol samplers including filters and impactors is 
that a great proportion of the collected virus is inactivated and unculturable. PCR overcomes this 
problem by detecting the nuclei acid which is usually untouched. It has been reported that PCR 
can increase virus detection by 5-log compared with culture based titration. Due to its high 
stability and sensitivity, PCR benefits from longer sampling duration and performs well with low 
concentration samples (van Elden 2001; Whiley 2003; Richt 2004; Farnsworth 2006; Burton 
2007; Li 2008; Verreault 2008; Weesendorp 2008; Yao 2009; Dong 2010; Blachere 2011). 
 
PCR procedures for DNA and RNA viruses were slightly different. For HAdV-1, virus DNA was 
extracted from 200 μl of sample using the QIAamp DNA Mini kit and protocol (Qiagen, Valencia, 
CA). For the other five RNA viruses, virus RNA was extracted from 140 μl of sample using the 
QIAamp viral RNA kit and protocol (Qiagen, Valencia, CA). The DNA/RNA extraction was 
added to 40 μl elution buffer, and stored at -20 ˚C until being quantified with real-time 
quantitative PCR which was performed in a Mastercycler Realplex thermocycler (Eppendorf, 
Hamburg, Germany) using QIAGEN One-Step RT-PCR Kit (Qiagen, Valencia, CA). Forward 
primers, reverse primers, and probes have been described in Spackman 2002 and O’Connell 2006. 
Samples were loaded in a 96-well plate and analyzed in duplicate, each of which contained 3 μl 
of viral RNA/DNA template in the final volume of 20 μl. Standard curves were constructed with 
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serial 10-fold dilutions of DNA/RNA extracted from the virus stock of known titer. For each run 
of PCR, standard curve samples and water were used as positive and negative controls 
respectively. For HAdV-1, the initial cycle of PCR was 50 ˚C preheat for 2 min followed by 95 
˚C heat activation for 15 min. For the five RNA viruses, the initial cycle was 50 ˚C reverse 
transcription for 30 min followed by 95 ˚C heat activation for 15 min. The thermal amplification 
cycle for HAdV-1 was 40 cycles of 95 ˚C for 15 s and 56 ˚C for 45 s. For MS2, it was 40 cycles 
of 95 ˚C for 15 s and 55 ˚C for 45 s. For AIV and SIV, it was 45 cycles of 94 ˚C for 1 s and 60 ˚C 
for 20 s. For aMPV, it was 40 cycles of 94 ˚C for 15 s and 60 ˚C for 45 s. Finally, for TGEV, it 
was 40 cycles of 95 ˚C for 15 s and 60 ˚C for 45 s. After each run of quantitative PCR, a cycle 
threshold (Ct) value for each sample was generated. The amplification efficiency was then 
determined for each sample using the DART-PCR method to correct the raw Ct values (Peirson 
2003). The corrected Ct values were finally projected onto the standard curve to calculate the 
total virus concentrations, which were also expressed in PFU/100 µl for MS2, or TCID50/100 µl 
for the animal viruses. 
 
3.2 Physical loss of virus and fluorescein tracer 
Viral aerosol travelling in the air is subject to both physical and biological losses. Analysis of live 
virus usually underestimates actual viral aerosol survival (Thorne 1992; Yang 2011). By 
measuring physical loss of the viral aerosol, the underestimation could be corrected. Physical loss 
is usually caused by gravitational settling, convection, diffusion, electrostatic attraction, or 
dilution (Harper 1958), and it can be determined in several ways including direct count using a 
microscope or a particle counter. A test virus can also be tagged radioactively for measuring its 
physical loss, but the method needs additional work to address the safety issues. Currently, 
chemical tracers are more commonly used for such purpose. They have been considered 
economical, simple, fast, and reliable by several researchers (Ijaz 1987; Agranovski 2005; 
Verreault 2008). They usually have inert properties and the similar physical loss rates with 
viruses. More importantly, they do not affect the survival and quantification of test viruses 
(Harper 1958, 1961; Ijaz 1987; Sattar1987). 
 
20 
 
In this study, fluorescein was used as the chemical tracer: fluorescein solution was added to the 
nebulizer fluid before each test, and was collected together with the virus samples. For 
measurement, each sample was added to a fused quartz cuvette with 3 ml 0.01N NaOH solution 
in de-ionized and filtered (DIF) water. The cuvettes were then put into a spectroﬂuorometer 
(Model RF-5201PC, Shimadzu Scientiﬁc Instruments, Columbia, MD) one by one to measure the 
fluorescence intensity (FI). FI was measured at 515 nm wavelength after excitation at 485 nm. 
The spectroﬂuorometer was calibrated with solutions of standardized fluorescein concentrations 
before this study. Before evaluating each batch of samples, the spectroﬂuorometer was zeroed 
with a blank made of DI water. The lower detection limit of this method was 0.1 FI. 
 
In this study, the measurement of the total virus (TV) concentration using quantitative PCR was 
theoretically an ideal method to calculate the physical loss of virus, given that the RNA/DNA was 
not damaged significantly. Therefore, both FI and TV were analyzed. The biological loss based 
on each of them was calculated and compared with each other. 
 
3.3 Relative recovery and survival 
As discussed in the previous sections, the total loss of virus in aerosol transmission includes 
physical loss and biological loss (Songer 1967): 
                   
            
               
. (3.3.1) 
 
Total loss could be calculated using live virus (LV) titer. Physical loss could be calculated based 
on either fluorescence intensity (FI) or total virus (TV) concentration, resulting in two biological 
losses calculated for each sample. To differentiate the two, relative recovery is used for the 
biological loss based on FI and survival is used for the biological loss based on TV (Hood 1963; 
Agranovski 2005; Zuo 2013): 
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The nebulizer value in EQUATIONS 3.3.2 and 3.3.3 was the geometric mean of the nebulizer 
samples taken before and after nebulization, namely “pre” and “post”. Because the impactor stage 
concentrations were normalized using a corresponding nebulizer concentration, virus inactivation 
during sample transportation or storage should not affect relative recovery or survival. On the 
other hand, virus inactivation in the chamber, in the impactor, and during the elution process 
contributed to the final relative recovery and survival. As the elution process was standardized in 
this study, the inactivation during elution for each virus could be assumed to be constant. 
 
3.4 Test procedure 
Before each test, fresh virus stock was carried from the -80 ˚C freezer in the Veterinary 
Diagnostics Lab (St Paul, MN) to the Environmental Health Lab in the School of Public Health 
(Minneapolis, MN) to make the nebulizer fluid in a certified biosafety level-2 (BSL-2) cabinet. 
The volume of nebulizer fluid varied depending on test duration, but the proportion of each 
ingredient was constant throughout this study. The ingredients were virus stock, 0.05 g/ml 
fluorescein solution (Fluka, Buchs, Switzerland), and anti-foam Y204 (Sigma Chemical Co., St. 
Louis, MO). The proportion of the three ingredients was 48:1:0.1. After sufficient mixing, a 1 ml 
sample was taken from the nebulizer fluid as “pre”, and was kept in an ice box. A clean nebulizer 
and impactors with clean impaction plates were secured in a biosafety labeled thermal insulated 
foam box, and carried to the environmental chamber in the HVAC lab in the Department of 
Mechanical Engineering (Minneapolis, MN) for the tests. 
 
In the HVAC lab, the chamber air handling unit and data logging system were first started to 
allow for warm-up and necessary adjustment. When the desired test conditions were reached, the 
nebulizer and impactors were taken out of the insulated box, placed in the chamber through the 
access window, connected to the appropriate tubing, and started simultaneously. After the desired 
test duration, the nebulizer and impactors were stopped simultaneously, their exterior surfaces 
wiped with 70% alcohol wipes using the glove ports in the door, removed from the chamber 
through the access window, secured inside the insulated box, and transported back to the 
Environmental Health Lab. 
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Using the biosafety cabinet in the Environmental Health Lab, a 1 ml sample from the nebulizer 
was first taken as “post”. The plates were then removed from the impactors to be eluted with 
elution buffer. The elution buffer stock was prepared by adding 15 g 3x beef extract powder, and 
1.875 g (0.05 M) glycine amino acid (molecular weight 75.07) into 500 ml DIF water. The 
solution was mixed and autoclaved in the Veterinary Diagnostics Lab, and kept at 4 ˚C before use. 
For plate elution, all plates were first removed from the impactors, and placed in petri-dishes. 
Each plate was eluted with 1 ml elution buffer using a clean cell scraper. After having scraped all 
areas at least twice, and removed all visible dots on the plate, the eluate was collected with a 
pipette and transferred to a 1.5 ml Eppendorf tube. A blank Andersen impactor plate served as the 
blank control and was also eluted using the same procedure. The elution process was standardized 
to improve test repeatability. Each sample was divided into two parts: a 50 µl aliquot for 
fluorescein measurement, and the rest for virus titration. The fluorescein part was stored at 4 ˚C in 
the same lab. The remaining samples were transported to the Veterinary Diagnostics Lab in an ice 
box, and stored at -80 ˚C before titration. 
 
Both the biosafety cabinet in the Environmental Health Lab and the environmental chamber in the 
HVAC lab were disinfected after each test. Cell scrapers, impactor plates, petri-dishes, and the 
nebulizer were washed with 1:32 bleach solution, rinsed with DIF water at least twice, and kept in 
a clean pan to dry for the next test. The chamber was disinfected with the UVGI lamps on and the 
ventilation system operating for at least 3 hours. The next test was conducted at least 15-hr after 
the end of the disinfection process. The disinfection effectiveness was verified by leaving several 
stainless steel plates in petri-dishes in the chamber throughout the entire test and disinfection 
process. No live virus was found on any of the plates, indicating that most surfaces were properly 
disinfected. The disinfection effectiveness was also verified by doing a one-hour sampling test 
without aerosol generation and operation of the chamber AHU. No virus was detected in the 
impactor samples, indicating that the air was virus free. A small amount of viruses deposited on 
surfaces might not be inactivated by UVGI due to a blocking effect by equipment or shielding 
effect. A previous study also showed that about 3% to 10% of deposited viruses were protected 
from UVGI (Sagripanti 2011). In order to prevent interference between different types of viruses 
for titration, additional chamber interior disinfection was carried out using bleach spray and 
manual wiping of the interior surfaces after each group of tests for the same virus. Additionally, 
the exterior surfaces of the instruments inside the chamber were wiped with 70% isopropanol 
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wipes, and the washable parts were washed with 1:32 bleach solution. Remaining viruses still not 
inactivated should not be resuspended, or cause any test error in the rest of the study. 
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4 One-hour and six-hour viral aerosol 
sampling tests 
4.1 Introduction 
In a previous study, the ACI collected viral aerosols size-selectively with satisfactory 
concentration and recovery on most impactor stages in 15-minute sampling tests using the same 
viral aerosols (Appert 2012). Before testing the viral aerosol survivability and transmission in the 
environmental chamber, however, it was necessary to know how the ACI would perform in the 
low concentration environment, and how well the collected viruses would survive during the 
long-term sampling. The goal of this group of tests was to resolve the above questions, and to 
determine the proper sampling duration and viruses to be used for the remainder of this study. 
 
4.2 Modification and test of the nebulizer 
During long-term nebulization, the fluid level in the nebulizer dropped continuously, making it 
necessary to adjust the height of the nebulizer nozzle stem periodically for continuous aerosol 
generation. To make this task easier, a modification to the nebulizer was done by attaching six 
flexible plastic tubes to the end of the stem to extend its effective length (FIGURE 4.2.1). This 
modification significantly reduced the frequency of adjustment during a test. However, it could 
also affect the consumption rate of nebulizer fluid, thus the modified nebulizer was tested. 
 
The most important parameter for viral aerosol generation rate from a specified fluid is the 
compressed air pressure. If the pressure is too high, virus could be significantly inactivated due to 
excess stress, or the nebulizer fluid would be used up earlier than the planned test duration. The 
maximum volume in the nebulizer for proper operation was about 150 ml, thus the fluid 
consumption rate should be less than 25 ml/hr for the six-hour tests. A nebulization rate test was 
conducted with the nebulizer fluid identical with viral aerosol tests, except using MEM and TSB 
25 
 
to replace the corresponding virus stock. Each condition was tested five times. With the tubes 
attached, for 10 psi (69 kPa) compressed air, the fluid consumption rate was 15+/-1.5 ml/hr, and 
for 20 psi (138 kPa) the rate was 25+/-2 ml/hr. Without tubes, for 10 psi (69 kPa) the rate was 
11+/-1 ml/hr. Therefore, using 20 psi (138 kPa) may lead to a lack of nebulizer fluid approaching 
the end of a six-hour test, and 10 psi (69 kPa) was chosen for this group of tests. In a previous 
study using the same nebulizer fluid (Appert 2012), 20 psi (138 kPa) was used for 15 minutes of 
nebulization, and no significant inactivation of virus in the nebulizer fluid was found. In another 
study, viral aerosols were generated from the same nebulizer for 10 min using the compressed air 
pressure of 180 kPa, and no significant inactivation of virus was found as well (Ijaz 1987). 
Therefore, virus inactivation due to nebulization stress should also be negligible in this group of 
tests. 
 
 
FIGURE 4.2.1 Modified 6-jet Collison nebulizer with extension tubes used for this study. 
 
In addition, the nebulizer test results showed that the attached tubes increased the fluid 
consumption rate. Although the mechanism is not clear, it is a desirable outcome for the higher 
concentrations preferred in the impactor samples. To make all the test results comparable, the 
tubes were always attached throughout this study. 
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4.3 Test method 
All six viruses (MS2, HAdV-1, AIV, SIV, aMPV, and TGEV) were tested for one and six hours. 
The long test durations offered good challenges to test the impactor’s performance of longer-term 
sampling. 
 
 
FIGURE 4.3.1 The chamber center plane schematic showing the main dimensions and positions of viral 
aerosol injection and sampling. 
 
As shown in FIGURE 4.3.1, viral aerosol was injected 20 cm below the center of the supply 
diffuser and directed toward the left chamber wall. This was to avoid direct movement of the 
injected aerosol toward the return air grille without being circulated in the chamber. Viral aerosol 
was sampled 80 cm above the floor in the downward direction below the return grille. Flexible 
Tygon tubing of 1/2 in (1.27 cm) inside diameter (ID), and 3/4 in (1.91 cm) outside diameter (OD) 
was used to control the positions and directions of aerosol injection and sampling. The length of 
the Tygon tubing used for injection was 55 in (139.70 cm), and that for sampling was 53 in 
(134.62 cm). The Tygon tubing was attached to two spring rods that assisted in positioning them. 
The overall sampling efficiency was estimated to be greater than 85% for impactor stages 3-7 
(0.4-4.7 µm), greater than 90% for impactor stages 4-7 (0.4-3.3 µm), and greater than 95% for 
impactor stages 5-7 (0.4-2.1 µm) (Appendix A). 
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For these tests, the air change rate in the chamber was 15 air changes per hour (ACH), which is 
similar to some typical indoor environments, such as a computer room, a dining room, or an 
examination room in the hospital (Atkinson 2009; Blachere 2009). The chamber volume was 
approximately 6 m
3
, thus the corresponding volumetric flow rate was about 53 ft
3
/min (1500 
l/min). At this ventilation rate, the negative pressure of the chamber environment compared to lab 
was greater than 25 Pa, which was recommended by the American Institute of Architects to 
ensure containment of generated viral aerosol (Garner 1996; AIA 2001). The thermal condition 
was maintained at 25 ˚C with a variation less than 1 ˚C, and 50% RH with a variation less than 
5%. The nebulizer compressed air pressure was 10 psi (69 kPa) as was determined in the previous 
section. The nebulizer fluid volume was 49.1 ml for one-hour tests, and was increased to 147.3 ml 
for the six-hour tests. The proportion among virus stock, fluorescein dye (50 mg/ml), and anti-
foam was always 48:1:0.1 by volume. 
 
The tests were conducted in triplicate, and the test order was randomized. Analysis of uncertainty 
and analysis of variance (ANOVA) were carried out on a logarithmic scale as variance was 
assumed to be log-normally distributed about the mean. ANOVA was performed in R (Version 
2.15.0, the R Foundation for Statistical Computing) to test the significance of the factors 
including virus type, test duration, particle size, and their interactions to responses including 
relative recovery and survival. A factor or an interaction was significant if its p-value was smaller 
than 0.05. Considering accuracy, ANOVA was performed for samples from impactor stages 3-7 
only, as for impactor stages 0-2, their concentrations were much lower, and uncertainties were 
much higher. For the figures, however, the results for all impactor stages are shown whenever 
possible. 
 
4.4 Results and discussion 
4.4.1 Viability analysis of impactor stage samples 
Live virus (LV) titer from the impactor stage samples normalized with respect to the nebulizer 
fluid titer was related to the total loss: 
  
        
         
                . (4.4.1) 
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Size distributions of normalized live virus titer are plotted in FIGURE 4.4.1. The pooled relative 
standard deviations in TABLE 4.1.1 were calculated by assuming that the uncertainty did not 
depend on particle size (Appendix D). From these results, MS2 had the lowest total loss, followed 
by AIV and HAdV-1. These three viruses also had much lower uncertainties than SIV, TGEV, 
and aMPV. To compare the viruses and test durations more clearly, the overall normalized live 
virus titer for all impactor stages for each virus is shown in FIGURE 4.4.2. The p-values for 
normalized live virus titer are shown in TABLE 4.4.2. Virus type, particle size, and test duration 
were all significant factors. No interaction was significant, which means the size distribution of 
live virus did not significantly change with test duration or virus type. 
 
 
FIGURE 4.4.1 Normalized live virus titer (dimensionless, vertical axes) versus particle aerodynamic 
diameter [µm] (horizontal axes) for all six viruses for one-hour and six-hour tests. 
 
TABLE 4.4.1 Pooled relative standard deviation for each data series shown in FIGURE 4.4.1. 
Virus MS2 HAdV-1 AIV SIV TGEV aMPV 
1-hr +100.4% 
-50.1% 
+318.1% 
-76.1% 
+320.4% 
-76.2% 
+1246.8% 
-92.6% 
+1029.2% 
-91.1% 
+848.7% 
-89.5% 
6-hr +130.7% 
-56.7% 
+112.9% 
-53.0% 
+187.5% 
-65.2% 
+2212.4% 
-95.7% 
+3050.5% 
-96.8% 
+467.6% 
-82.4% 
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FIGURE 4.4.2 Overall normalized live virus (LV) titer (dimensionless) for all six viruses for one-hour and 
six-hour tests with error bars showing standard errors. 
 
TABLE 4.4.2 P-values for normalized live virus titer with significant factors in bold. 
Factor Virus Size Duration V:S V:D S:D V:S:D 
P-value <0.001 <0.001 0.001 0.268 0.736 0.916 0.905 
 
Total virus (TV) concentration or fluorescence intensity (FI) of the impactor samples normalized 
with respect to the nebulizer fluid value was related to the physical loss: 
  
        
         
                         . (4.4.2) 
 
For normalized fluorescence intensity, both the size distributions (FIGURE 4.4.3 and TABLE 
4.4.3) and the overall values (FIGURE 4.4.4) were very similar for the test viruses. The 
uncertainties of the normalized fluorescence intensity were much smaller than those of the 
normalized live virus titer. ANOVA (TABLE 4.4.4) shows that, however, virus type was a 
significant factor. By further comparing the viruses, MS2 was significantly different from HAdV-
1 (p=0.001), but the other four animal viruses were not (p=0.527 for AIV, 0.979 for SIV, 0.166 
for TGEV, and 0.142 for aMPV). The interaction between virus type and particle size was not 
significant, meaning that the particle size distribution was not significantly affected by virus type 
for particles smaller than 4.7 µm. However, it seems from FIGURE 4.4.3 that the five animal 
viruses had similar particle size distributions, but MS2 was a slightly different, especially for 
impactor stages 0-2 (>4.7 µm), which were not considered in ANOVA. The differences between 
MS2 HAdV-1 AIV SIV TGEV aMPV 
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MS2 and the animal viruses could be due to the different types of suspension media, as TSB was 
used for MS2, while MEM was used for the animal viruses. For the five animal viruses, virus 
type did not seem to affect either particle size distribution or overall particle size as concluded in 
some past studies (Ijaz 1987; Xu 2003; Hogan 2005). 
 
 
FIGURE 4.4.3 Normalized fluorescence intensity (dimensionless, vertical axes) versus particle 
aerodynamic diameter [µm] (horizontal axes) for all six viruses for one-hour and six-hour tests. 
 
TABLE 4.4.3 Pooled relative standard deviation for each data series shown in FIGURE 4.4.3. 
Virus MS2 HAdV-1 AIV SIV TGEV aMPV 
1-hr +31.1% 
-23.7% 
+42.6% 
-29.9% 
+44.0% 
-30.5% 
+17.7% 
-15.0% 
+12.9% 
-11.4% 
+11.2% 
-10.1% 
6-hr +48.6% 
-32.7% 
+67.0% 
-40.1% 
+8.5% 
-7.9% 
+8.5% 
-7.8% 
+14.5% 
-12.6% 
+18.8% 
-15.8% 
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FIGURE 4.4.4 Overall normalized fluorescence intensity (FI) (dimensionless) for all six viruses for one-
hour and six-hour tests with error bars showing standard errors. 
 
TABLE 4.4.4 P-values for normalized fluorescence intensity with significant factors in bold. 
Factor Virus Size Duration V:S V:D S:D V:S:D 
P-value <0.001 <0.001 <0.001 0.373 0.829 <0.001 0.989 
 
Particle size and test duration were both significant factors for normalized fluorescence intensity 
as expected. No interactions were significant except for that between particle size and test 
duration, meaning that the particle size distribution was different for one-hour and six-hour tests. 
To help explain this, the normalized fluorescein size distributions for both test durations are 
plotted in FIGURE 4.4.5 using the data for all the viruses. The normalized particle size 
distributions were calculated by normalizing the fluorescence intensity of each impactor stage by 
the sum of all impactor stage values. The figure shows that the particle size distributions for the 
six-hour tests were more uniform than those for the one-hour tests according to the lower peak on 
impactor stage 5. One possible reason was that the aerosol collected on impactor stage 5 in the 
six-hour tests overloaded the collection plate as stated in Agranovski 2005. Plate overloading 
caused the unevenness on its surface, and could negatively affect its collection efficiency. During 
the elution process, the unevenness was observed in the six-hour test samples. Another possibility 
could be that the size distribution of the generated aerosol from the nebulizer changed over time, 
as the nebulizer fluid was gradually concentrated. 
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FIGURE 4.4.5 Fluorescence intensity (FI) distribution (per impactor stage) plotted with data of all six 
viruses (labels not shown) for one-hour and six-hour tests. 
 
TABLE 4.4.5 Pooled relative standard deviation for each virus and test duration in FIGURE 4.4.5. 
Virus MS2 HAdV-1 AIV SIV TGEV aMPV 
1-hr +19.4% 
-16.2% 
+24.2% 
-19.5% 
+28.7% 
-22.3% 
+11.9% 
-10.6% 
+8.5% 
-7.8% 
+6.6% 
-6.2% 
6-hr +46.5% 
-31.8% 
+57.7% 
-36.6% 
+8.9% 
-8.2% 
+3.9% 
-3.7% 
+7.0% 
-6.5% 
+9.1% 
-8.4% 
 
The results of normalized total virus concentration are presented in the same way as for live virus 
titer and fluorescence intensity in FIGURES 4.4.6-4.4.7 and TABLES 4.4.6-4.4.7. From ANOVA 
(TABLE 4.4.7), virus type was a significant factor. It is the same as the normalized fluorescence 
intensity result: when compared with HAdV-1, MS2 was significantly different (p<0.001), but the 
other viruses were not (p=0.244 for AIV, 0.928 for SIV, 0.460 for TGEV, and 0.464 for aMPV). 
From the size distributions (FIGURE 4.4.6 and TABLE 4.4.6), it can be seen that the physical 
loss of MS2 was smaller than those of the five animal viruses for all impactor stages. This was 
different than the fluorescein result where MS2 had smaller losses only for the larger particles. By 
comparing FIGURES 4.4.6 and 4.4.3, it can be seen that the physical losses of MS2 were not very 
different, while for the five animal viruses their physical losses calculated using total virus were 
greater than those calculated using fluorescein, indicating that the actual physical loss of virus 
may not be accurately represented by fluorescein, and the accuracy would be lower for larger 
viruses. For the other ANOVA results (TABLE 4.4.7), particle size and test duration were both 
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significant factors as expected. No interactions were significant, meaning that the size distribution 
for particles smaller than 4.7 µm was not significantly affected by either virus type or test 
duration. In contrast with the fluorescein result, the decrease in collection efficiency on impactor 
stage 5 was not significant, probably due to the greater uncertainty associated with the PCR 
measurements. 
 
 
FIGURE 4.4.6 Normalized total virus concentration (dimensionless, vertical axes) versus particle 
aerodynamic diameter [µm] (horizontal axes) for all six viruses for one-hour and six-hour tests. 
 
TABLE 4.4.6 Pooled relative standard deviation for each data series shown in FIGURE 4.4.6. 
Virus MS2 HAdV-1 AIV SIV TGEV aMPV 
1-hr +57.7% 
-36.6% 
+105.3% 
-51.3% 
+139.8% 
-58.3% 
+69.1% 
-40.9% 
+80.6% 
-44.6% 
+49.9% 
-33.3% 
6-hr +147.0% 
-59.5% 
+87.4% 
-46.6% 
+162.7% 
-61.9% 
+147.4% 
-59.6% 
+55.4% 
-35.6% 
+61.0% 
-37.9% 
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FIGURE 4.4.7 Overall normalized total virus (TV) concentration (dimensionless) for all six viruses for 
one-hour and six-hour tests with error bars showing standard errors. 
 
TABLE 4.4.7 P-values for normalized total virus concentration with significant factors in bold. 
Factor Virus Size Duration V:S V:D S:D V:S:D 
P-value <0.001 <0.001 <0.001 0.189 0.183 0.699 0.049 
 
Based on live virus titer, total virus concentration, and fluorescence intensity for all viruses, stage 
5 (1.1-2.1 µm) of the Andersen impactor collected about 40% of the total amount collected, and 
impactor stages 3-7 (0.4-4.7 µm) collected more than 95%, indicating that the most particles 
collected were small droplet nuclei that could be inhaled and retained in the lower tract of the 
human respiratory system. This size distribution is similar to some previous studies (Yang 2011; 
Appert 2012). 
 
MS2 HAdV-1 AIV SIV TGEV aMPV 
1 hr 1.49E-01 2.69E-02 3.93E-02 2.92E-02 2.70E-02 4.95E-02 
6 hr 9.06E-01 1.54E-01 1.47E-01 1.03E-01 8.58E-02 2.39E-01 
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FIGURE 4.4.8 Relative recovery (dimensionless, vertical axes) versus particle aerodynamic diameter [µm] 
(horizontal axes) for all six viruses for one-hour and six-hour tests. 
 
TABLE 4.4.8 Pooled relative standard deviation for each data series shown in FIGURE 4.4.8. 
Virus MS2 HAdV-1 AIV SIV TGEV aMPV 
1-hr +96.0% 
-49.0% 
+320.1% 
-76.2% 
+457.8% 
-82.1% 
+1208.3% 
-92.4% 
+1030.9% 
-91.2% 
+797.4% 
-88.9% 
6-hr +133.6% 
-57.2% 
+90.8% 
-47.6% 
+197.0% 
-66.3% 
+2093.6% 
-95.4% 
+2911.6% 
-96.7% 
+521.1% 
-83.9% 
 
Relative recovery and survival were calculated by isolating physical loss from total loss as 
discussed in Chapter 3. For relative recovery, size distributions are plotted in FIGURE 4.4.8 with 
the uncertainties given in TABLE 4.4.8. Overall relative recovery calculated using the sum of live 
virus titer and sum of fluorescence intensity from all impactor stages is plotted in FIGURE 4.4.9. 
The corresponding ANOVA p-values are listed in TABLE 4.4.9. For survival, corresponding 
plots and tables are presented in FIGURES 4.4.10-4.4.11 and TABLES 4.4.10-4.4.11. 
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FIGURE 4.4.9 Overall relative recovery (dimensionless) for all six viruses for one-hour and six-hour tests 
with error bars showing standard errors. 
 
TABLE 4.4.9 P-values for relative recovery with significant factors in bold. 
Factor Virus Size Duration V:S V:D S:D V:S:D 
P-value <0.001 <0.001 0.001 0.367 0.814 0.757 0.911 
 
ANOVA results were similar for relative recovery and survival. Virus type was significant; MS2, 
HAdV-1, and AIV were higher in both parameters than SIV, TGEV, and aMPV. Test duration 
was significant; the one-hour tests showed higher relative recovery and survival results than the 
six-hour tests, showing obvious virus inactivation in the impactor. Particle size was also 
significant. It can be seen from FIGURES 4.4.8 and 4.4.10 that both parameters of the animal 
viruses tended to decrease with the increasing particle size. The trend, however, was not obvious 
for MS2. This difference agrees with Appert 2012. No interaction between the above factors was 
significant, showing that the size distributions of either relative recovery or survival were similar 
for all viruses and both test durations. By comparing FIGURES 4.4.9 and 4.4.11, it can be seen 
that except for MS2, virus survival was generally greater than relative recovery. This was because 
that the same physical loss measured with total virus was greater than that measured with 
fluorescein. The discrepancy might depend on virus size. 
 
MS2 HAdV-1 AIV SIV TGEV aMPV 
1 hr 5.31E-01 1.01E-01 2.24E-01 1.17E-02 5.55E-03 2.58E-02 
6 hr 1.89E-01 4.78E-02 1.01E-01 5.76E-03 1.97E-03 1.01E-02 
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FIGURE 4.4.10 Survival (dimensionless, vertical axes) versus particle aerodynamic diameter [µm] 
(horizontal axes) for all six viruses for one-hour and six-hour tests. 
 
TABLE 4.4.10 Pooled relative standard deviation for each data series shown in FIGURE 4.4.10. 
Virus MS2 HAdV-1 AIV SIV TGEV aMPV 
1-hr +122.3% 
-55.0% 
+490.4% 
-83.1% 
+526.0% 
-84.0% 
+1085.2% 
-91.6% 
+1482.7% 
-93.7% 
+671.0% 
-87.0% 
6-hr +320.1% 
-76.2% 
+200.1% 
-66.7% 
+371.7% 
-78.8% 
+1233.2% 
-92.5% 
+2395.0% 
-96.0% 
+317.1% 
-76.0% 
 
In order to evaluate virus inactivation in the impactor, six-hour to one-hour ratios were calculated 
for normalized live virus titer, normalized total virus concentration, normalized fluorescence 
intensity, relative recovery, and survival (FIGURE 4.4.12.). All ratios were calculated based on 
all viruses collected in the impactor. For normalized fluorescence intensity, the mean ratio for 
MS2 was 5.20 with a standard error of +0.61/-0.54. The ratio for the five animal viruses was 5.12 
(+0.45/-0.41). For normalized total virus concentration, the ratio for MS2 was 6.08 (+1.73/-1.35), 
and for the five animal viruses was 4.11 (+0.72/-0.61). Ideally the ratios of normalized total virus 
concentration and normalized fluorescence intensity should be close to 6. However, as the actual 
ratios were generally close to 5, the aerosol collection rate of the Andersen impactor was 
decreasing during a test. The reason could be the decrease of the aerosol generation rate, the 
sampling efficiency, or both. The ratio of the normalized total virus concentration of the five 
animal viruses was lower than that for MS2 and that for normalized fluorescence intensity, 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.E-06
1.E-04
1.E-02
1.E+00
1.E+02
0.1 1 10
1.E-06
1.E-04
1.E-02
1.E+00
1.E+02
0.1 1 10
6-hr 1-hr 
 
 
 
1.E-06
1.E-04
1.E-02
1.E+00
1.E+02
0.1 1 10
1.E-06
1.E-04
1.E-02
1.E+00
1.E+02
0.1 1 10
6-hr 1-hr 
Survival 
38 
 
showing that the nebulizer output might have decreased faster for the five animal viruses. The 
decrease rate possibly depended on virus size. 
 
 
FIGURE 4.4.11 Overall survival (dimensionless) for all six viruses for one-hour and six-hour tests with 
error bars showing standard errors. 
 
TABLE 4.4.11 P-values for survival with significant factors in bold. 
Factor Virus Size Duration V:S V:D S:D V:S:D 
P-value <0.001 <0.001 0.014 0.263 0.835 0.841 0.395 
 
Given that inactivation of virus in the nebulizer fluid can be neglected, as will be proven in the 
next section, and if no significant inactivation occurs in the impactor, the live virus ratio should 
be comparable to the total virus ratio. On the other hand, if all virus collected was inactivated 
within one hour, the ratio could be slightly smaller than unity, considering the decrease in 
collection rate over time. In this study, the ratios of normalized live virus titer for the six viruses 
were lower than those of normalized total virus concentration and greater than unity, indicating 
virus inactivation in the impactor, but the collected viruses remained infectious longer than one 
hour. Inactivation can also be seen from the ratios of relative recovery and survival, which are 
very similar in value, and generally lower than one. For the six viruses, the relative recovery or 
survival for the six-hour tests are about 30%-60% of that for the one-hour tests. Due to large 
uncertainties, however, more tests are needed to determine which virus was inactivated faster or 
slower. The comparison of one-hour and six-hour results shows that due to significant virus 
inactivation in the dry impactor, when detecting viruses with the Andersen impactor, PCR could 
MS2 HAdV-1 AIV SIV TGEV aMPV 
1 hr 3.67E-01 3.01E-01 5.71E-01 3.12E-02 2.02E-02 5.36E-02 
6 hr 1.12E-01 1.52E-01 3.15E-01 2.20E-02 1.12E-02 2.16E-02 
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benefit from longer sampling duration, but live virus titration may not. As a result of this 
investigation, one-hour tests were conducted for the rest of this study. 
 
 
FIGURE 4.4.12 Ratios (dimensionless) of six-hour results over one-hour results for overall normalized 
fluorescence intensity (Norm FI), normalized total virus (Norm TV) concentration, normalized live virus 
(Norm LV) titer, relative recovery (RR), and survival for each virus with error bars showing standard errors. 
 
Virus inactivation rate in the impactor could not be estimated with surface tests, since the virus on 
a collection plate is subjected to continuous impaction, and is covered and shielded by newly 
collected material. However, the inactivation curve could be solved by conducting tests with 
different sampling durations. For the same virus with the same test conditions and procedure, but 
different sampling durations, the inactivation rates in the airborne state and during the elution 
process could be considered a constant. For the other processes including transportation and 
storage, relative recovery or survival should not be affected as the same inactivation rate should 
apply to both impactor and nebulizer samples. As a result, differences in relative recovery and 
survival would be solely due to the virus inactivation in the impactor for different sampling 
durations. Large propagated uncertainties as shown in FIGURE 4.4.12, however, could be a 
MS2 HAdV-1 AIV SIV TGEV aMPV 
Norm FI 5.20 6.10 4.60 5.07 5.00 4.96 
Norm TV 6.08 5.75 3.75 3.53 3.17 4.84 
Norm LV 1.85 2.90 2.07 2.49 1.77 1.95 
0.1 
1 
10 
MS2 HAdV-1 AIV SIV TGEV aMPV 
RR 0.36 0.48 0.45 0.49 0.35 0.39 
Survival 0.30 0.51 0.55 0.71 0.56 0.40 
0.1 
1 
10 
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major problem when utilizing this method. Therefore, more repeats and improved virus analysis 
techniques especially for live virus titration are desirable. 
 
4.4.2 Inactivation of virus in the nebulizer 
Evaporation during nebulization gradually concentrates the nebulizer fluid. The effect can be 
calculated by dividing the “post” concentration with the “pre”. The ratio of fluorescein for the 
one-hour tests was 1.11 with a standard error of 0.04. For the six-hour tests, the ratio was 1.21+/-
0.06. The ratio did not significantly depend on the virus type (p=0.481) or test duration (p=0.105) 
by ANOVA, but based on the mean value, the evaporation effect seemed to be more obvious in 
the six-hour tests. 
 
In order to check virus inactivation in the nebulizer, γ was calculated using live virus (LV) titer 
and fluorescence intensity (FI) as defined in Appert 2012: 
   
 
  
  
     
 
  
  
    
 
 
    
   
   
 
    
   
   
. (4.4.3) 
If inactivation was significant during nebulization, γ should be smaller than unity. From ANOVA, 
γ did not significantly depend on the virus type (p=0.887) or test duration (p=0.663). Its average 
was 1.12 with a 95% confidence interval from 0.89 to 1.40, which means the virus inactivation 
during the nebulization process was not significant up to six hours of nebulization with 10 psi (69 
kPa) compressed air. 
 
TABLE 4.4.12 Concentration ratios and γ calculated based on total virus instead of fluorescein. 
Evaporation 
1-hour post/pre (standard error) 6-hour post/pre (standard error) Virus p-value Time p-value 
1.27 (+0.12/-0.11) 1.32 (+0.13/-0.12) 0.320 0.490 
Inactivation 
γ [95% confidence interval] Virus p-value Time p-value 
0.98 [0.80, 1.20] 0.847 0.634 
 
The same process of evaluating evaporation and virus inactivation in the nebulizer was performed 
using total virus instead of fluorescein, and the same conclusion was reached (TABLE 4.4.12). 
The concentration ratios based on total virus were greater than those based on fluorescein, 
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suggesting that the nebulization of fluorescein was faster. This should be one of the reasons 
causing the different physical losses between total virus and fluorescein. In the next tests for 
temperature, humidity, and UVGI effects, 10 psi (69 kPa) compressed air was used with one-hour 
of nebulization, thus the virus inactivation during the nebulization process could still be neglected. 
 
4.5 Conclusions 
MS2, HAdV-1, AIV, SIV, aMPV, and TGEV were size-selectively sampled with the ACI for one 
and six hours. The ACI collected detectable virus on most stages at the current test settings for 
one-hour sampling. Six hour samples did not show much higher live virus titers than one-hour 
samples, suggesting that inactivation of virus in the impactor was significant. For field tests using 
dry impactor plates, longer sampling durations may not lead to better live virus detection, thus 
PCR for total virus detection is recommended. 
 
In the impactor samples, more than 95% of the collected aerosol by mass was smaller than 4.7 
µm, and about 40% was collected on impactor stage 5 (1.1-2.1 µm). Thus most particles collected 
were in the region of small droplet nuclei, which can be inhaled and retained in the lower tract of 
the human respiratory system. The size distribution slightly depended on suspension medium. In 
the six-hour tests, the impactor collection efficiency may have decreased due to overloading 
especially for impactor stage 5. This could be seen from the change in size distribution of 
fluorescence intensity, and should be noted for long-term sampling. 
 
For MS2, the physical loss measured using fluorescein was similar to that measured using total 
virus. For the other five viruses, however, physical loss measured using total virus was greater. 
Therefore, the actual physical loss of virus may not be accurately represented by fluorescein, and 
the discrepancy may depend on virus size, since MS2 is much smaller than the five animal 
viruses. Virus type was not significant for particle size distribution based on the five animal 
viruses. 
 
In Appert 2012, MS2, HAdV-1, and TGEV had higher relative recovery than AIV and SIV. In 
this study, the relative recovery of AIV was similar to that of MS2 or HAdV-1, and higher than 
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that of SIV, TGEV, or aMPV, among which TGEV had the lowest relative recovery. The reason 
for this difference is not clear yet, given that virus sources, preparation, and analysis were the 
same for the two studies. The current results also show that MS2, HAdV-1, and AIV had higher 
survival and lower uncertainty than SIV, TGEV, and aMPV. Therefore, only MS2, HAdV-1, and 
AIV were further tested in this study. 
 
For MS2, the relative recovery and survival were similar for aerosol sizes from 0.4 to 10 µm, but 
for the five animal viruses, a decrease in relative recovery and survival was observed as the 
particle size increased. The reason is possibly the lower concentration or higher uncertainty for 
the larger particle sizes for the five animal viruses. 
 
Using 10 psi (69 kPa) compressed air for up to six hours did not significantly inactivate virus in 
the nebulizer suspension. Although not statistically conclusive, the evaporation effect appeared to 
be more significant for six-hour tests than one-hour tests. Viruses were concentrated faster than 
fluorescein in the nebulizer fluid, suggesting the nebulization of fluorescein was faster. This 
should be one of the reasons leading to the different physical losses measured using total virus 
and using fluorescein. 
 
For future work, more repeats and test durations are recommended to reduce uncertainties, and to 
determine the inactivation rate as a function of time for the collected viruses in the impactor. 
Improvement in the method of live virus titration is desirable as it was the main contributor to the 
uncertainties of relative recovery and survival. 
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5 Viral aerosol tests at different temperatures 
and humidities 
5.1 Background 
For viral aerosols, higher temperature generally results in lower survival (Harper 1961; Mbithi 
1991; Farnsworth 2006; Zuk 2009; McDevitt 2010; Memarzadeh 2012), but the vulnerability to 
high temperature can be different for different viruses. For adenovirus, a previous study found 
that its survival was stable between 4 and 36 ˚C, and was significantly lower at higher 
temperatures (Ginsberg 1956). A more recent study showed that its infectivity dropped 
dramatically at temperatures above 29 ˚C (Li 2008). Relative humidity (RH) is another significant 
factor that affects viral aerosol survival and transmission. RH affects the amount of water in the 
aerosol. Some studies reported that RH had an effect on the aerosol size distribution (Lowen 2007; 
Verreault 2008), but others did not find significant changes for the RH range from 30% to 80% 
(Ijaz 1987; Peccia 2001a). For viral aerosol survival, unlike temperature, the RH effect is more 
complex, and depends on virus type (Akers 1969, 1973; Benbough 1971; de Jong 1973; 
Farnsworth 2006; Verreault 2008). Generally, lipid viruses (influenza viruses, aMPV, and TGEV) 
have higher survival at lower RH (< 30%), and non-lipid viruses (adenovirus) are more stable at 
higher RH (> 70%) (Benbough 1971; de Jong 1973; Mohr 1991; Cox 1995; Assar 2000; 
Farnsworth 2006; Tang 2009; McDevitt 2010). This generalization is based on a number of 
observed cases, but exceptions exist (Mbithi 1991). As viral aerosol inactivation depends on 
humidity and virus lipid coating, it has been proposed that the inactivation might be due to stress 
at the air-water interface, but not the toxicity of concentrated salt solution in the aerosol droplet 
(Dubovi 1970; Trouwborst1973; Sattar 1987; Casanova 2010). The virus survival response to RH 
also depends on suspension ingredients, especially the content of salts, proteins, and polyhydroxy 
(Harper 1963; Webb 1963; Akers 1969, 1973; Rechsteiner 1969; Dubovi 1970; Benbough 1969, 
1971; de Jong 1973; Trouwborst 1973; Schaffer 1976; Cox 1995; Appert 2012; Yang 2012). 
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In previous studies, MS2 aerosol generally had highest survival at RH lower than 30%, lowest 
survivability near 60% RH, and increasing survivability at RH greater than 60% (Dubovi 1970; 
Trouwborst1973; Woo 2010). For some suspensions, such as tryptone, the recoveries at all RH 
levels were similar (Dubovi 1970). MS2 in TSB, which was the same as the current study, was 
found to have the highest relative recovery at 50% compared with results at 15% and 85% 
(Appert 2012). Adenovirus was reported to be more stable at high RH than low RH, and was 
most stable at RH above 80% (Harper 1961; Miller 1967; Davis 1971; Appert 2012). HAdV-1 in 
MEM had the lowest relative recovery at 50% RH compared with 15% and 85% RH (Appert 
2012). Influenza A virus was reported to survive better at RH lower than 40%, and have higher 
inactivation at higher RH (Loosli 1943; Hemmes 1960; Harper 1961; Buckland 1962; de Jong 
1964, 1973; Tellier 2006; Zuk 2009; McDevitt 2010). Some other studies showed that influenza 
A virus had the lowest recovery at about 50% RH, the highest recovery at low RH, and moderate 
recovery at high RH (Shechmeister 1950; Hood 1963; Schaffer 1976; Yang 2012). In Appert 
2012, the relative recovery of AIV in MEM was lowest at 50% RH, highest at 85%, and moderate 
at 15%. It was also reported that both extremely low and high RH could reduce the survival of 
influenza A virus (Memarzadeh 2012). One reason for the different findings might be the 
different virus suspensions. 
 
Interaction between temperature and RH has been discussed for viral aerosol survival and 
transmission (Tang 2009; Zuk 2009). Some studies suggested that absolute humidity (AH) might 
be a better predictor than RH for the survival, transmission, and seasonality of influenza viruses, 
and using AH could eliminate the interaction term between temperature and humidity. Generally, 
as AH increases at a constant temperature, the survival or transmission of influenza virus was 
found to decrease exponentially (Shaman 2009, 2010; McDevitt 2010; Memarzadeh 2012). 
However, one study on the seasonality of influenza A virus reached the opposite conclusion that 
temperature and RH were significant factors, while AH was not (Tang 2010). Therefore, further 
tests on the effect of AH are still needed for influenza viruses as well as for other types of viruses. 
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5.2 Test method 
Based on the capacity of the chamber AHU, MS2, HAdV-1, and AIV were tested at five thermal 
conditions chosen for at least two levels of temperature, RH, and AH (FIGURE 5.2.1 and TABLE 
5.2.1). For each condition, the temperature variation was kept below 1 °C, and RH variation 
below 5%. The chamber was always operated isothermally, which means the heat exchangers in 
the chamber walls and in the AHU were run at the same temperature. This was to keep the flow 
fields, particle trajectories, and residence times for different test conditions comparable. 
 
 
FIGURE 5.2.1 Five thermal and moisture conditions tested for MS2, HAdV-1, and AIV aerosols. 
 
TABLE 5.2.1 Five thermal conditions tested for MS2, HAdV-1, and AIV aerosols. 
Condition I II III IV V 
Temperature [˚C] 25 25 25 30 30 
RH [%] 38 50 66 38 50 
AH [g/m3] 8.8 11.5 15.2 11.5 15.2 
 
AH is the actual water vapor content in the air, or the mass of vapor content (mv [g]) per volume 
of air (Va [m
3
]): 
    
  
  
. (5.2.1) 
To calculate AH, saturated vapor pressure (ps [Pa]) needs to be calculated first from absolute 
temperature (T [K]) (Hyland 1983): 
             
          
 
   
 . (5.2.2) 
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TABLE 5.2.2 Values of the coefficients in EQUATION 5.2.2 for saturated vapor pressure. 
C0 C1 C2 C3 C4 C5 C6 
-5.80022e3 1.39150 -4.86402e-2 4.17648e-5 -1.44521e-8 0 6.54597 
 
EQUATION 5.2.2 is valid for the temperature range between 0 and 200 ˚C, which fully covers 
that of the chamber tests. Then, vapor pressure (pv [Pa]) can be determined using the definition of 
RH for an ideal gas: 
         . (5.2.3) 
Finally, AH in kg/m
3
 can be calculated using the ideal gas law, given that the molar mass of water 
vapor (Mv) is 18.015e-3 kg/mol, and the universal gas constant (R) is 8.314 J/(mol K): 
    
  
  
 
    
  
. (5.2.4) 
 
In this study, AH is given in g/m
3
 as normally found in the literature. In some publications, AH 
could be expressed as specific humidity (SH) or humidity ratio which is the vapor mass per unit 
dry air mass [kg/kg], or as vapor pressure (VP) [mbar]. The values in different units for the tested 
humidity levels are listed in TABLE 5.2.3. 
 
TABLE 5.2.3 AH levels tested in the current study expressed in various common units. 
AH [g/m3] 8.8 11.5 15.2 
SH [kg/kg] 0.008 0.010 0.013 
VP [mbar] 12.1 15.7 20.7 
 
The test setup, including aerosol injection, sampling, and chamber ventilation rate was the same 
as the previous one-hour tests. The tests were conducted in triplicate with randomized order for 
each virus. ANOVA was carried out on a logarithmic scale for impactor stages 3-7 (0.4-4.7 µm) 
to test the significance of temperature, RH, AH, and their interactions for responses including 
relative recovery and survival. 
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5.3 Results and discussion 
Normalized live virus titer versus particle aerodynamic diameter was plotted for each virus and 
test condition in FIGURE 5.3.1. One uncertainty was obtained for each virus by assuming it did 
not significantly depend on particle size, temperature, or humidity (TABLE 5.3.1). The overall 
normalized live virus titers are shown in FIGURE 5.3.2. 
 
 
FIGURE 5.3.1 Normalized live virus titer (dimensionless, vertical axes) versus particle aerodynamic 
diameter [µm] (horizontal axes). Temperature [˚C], RH [%], and AH [g/m3] are respectively used in the 
data series’ names. 
 
TABLE 5.3.1 Pooled relative standard deviation for each virus in FIGURE 5.3.1. 
Virus MS2 AIV HAdV-1 
Relative standard deviation +167.7%/-62.6% +271.9%/-73.1% +135.7%/-57.6% 
 
ANOVA was carried out with two models. One consisted of virus type, particle size, temperature, 
and RH. The other used AH instead of RH. The p-values of the two models are listed in TABLE 
5.3.2. Virus was a significant factor; in FIGURE 5.3.2, MS2 had lowest total loss, and HAdV-1 
had the highest. Particle size was significant as expected. Temperature was significant; all three 
viruses seemed to have greater total losses at the higher temperature, but the difference was not as 
obvious for HAdV-1 as for MS2 and AIV, which was reflected in the significant interaction 
between virus and temperature. Neither RH nor AH was significant. 
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FIGURE 5.3.2 Overall normalized live virus (LV) titer (dimensionless) with error bars showing standard 
errors. Temperature [˚C], RH [%], and AH [g/m3] are respectively used in the data series’ names. 
 
TABLE 5.3.2 P-values for normalized live virus titer with significant factors in bold. 
Factor Virus Size Temp RH V:S V:T S:T V:R S:R T:R 
P <0.001 <0.001 <0.001 0.117 0.108 0.018 0.077 0.297 0.099 0.877 
Factor Virus Size Temp AH V:S V:T S:T V:A S:A T:A 
P <0.001 <0.001 <0.001 0.528 0.108 0.020 0.077 0.252 0.177 0.074 
  
 
FIGURE 5.3.3 Normalized fluorescence intensity (dimensionless, vertical axes) versus particle 
aerodynamic diameter [µm] (horizontal axes). Temperature [˚C], RH [%], and AH [g/m3] are respectively 
used in the data series’ names. 
 
Physical loss versus particle size measured with fluorescein for each virus and condition is shown 
in FIGURE 5.3.3. By assuming that the uncertainty did not significantly depend on virus type, 
particle size, and thermal condition, one pooled relative standard deviation was calculated for all 
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the data points in FIGURE 5.3.3, and the result was +33.2%/-24.9%. The overall normalized 
fluorescence intensities for each virus are shown in FIGURE 5.3.4. The p-values are listed in 
TABLE 5.3.3. 
 
 
FIGURE 5.3.4 Overall normalized fluorescence intensity (FI) (dimensionless) with error bars showing 
standard errors. Temperature [˚C], RH [%], and AH [g/m3] are respectively used in the data series’ names. 
 
TABLE 5.3.3 P-values for normalized fluorescence intensity with significant factors in bold. 
Factor Virus Size Temp RH V:S V:T S:T V:R S:R T:R 
P 0.015 <0.001 0.166 <0.001 0.068 0.166 0.753 <0.001 <0.001 0.013 
Factor Virus Size Temp AH V:S V:T S:T V:A S:A T:A 
P 0.015 <0.001 0.166 <0.001 0.068 0.171 0.753 0.009 <0.001 0.403 
 
As shown in FIGURES 5.3.3 and 5.3.4, normalized fluorescence intensity did not change much 
from virus to virus, or between different thermal conditions. In ANOVA, however, virus type was 
significant. By comparing the three viruses, it was found that MS2 was significantly different 
than HAdV-1 (p=0.010), while AIV was not (p=0.707). This result is similar to that in the 
previous tests for different sampling durations, and the reason could be the different types of 
suspension media. Interaction between particle size and virus had a p-value of 0.068, close to the 
critical value, also showing the likely effect of the suspension medium. Both RH and AH were 
significant, as well as their interactions with particle size, suggesting that humidity affected both 
overall aerosol size and size distribution. Interactions between virus and both humidities were 
significant, indicating that different suspensions may have different responses to the change of 
humidity. Temperature was not significant, suggesting that the flow field was relatively stable, 
and a similar amount of aerosol was collected for different temperatures. This was desirable, as 
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comparison between different thermal conditions required similar aerosol residence times and 
trajectories. Interaction between temperature and RH was significant, while that between 
temperature and AH was not, meaning that to predict aerosol physical loss, using AH may 
eliminate the interaction term between temperature and humidity. 
 
Normalized total virus concentration versus particle size for each virus and condition is plotted in 
FIGURE 5.3.5 with the pooled relative standard deviation for each virus listed in TABLE 5.3.4. 
The overall normalized total virus concentrations are plotted in FIGURE 5.3.6. The p-values are 
listed in TABLE 5.3.5. 
 
 
FIGURE 5.3.5 Normalized total virus concentration (dimensionless, vertical axes) versus particle 
aerodynamic diameter [µm] (horizontal axes). Temperature [˚C], RH [%], and AH [g/m3] are respectively 
used in the data series’ names. 
 
TABLE 5.3.4 Pooled relative standard deviation for each virus in FIGURE 5.3.5. 
Virus MS2 AIV HAdV-1 
Relative standard deviation +119.4%/-54.4% +99.5%/-49.9% +115.5 %/-53.6% 
 
In the ANOVA results, the virus type was a significant factor. From FIGURES 5.3.6 and 5.3.4, 
the physical losses of AIV and HAdV-1 calculated using total virus were higher than those 
calculated using fluorescein. For MS2, both physical losses were similar. This result is similar to 
that of the previous tests for different sampling durations, and suggests that using fluorescein to 
calculate the physical loss of virus would be valid only for small viruses such as MS2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.E-05
1.E-04
1.E-03
1.E-02
1.E-01
0.1 1 10 0.1 1 10 0.1 1 10
HAdV-1 AIV MS2 
Normalized total virus titer Normalized total virus concentration 
51 
 
Temperature and RH were not significant for normalized total virus, but AH was significant. 
Interactions between virus and RH, and between virus and AH were both significant, showing the 
possibility of different hygroscopic properties for different suspension media or viruses. 
Interaction between particle size and RH, and that between particle size and AH were not 
significant, meaning the humidity effect on particle size distribution was not significant. This was 
different from the fluorescein result, probably due to larger uncertainty in the PCR measurements. 
Interaction between temperature and RH was significant, but neither temperature nor RH was 
significant by itself. Interaction between temperature and AH was significant, which was different 
from the fluorescein result. This was probably due to larger uncertainty associated with the PCR 
measurements as well. Further tests are recommended. 
 
 
FIGURE 5.3.6 Overall normalized total virus (TV) concentration (dimensionless) with error bars showing 
standard errors. Temperature [˚C], RH [%], and AH [g/m3] are respectively used in the data series’ names. 
 
TABLE 5.3.5 P-values for normalized total virus concentration with significant factors in bold. 
Factor Virus Size Temp RH V:S V:T S:T V:R S:R T:R 
P <0.001 <0.001 0.488 0.214 0.079 0.636 0.980 <0.001 0.614 <0.001 
Factor Virus Size Temp AH V:S V:T S:T V:A S:A T:A 
P <0.001 <0.001 0.488 <0.001 0.079 0.654 0.980 <0.001 0.392 0.004 
 
Based on normalized live virus titer and normalized fluorescence intensity, size distribution of 
relative recovery was calculated for each virus and condition, and is shown in FIGURE 5.3.7 with 
uncertainties listed in TABLE 5.3.6. Overall relative recovery for each virus is plotted in 
FIGURE 5.3.8. Since virus type was significant (p<0.001) as expected, and different viruses 
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reacted differently to changes of thermal condition, ANOVA was carried out for each virus 
individually (TABLE 5.3.7). 
 
Overall, MS2 had the highest relative recovery, and HAdV-1 had the lowest. For MS2, particle 
size was not significant, meaning relative recovery was constant for all impactor stages. 
Temperature was significant, and MS2 had a higher relative recovery at the lower temperature. 
RH and AH were both significant. MS2 had a higher relative recovery at lower RH or AH, which 
was different than the previous study using the same suspension medium (Appert 2012), where 
MS2 had the highest relative recovery in the mid-range of RH. The difference could be likely due 
to the smaller range of RH tested in this study than in Appert 2012. None of the interactions were 
significant for MS2. 
 
 
FIGURE 5.3.7 Relative recovery (dimensionless, vertical axes) versus particle aerodynamic diameter [µm] 
(horizontal axes). Temperature [˚C], RH [%], and AH [g/m3] are respectively used in the data series’ names. 
 
TABLE 5.3.6 Pooled relative standard deviation for each virus in FIGURE 5.3.7. 
Virus MS2 AIV HAdV-1 
Relative standard deviation +160.9%/-61.7% +311.0%/-75.7% +167.0%/-62.5% 
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FIGURE 5.3.8 Overall relative recovery (dimensionless) with error bars showing propagated standard 
errors. Temperature [˚C], RH [%], and AH [g/m3] are respectively used in the data series’ names. 
 
TABLE 5.3.7 P-values for relative recovery for individual virus with significant factors in bold. 
Factor Size  Temp RH S:T S:R T:R S:T:R 
MS2 0.838 <0.001 0.003 0.897 0.916 0.502 0.930 
AIV 0.958 0.034 0.228 0.428 0.920 0.191 0.843 
HAdV-1 0.001 0.223 0.800 0.027 0.580 0.318 0.375 
Factor Size Temp AH S:T S:A T:A S:T:A 
MS2 0.838 <0.001 0.003 0.897 0.936 0.540 0.884 
AIV 0.958 0.034 0.693 0.428 0.981 0.049 0.631 
HAdV-1 0.001 0.223 0.549 0.027 0.250 0.620 0.986 
 
For AIV, particle size was not a significant factor, showing similar relative recovery for all 
impactor stages. Temperature was significant; AIV had higher relative recovery at the lower 
temperature. Neither RH nor AH was significant, but from FIGURE 5.3.8, AIV had the lowest 
relative recovery at 50% RH by mean value. This trend agrees with Appert 2012 using the same 
suspension medium. None of the interactions were significant except for that between 
temperature and AH, but the p-value was 0.049, just on the threshold of significance. 
 
HAdV-1 behaved quite differently than the other two viruses. Particle size was significant. 
FIGURE 5.3.7 shows that relative recovery decreased as particle size increased, similar to the 
results in the previous tests for different sampling durations. Temperature was not significant. 
From FIGURE 5.3.8, relative recovery was quite similar except for the 25 ˚C 38% RH condition. 
RH and AH were not significant. Still from FIGURE 5.3.8, HAdV-1 might have the lowest 
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inactivation rate at low AH, but this needs to be proven with further tests. The current tests did 
not show the possible increase of relative recovery at high RH (> 80%) as discussed in other 
studies (Harper 1961; Miller 1967; Davis 1971; Appert 2012). The test facility needs to be 
improved in order to test more extreme conditions. None of the interactions were significant, 
except for that between temperature and particle size, meaning that temperature significantly 
affected the size distribution of relative recovery. This, however, could be due to test 
uncertainties. 
 
Similar to relative recovery, survival was calculated from normalized live virus titer and 
normalized total virus concentration. The size distributions are shown in FIGURE 5.3.9 with 
pooled relative standard deviations listed in TABLE 5.3.8. The overall survival is plotted in 
FIGURE 5.3.10. P-values for each virus are shown in TABLE 5.3.9. 
 
 
FIGURE 5.3.9 Survival (dimensionless, vertical axes) versus particle aerodynamic diameter (horizontal 
axes). Temperature [˚C], RH [%], and AH [g/m3] are respectively used in the data series’ names. 
 
TABLE 5.3.8 Pooled relative standard deviation for each virus in FIGURE 5.3.9. 
Virus MS2 AIV HAdV-1 
Relative standard deviation +176.4%/-63.8% +398.6%/-79.9% +250.2%/-71.4% 
 
For MS2, particle size was not significant. Temperature was significant, and MS2 had higher 
survival at the lower temperature. RH and AH were both significant, and from FIGURE 5.3.10 
MS2 had the highest survival at 8.8 g/m
3
 AH. The trend agrees with the Dubovi 1970 buffered 
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saline solution result, Trouwborst 1973 NaCl solution result, and Woo 2010 result. None of the 
interactions were significant, except for that between temperature and RH, implying that 
modeling with AH would decouple the effects of humidity and temperature. 
 
 
FIGURE 5.3.10 Overall survival (dimensionless) with error bars showing propagated standard errors. 
Temperature [˚C], RH [%], and AH [g/m3] are respectively used in the data series’ names. 
 
TABLE 5.3.9 P-values for survival for individual virus with significant factors in bold. 
Factor Size Temp RH S:T S:R T:R S:T:R 
MS2 0.885 <0.001 0.015 0.799 0.985 0.023 0.970 
AIV 0.846 0.075 0.011 0.590 0.903 0.276 0.963 
HAdV-1 0.022 0.666 0.178 0.304 0.993 0.002 0.858 
Factor Size Temp AH S:T S:A T:A S:T:A 
MS2 0.885 <0.001 0.003 0.799 0.988 0.278 0.957 
AIV 0.846 0.075 0.008 0.590 0.967 0.449 0.794 
HAdV-1 0.022 0.666 0.002 0.304 0.956 0.619 0.996 
 
For AIV, particle size was not significant. Temperature was not significant, but from FIGURE 
5.3.10 AIV had lower survival at higher temperature for the same AH by mean value. RH and AH 
were significant. From FIGURE 5.3.10, the AH effect is more obvious than RH as suggested in 
other studies. However, a significant difference with past studies is that the survival of AIV was 
higher at 15.2 g/m
3
 than at 11.5 g/m
3
, but did not monotonically decrease as AH increased
 
(Loosli 
1943; Hemmes 1960; Harper 1961; Buckland 1962; de Jong 1964, 1973; Tellier 2006; Zuk 2009; 
McDevitt 2010). The reason could be the different suspension ingredients used in the current tests 
with the natural suspension or those used in the above studies. For the RH effect, survival at 50% 
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was not lower than that at 38%. How survival would change at even lower RH could not be seen 
from the current test results. Survival at 66% was much higher than that at the two lower levels, 
agreeing with some studies (Shechmeister 1950; Hood 1963; Schaffer 1976; Appert 2012; Yang 
2012). None of the interactions for AIV was significant. 
 
For HAdV-1, particle size was a significant factor as for the relative recovery results and as in the 
previous tests for different sampling durations. From FIGURE 5.3.9, survival decreased for larger 
particles. Temperature was not significant. From FIGURE 5.3.10, the overall survival at 30 ˚C 
was not lower than that at 25 ˚C. RH was not significant, but the interaction between temperature 
and RH was significant. AH was significant. HAdV-1 had the highest survival at 8.8 g/m
3
, the 
lowest at 11.5 g/m
3
, and the medium at 15.2 g/m
3
. None of the other interactions were significant. 
ANOVA results show that when modeling HAdV-1 survival with AH, the interaction term 
between temperature and humidity disappeared. This agrees with the MS2 result and the 
published studies on AIV. 
 
5.4 Conclusions 
The test results show that with current test setup and sampling method, the relative recovery and 
survival of the viral aerosol collected by the Andersen impactor depended on temperature and 
humidity. Based on the fluorescein measurement, the viral aerosol size distribution was also 
affected by humidity. Generally, viruses survived better at 25 ˚C than at 30 ˚C, however, the 
difference was not significant for HAdV-1, suggesting that HAdV-1 is less vulnerable than MS2 
and AIV to the moderately high temperatures. Based on the survival results, AH had lower p-
values than RH for the three viruses, showing that AH could be a better predictor than RH for 
virus survival. Using AH also decoupled the effects of humidity and temperature for MS2 and 
HAdV-1. This result agrees with past studies on AIV, and suggests that the conclusion could be 
extended to other viruses. It is thus suggested that AH should be documented in future viral 
aerosol tests. For the three test viruses, MS2 had higher survival at 8.8 g/m
3
 AH than 11.5 g/m
3
 or 
15.2 g/m
3
, with the latter two had similar survival. AIV had higher survival at 15.2 g/m
3
 than 11.5 
g/m
3
 or 8.8 g/m
3
, with the latter two had similar survival. HAdV-1 had the highest survival at 8.8 
g/m
3
, and the lowest at 11.5 g/m
3
. Its survival at 15.2 g/m
3
 was slightly higher than that at 11.5 
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g/m
3
. The changes of relative recovery and survival of the three viruses due to the changes of 
temperature and humidity agree with some of the past studies. The main limitations, however, 
were the number of data points and the range of test conditions, even though it covered the most 
common indoor environments. Since the relationship could be non-linear, the complete response 
of virus inactivation especially that to humidity was still unknown. To fully explore the responses 
and compare with the published data, the method used in this group of tests should be extended 
for broader test conditions in the future. For example, AIV aerosol transmission has been studied 
for the AH range covering 0-30 g/m
3
, much greater than the range tested in this study (8.8-15.2 
g/m
3
). Additionally, more tests are suggested for other viruses and suspension media. 
 
Relative recovery showed similar trends with survival for the three viruses, but ANOVA did not 
indicate significant interaction between temperature and RH, which was different from the 
survival result. The disagreement suggests that the physical loss of fluorescein was different from 
that of virus in this study, resulting in the different ANOVA conclusion using the two methods. 
One reason could be in the different nebulizer output rates for virus and fluorescein as discussed 
in Chapter 4. 
 
As virus inactivation occurred both in the airborne state and on the impactor plates in these tests, 
the virus relative recovery and survival should not be used directly to compare viral aerosol 
inactivation rates, unless the trend of inactivation in the airborne state and in the impactor could 
be assumed to be the same for the same virus. This assumption, however, should be verified with 
further study. As the chamber conditions were selected to simulate real indoor environments, the 
results should predict field sampling situations within the tested temperature and humidity ranges 
using a similar aerosol sampler. 
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6 Experimental tests of viral aerosol 
inactivation by UVGI 
6.1 Background 
6.1.1 Introduction 
Ultraviolet germicidal irradiation (UVGI) systems are designed to disinfect air, water, and 
surfaces. The germicidal range of UV wavelength is 200-320 nm that includes part of the UVC 
band (200-280 nm), all of the UVB band (280-320 nm), but none of the UVA band (320-400 nm) 
(CDC 1994; Kowalski 2009). Unlike inactivation due to desiccation or adverse humidity when 
inactivation most likely happens at the virus coating, UVGI reduces infection by photochemical 
reaction which damages the genetic material by producing dimers and other photo products, 
causing the microorganism to be incapable of replicating (Sattar 1987; Navy Environmental 
Health Center 1992; Rahn 1999; Chandrasekhar 2000; Miller 2000; Beggs 2002a; Noakes 2004b, 
2006; Ko 2005; Kowalski 2009; Rudnick 2009). The UV absorption by nucleic acid peaks around 
260 nm, at lower and higher (up to 320 nm) wavelengths the sensitivity decreases, but increases 
again below 230 nm (Luckiesh 1946; Summer 1962; NIOSH 1972; Jacobs 1992; Rahn 1999; 
Hijnen 2006; Kowalski 2009). In applications, low-pressure mercury lamps are often used to 
generate 253.7 nm UVC light to reduce disease transmission in indoor environments. This 
wavelength is very close to the absorption peak and ready to be absorbed by microorganisms 
(Rudnick 2009). 
 
Generally, UVGI is effective in inactivating viruses and most bacteria, and its effectiveness 
depends on the type of microorganism (Miller 2000; Kowalski 2001; Noakes 2004a, 2004b, 2006; 
Memarzadeh 2010). Virus resistance to UVGI was reported to be lower than bacteria and fungi 
spores by some researchers (Jensen 1964; Brickner 2003; Tseng 2005b), but others reported that 
viruses were on average more resistant to UVGI than bacteria (Kowalski 2009). For viruses, the 
resistance to UVGI was observed to depend on the type of nucleic acid. Viruses with double-
stranded genomes are less susceptible than those with single-stranded ones. This is possibly 
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because of the redundancy of genetic information which helps the double-stranded type have 
more chance to be repaired (Bishop 1967; Deshmukh 1969; Harm 1980; Becker 1989; 
Kallenbach 1989; Gerba 2002; Thurston-Enriquez 2003; Tseng 2005b; Kowalski 2009). 
Generally, adenoviruses are extremely resistant to UVGI compared to other enteric viruses, 
possibly due to its double-stranded DNA (Meng 1996; Gerba 2002; Thurston-Enriquez 2003; 
Nwachuku 2005; Hijnen 2006). Adenoviruses were found to be much more resistant to UVGI 
than influenza viruses and slightly more resistant than MS2 (Jensen 1964; Thurston-Enriquez 
2003; Ko 2005; Nwachuku 2005; Tseng 2005b). 
 
Virus susceptibility to UVGI does not depend on temperature (Rentschler 1941). Viral aerosol 
susceptibility to UVGI has been reported to be affected by RH, but the trend is not conclusive, 
and may be species dependent (Rentschler 1941; Wells 1942a; Riley 1971, 1976; Blatchley 2007; 
Kowalski 2009). Most recent studies mentioned that high RH (>60%) reduced the effectiveness 
of UVGI (Peccia 2001a, 2004; Beggs 2002b; Xu 2003; Tseng 2005b; Verreault 2008; Tang 2009; 
Memarzadeh 2010, 2012). This was possibly due to reduced susceptibility of microorganisms, as 
studies did not find a decrease in irradiance at high RH up to 95% (Miller 2000; Peccia 2001a). 
At extremely high RH, virus susceptibility to UVGI would approach that in water (Kowalski 
2009). 
 
Compared to chemical disinfection methods, although UVGI is harmful to human skin and eyes, 
it has several advantages. First, it has little toxic byproduct or emissions (Ko 2005). Second, it has 
no smell. Third, it does not require storage of hazardous materials. Fourth, it does not have an 
overdosing problem. However, a significant amount of work is still needed to make UVGI safer 
and more efficient for viral aerosol disinfection. Lack of data and standards for measurement and 
application of UVGI systems is the main obstacle preventing its widespread use. Therefore, more 
tests are needed to build the database on how well UVGI disinfects viral aerosols under various 
conditions. 
 
Based on the damage level in nucleic acid, microorganisms inactivated by UVGI may partially 
recover. The repair process requires the presence of 320-410 nm wavelength, thus it is called 
photoreactivation (Liao 2010). Photoreactivation is usually available for bacteria or when cells 
are present for virus (Lennox 1954; Jagger 1965; Deshmukh 1969; Peccia 2001b; Beggs 2002a; 
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Masschelein 2002; Nuanualsuwan 2002; Thurston-Enriquez 2003; Xu 2003). Photoreactivation in 
bacteria was discovered and studied a long time ago (Prat 1936; Kelner 1949). Due to the 
randomness of the repair process, mutation could occur in the recovered microorganisms (Beggs 
2002a). For viruses, photoreactivation is usually not applicable due to the lack of enzymes for 
repair out of a cell host (Bishop 1967; Deshmukh 1969; Samad 1987; Nuanualsuwan 2002, 2003). 
The photoreactivation effect was therefore neglected in this study. 
 
6.1.2 History and applications 
Studies of UV effects on microorganisms including viruses started in the late 1800s (Widmark 
1889; Ward 1892; Henri 1914; Rivers 1928; Sturm 1932). Use of UVGI for disinfecting water, 
surfaces, and air for disease reduction also has a long history (Hollander 1942; Wells 1942a, 1955; 
Luckiesh 1946; Riley1957, 1976; Summer 1962; Jensen 1964; Collins 1971; David 1973; 
Goldner 1980; Kowalski 2009). Especially for water disinfection, the history has been more than 
a hundred years (Downes 1877; von Recklinghausen 1914). Since then, UVGI has been most 
widely used in water treatment and food process industries (Blatchley 1997; Xu 2003; Ko 2005; 
Hijnen 2006).  
 
Use of UVGI for indoor air disinfection started in the 1930s (Hart 1937; Wells 1955). In 1942, 
the use of UVGI in schools greatly reduced the spread of measles, chickenpox, and mumps 
(Wells 1942b). In 1957, UVGI was demonstrated to be able to control the spread of tuberculosis 
(TB) (Riley 1957). Many other studies also showed the effectiveness of UVGI in infection 
control (McLean 1961; Kundsin 1984; Tseng 2005b). However a few studies that failed to show 
the effectiveness of UVGI have been cited as proof of its ineffectiveness, and hindered the 
development of its application, which is still far from being common in modern buildings 
(Kowalski 2009). 
 
Until very recently, with the development of drug resistant TB, UVGI effectiveness for air 
disinfection was officially acknowledged, and was recommended for use in hospitals as a 
supplement to other air cleaning methods, such as pressurization, dilution, or filtration (CDC 
1994, 2005; Beggs 2002a, 2002b; Kowalski 2009; Memarzadeh 2010). UVGI effectiveness to 
prevent infection on its own was still not considered to be reliable (Memarzadeh 2000b; Miller 
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2000). When working with ventilation systems, UVGI can disinfect areas where ventilation is not 
effective (Memarzadeh 2000b). The relationship between UVGI effectiveness and ventilation rate 
is not simple, but generally UVGI works best at low ventilation rates (< 6 ACH) (Beggs 2002b; 
Xu 2003). UVGI is also believed to work complementarily with filtration systems, since filtration 
generally has high efficiency for larger particles, while UVGI is more effective for smaller 
particles, for which the protection from irradiation is much weaker (Jensen 1964; Kowalski 2001). 
 
UVGI has been suggested to be a better method for indoor air disinfection than changing 
temperature or humidity, as the latter would cause discomfort and cost more energy (Memarzadeh 
2012). For indoor applications of UVGI, the upper-room system and the in-duct system are the 
two configurations that have been most commonly studied and used (Wells 1938; McLean 1961; 
Riley 1962; Jagger 1965; Ko 2002; CDC 2005; van Osdell 2002; Xu 2003, 2005; Kujundzic 2007; 
Rudnick 2009). When installed in an air handling unit, UVGI also reduces mold growth on coils 
and saves energy by minimizing pressure drop. When installed as an upper-room system, louvers 
are used to direct and confine UV light to the upper part of room to avoid direct exposure to the 
occupants. Ventilation is also designed to create multiple passes of air in the UV irradiated region 
to maximize the disinfection effect. UVGI disinfection systems can be also designed as a 
moveable unit, which can be used to decontaminate unoccupied rooms. 
 
The low pressure mercury lamps which are most frequently used in UVGI systems generate 253.7 
nm UVC with about 90% of their spectral output (Luckiesh 1946; Summer 1962; NIOSH 1972; 
Navy Environmental Health Center 1992; Rahn 1999; IESNA 2000; Xu 2003; Hijnen 2006). In 
ﬂuorescent lamps for illumination, the glass is coated on the inside with phosphors which absorb 
UV and re-emit the energy as visible light. In UV lamps, no phosphor is used, and the quartz 
glass is almost transparent to the UVC wavelength. Softglass (sodium-barium glass) is often used 
instead of quartz glass to block 185 nm light for ozone-free requirements (Xu 2003; Kowalski 
2009; Schalk 2006). Cooling of the lamp surface by an airstream can reduce its output. For 
optimal operation, airstreams directed toward the lamps should be avoided and an ambient 
temperature between 20 ˚C and 24 ˚C is recommended (Kowalski 2001, 2009; Memarzadeh 
2010). 
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6.2 Test method 
UVGI effectiveness was tested with MS2, AIV, and HAdV-1 by comparing virus relative 
recovery and survival with and without UVGI. The test condition was 25 ˚C, 50% RH, and 15 
ACH, the same as the one-hour tests described in Chapter 4. The test setup was not changed from 
the previous tests either. Two UVGI lamps in opposite corners of the chamber ceiling were used 
as described in Chapter 2. Each lamp tube was Model G25T8 from General Electric, with a 6.9 W 
nominal output at 253.7 nm. The lamps were ozone free, thus virus inactivation due to ozone 
effect was unlikely. Before each UVGI test, both lamps were turned on for 30 min to warm up as 
in other studies (Thurston-Enriquez 2003; Xu 2003). The UVGI strength was assumed to be 
constant afterwards. In this study, the service time of the two UVGI lamps during these tests were 
between 200 and 300 hours; comparing with the 8000 hour designed service life, the output 
should be close to the peak (Kowalski 2009). Tests were conducted in triplicate, and the test order 
was randomized. The uncertainties were the same as those calculated in the previous tests, as they 
were assumed to be independent on the operation of the UVGI system. ANOVA was performed 
on a logarithmic scale to test the significance of UVGI to virus inactivation based on the samples 
from stages 3-7 in an Andersen impactor. 
 
6.3 Results and discussion 
The size distributions of the normalized live virus titer for each virus are plotted in FIGURE 6.3.1. 
The corresponding uncertainties are listed in TABLE 6.3.1. The overall normalized live virus 
titers for all impactor stages are shown in FIGURE 6.3.2. ANOVA p-values are listed in TABLE 
6.3.2. For normalized live virus titer, the virus type, particle size, and UVGI operation were all 
significant factors, but none of their interactions was significant. From FIGURE 6.3.2, all viruses 
had higher total loss when UVGI was on. 
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FIGURE 6.3.1 Normalized live virus titer (dimensionless) versus particle aerodynamic diameter [µm] for 
MS2, AIV, and HAdV-1 with and without UVGI. 
 
TABLE 6.3.1 Pooled relative standard deviation for each virus in FIGURE 6.3.1. 
Virus MS2 AIV HAdV-1 
Relative standard deviation +167.7%/-62.6% +271.9%/-73.1% +135.7%/-57.6% 
 
The size distributions of the normalized fluorescence intensity are shown in FIGURE 6.3.3. The 
pooled relative standard deviation for all viruses was calculated to be +33.2%/-24.9%. The ratios 
plotted on the right part of FIGURE 6.3.4 are all close to unity, showing that fluorescein was not 
damaged by UVGI. It also implies that the amount of aerosol collected by the Andersen impactor 
with and without UVGI was constant. 
 
By ANOVA (TABLE 6.3.3), virus type and the interaction between virus type and particle size 
were both significant, which is similar to the previous results in Chapters 2 and 3. The difference 
was likely caused by suspension medium, as MS2 was significantly different from HAdV-1 
(p=0.002), while AIV was not (p=0.779). The interaction between virus type and UVGI was 
significant, meaning that for different viruses or suspensions UVGI had different effects on 
normalized fluorescence intensity. From FIGURE 6.3.4, the difference is not obvious, and might 
be due to test uncertainties. 
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FIGURE 6.3.2 Overall normalized live virus (LV) titer (dimensionless): left is the direct comparison of 
UVGI “on” and “off”; right is the ratio of “on” over “off”. Error bars are standard errors. 
 
TABLE 6.3.2 P-values for normalized live virus titer with the significant factors in bold. 
Factor Virus Size UVGI V:S V:U S:U V:S:U 
P-value <0.001 <0.001 <0.001 0.735 0.868 0.911 0.986 
 
 
FIGURE 6.3.3 Normalized fluorescence intensity (dimensionless) versus particle aerodynamic diameter 
[µm] for MS2, AIV, and HAdV-1 with and without UVGI. 
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FIGURE 6.3.4 Overall normalized fluorescence intensity (FI) (dimensionless): left is the direct 
comparison of UVGI “on” and “off”; right is the ratio of “on” over “off”. Error bars are standard errors. 
 
TABLE 6.3.3 P-values for normalized fluorescence intensity with the significant factors in bold. 
Factor Virus Size UVGI V:S V:U S:U V:S:U 
P-value <0.001 <0.001 0.843 0.006 0.012 0.971 1.000 
 
The normalized total virus concentration results are shown in a similar way in FIGURES 6.3.5-
6.3.6 and TABLES 6.3.4-6.3.5. From the UVGI on/off ratio plot (FIGURE 6.3.6) and the 
significant p-value of UVGI effect, it can be seen that some of the viruses were damaged by 
UVGI, and could not be detected by PCR. Since UVGI damages the nucleic acid, and PCR 
measurements rely on the sequence of the DNA or RNA, the reduction in total virus measurement 
was reasonable. However, the issue also means that using the total virus concentration would 
falsely overestimate the physical losses of virus in these tests. Virus type was also a significant 
factor; similar to previous tests, MS2 was significantly different from HAdV-1 (p=0.003), while 
AIV was not (p=0.808). The reason could be the difference in suspension medium, virus size, or 
genetic material. 
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FIGURE 6.3.5 Normalized total virus concentration (dimensionless) versus particle aerodynamic diameter 
[µm] for MS2, AIV, and HAdV-1 with and without UVGI. 
 
TABLE 6.3.4 Pooled relative standard deviation for each virus in FIGURE 6.3.5. 
Virus MS2 AIV HAdV-1 
Relative standard deviation +119.4%/-54.4% +99.5%/-49.9% +115.5 %/-53.6% 
 
For biological losses, the results of relative recovery are shown in FIGURES 6.3.7-6.3.8 and 
TABLES 6.3.6-6.3.7. The results of survival are shown in FIGURES 6.3.9-6.3.10 and TABLES 
6.3.8-6.3.9. UVGI significantly reduced the relative recovery of the three viruses, but the effect is 
not significantly different from virus to virus by ANOVA. In FIGURE 6.3.8, the inactivation of 
AIV might be the greatest by mean value, but the uncertainty is also the greatest. Relative 
recovery is not significantly affected by the interaction between particle size and UVGI, showing 
that the UVGI effect is similar for the particle size range from 0.4 to 4.7 µm. 
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FIGURE 6.3.6 Overall normalized total virus (TV) concentration (dimensionless): left is the direct 
comparison of UVGI “on” and “off”; right is the ratio of “on” over “off”. Error bars are standard errors. 
 
TABLE 6.3.5 P-values for normalized total virus concentration with significant factors in bold. 
Factor Virus Size UVGI V:S V:U S:U V:S:U 
P-value <0.001 <0.001 0.007 0.976 0.518 0.751 0.995 
 
For survival, virus type was significant as it was for relative recovery. UVGI was not significant, 
meaning that UVGI did not significantly reduce virus survival. This proves that UVGI damages 
nucleic acid causing similar reductions in live virus titer and total virus concentration. In other 
words, most viruses inactivated by UVGI were undetectable by PCR as well. From FIGURE 
6.3.10, however, ratios of the three viruses were still slightly below unity by mean value, showing 
some viruses inactivated by UVGI could still be detected by PCR. An explanation is that for these 
viruses, UVGI damaged a part of DNA/RNA which was not the target sequence used by PCR, 
making them incapable of multiplying, but still replicable by PCR. Interaction between UVGI 
and particle size was not significant, meaning that UVGI effect could be considered constant for 
the particle sizes between 0.4 and 4.7 µm. 
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FIGURE 6.3.7 Relative recovery (dimensionless) versus particle aerodynamic diameter [µm] for MS2, 
AIV, and HAdV-1 with and without UVGI. 
 
TABLE 6.3.6 Pooled relative standard deviation for each virus in FIGURE 6.3.7. 
Virus MS2 AIV HAdV-1 
Relative standard deviation +160.9%/-61.7% +311.0%/-75.7% +167.0%/-62.5% 
 
 
FIGURE 6.3.8 Overall relative recovery (RR) (dimensionless): left is the direct comparison of UVGI “on” 
and “off”; right is the ratio of “on” over “off”. Error bars are standard errors. 
 
TABLE 6.3.7 P-values for relative recovery with significant factors in bold. 
Factor Virus Size UVGI V:S V:U S:U V:S:U 
P-value <0.001 0.253 <0.001 0.862 0.728 0.923 0.994 
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FIGURE 6.3.9 Survival (dimensionless) versus particle aerodynamic diameter [µm] for MS2, AIV, and 
HAdV-1 with and without UVGI. 
 
TABLE 6.3.8 Pooled relative standard deviation for each virus in FIGURE 6.3.9. 
Virus MS2 AIV HAdV-1 
Relative standard deviation +176.4%/-63.8% +398.6%/-79.9% +250.2%/-71.4% 
 
 
FIGURE 6.3.10 Overall survival (dimensionless): left is the direct comparison of UVGI “on” and “off”; 
right is the ratio of “on” over “off”. Error bars are standard errors. 
 
TABLE 6.3.9 P-values for survival with significant factors in bold. 
Factor Virus Size UVGI V:S V:U S:U V:S:U 
P-value 0.018 0.771 0.211 0.961 0.950 0.864 0.990 
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Since UVGI damaged the virus nucleic acid, most of the inactivated virus could not be detected 
by either cell-culture titration or PCR, resulting in underestimated UVGI effectiveness based on 
survival. Because fluorescein was not affected by UVGI, relative recovery could be used instead 
of survival to calculate the UVGI effectiveness. In the previous tests for different sampling 
durations discussed in Chapter 4, it was shown that even though relative recovery was different 
from survival, the six-hour to one-hour ratios of the two parameters were similar. This is possibly 
because any offset due to the use of fluorescein should be similar for six-hour and one-hour tests, 
and can be cancelled by taking the ratio. The conclusion should still be true for the UVGI tests, 
and the ratio of UVGI on over off for relative recovery should be close to that for the actual 
survival (rather than the measured virus survival using PCR analysis). Based on the relative 
recovery data, the average inactivation rates for the three viruses were: 49.8% for MS2, 74.5% for 
AIV, and 49.3% for HAdV-1. AIV was more susceptible to UVGI than MS2 or HAdV-1, and the 
latter two had similar resistances. This agrees well with published data. However, the uncertainty 
with AIV was also much larger, making it desirable to conduct further tests to verify this 
conclusion. 
 
6.4 Conclusions 
This group of tests showed that UVGI was effective in controlling viral aerosol transmission even 
for a hardy enteric virus such as HAdV-1. UVGI damaged the virus at the nucleic acid making 
most inactivated viruses undetectable by PCR as well, resulting in significantly overestimated 
survival of the irradiated viral aerosol. Since fluorescein did not seem to be affected, relative 
recovery was used to calculate the disinfection effectiveness of UVGI. The inactivation rates 
showed that AIV could be more susceptible to UVGI than MS2 or HAdV-1, and the latter two 
were similar. This result agrees with published data. However, more tests are needed, as the 
uncertainty with AIV was large, and the inactivation rates for the three viruses were not 
significantly different in the ANOVA results. For all three viruses, the inactivation rates were 
smaller than one log, indicating that the UVGI dose received might not be very high. As shown in 
Appendix II, the average residence time of the collected aerosol was only about 2 minutes, 
compared to the test duration of one hour. In order to increase inactivation, either more UVGI 
power or longer residence time is needed. The performance of the UVGI system was further 
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investigated using a numerical method as shown in the next chapter, where the dose received by 
the aerosol was calculated based on the irradiance field and particle trajectories in the chamber. It 
is recommended for future research to test the effects of suspension medium and humidity 
(especially at extreme levels) on viral aerosol susceptibility to UVGI for different viruses. 
 
72 
 
7 Numerical simulation of viral aerosol 
inactivation by UVGI 
7.1 Introduction 
In the experiment, the three test viruses were significantly inactivated by UVGI. AIV was more 
susceptible to UVGI than MS2 or HAdV-1, and MS2 had a similar resistance with HAdV-1. This 
result agrees qualitatively with previous studies. In order to compare quantitatively with 
published data, and to contribute to the database of UVGI effects on viral aerosols, the 
susceptibilities of the test viruses need to be quantified based on the experimental results. To 
accomplish this, a numerical model was developed in ANSYS CFX (13.0, ANSYS, Inc.). The 
model could serve as a prototype that can be used as a basis for applications to facilitate the test 
or design of UVGI systems. 
 
The numerical model consisted of three parts: flow field simulation, particle transport simulation, 
and UVGI field simulation. It directly output the trajectories of the particles that were collected 
by the sampler, and the irradiance field. The output was then post-processed to calculate the UV 
dose received by each particle, and eventually the susceptibility of each virus. The model is 
conceptually similar to those in several past studies on aerosol or water disinfection problems 
(Blatchley 1998, 2007; Memarzadeh 2000a; Alani 2001; Wright 2001; Beggs 2002b; Noakes 
2004a, 2004b, 2006). 
 
In the previous studies, particle transport simulation was conducted in either the Lagrangian or 
Eulerian framework. For steady state problems, both methods give similar results, but for 
unsteady state problems, the Lagrangian method is more suitable (Alani 2001; Memarzadeh 2004; 
Noakes 2004b; Ducoste 2005; Sozzi 2006; Gao 2007; Zhang 2007a; Jeong 2009; Wan 2009). The 
Eulerian method solves an additional scalar differential transport equation in parallel with the 
Navier-Stokes equations, and is capable of showing local concentration and inactivation rate in 
the results (Verstaag 1995; Memarzadeh 2004; Sozzi 2006; Mazumdar 2008; Yan 2009). On the 
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other hand, the Lagrangian method tracks a large number of particles, thus the particle movement 
or trajectories are visible, and the dose distribution of the collected particles can be calculated 
(Sozzi 2006; Zhang 2006, 2007a; Wan 2009). Due to the stochastic nature of particle tracking, a 
great number of trajectories are needed for the Lagrangian method so that the result reaches 
statistical stability before any further analysis such as susceptibility calculation can be carried out. 
In the current model, particle transport was conducted in the Lagrangian framework, calculating 
trajectories with a particle tracking algorithm. 
 
Some models in previous studies integrated the inactivation kinetics in the simulation (Noakes 
2004b; Ducoste 2005; Sozzi 2006), while others did not (Memarzadeh 2000b; Alani 2001; Wright 
2001). Those without inactivation kinetics required post-processing to determine inactivation rate 
from susceptibility or vice versa. With the kinetics included, the inactivation rate could be 
directly shown in the simulation results. However, the drawback is that the kinetic function is 
usually fixed; if a change of kinetics is needed, the entire simulation needs to be run again. 
Another major drawback with integrated kinetics is the accuracy is limited by the availability of 
reliable susceptibility constants for airborne microorganisms (Noakes 2004b). In this study, since 
the calculation was performed in reverse, from inactivation rate to susceptibility based on 
simulated dose distribution, the inactivation kinetic function was not included in the numerical 
model. 
 
7.2 Flow field simulation 
7.2.1 Background of turbulence models 
The turbulent flow field simulation is the basis for calculation of particle trajectories, especially 
for particles smaller than 10 µm (Wan 2009; Gao 2007). With the development of both hardware 
and software, computational fluid dynamics (CFD) has become one of the primary tools for 
studying indoor air flow (Nazaroff 1987; Wan 2009). For  the incompressible, Newtonian air flow 
in the chamber, the basic equations used for the flow field simulation in the Eulerian framework 
are the Reynolds-averaged Navier-Stokes (RANS) equations, which include conservation of mass, 
conservation of momentum, and conservation of energy: 
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where ρ is fluid density, t is time, Ui and Uj are the velocities in xi and xj directions respectively, 
   and    are the average turbulent fluctuations of Ui and Uj respectively, µ is fluid dynamic 
viscosity, SUi is the source term for the momentum in xi direction, cp is fluid specific heat capacity, 
T is temperature, k is heat conductivity, and ST is the source term for thermal energy. EQUATION 
7.2.3 is the differential transport equation for the scalar quantity of temperature. With a suitable 
substitution of parameters, it can also be used for other scalar quantities such as concentration. 
 
To predict the turbulent flow field, a turbulence model must be included in the simulation. The 
choice of a proper turbulence model can be critical for simulation accuracy. Since the chamber 
environment simulated a typical indoor environment featuring low Reynolds number, low 
turbulence intensity, and large recirculation eddies, all flow regimes including laminar, 
transitional, and turbulent flows might be present at the same time. Therefore, a proper turbulence 
model should handle this situation well. 
 
The turbulence models most frequently used with the RANS equations for indoor air flow 
simulations are k-ε and k-ω models. Both models consider turbulence effects as an increase in 
fluid viscosity, and calculate this by solving two additional differential transport equations. As 
shown in their names, k-ε models solve for turbulence kinetic energy (TKE) k and the dissipation 
rate of TKE ε, while k-ω models solve for k and turbulence frequency ω. The increase in fluid 
viscosity is named turbulent viscosity µt, which is calculated differently by the two models: 
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where Cµ1 and Cµ2 are empirical coefficients for the two models. The final viscosity of the fluid is 
named effective viscosity µeff: 
        
  
 
, (7.2.6) 
where the empirical coefficient σ has different values for momentum, k, ε, and ω equations based 
on which turbulence model is used. The exact formulation of k-ε and k-ω models can be found in 
several CFD publications (Nieuwstadt 1992; ANSYS 2010). 
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The standard k-ε model is robust, economic to run, and has reasonable accuracy for a broad range 
of turbulent flows, including indoor air flow (Posner 2003). For better accuracy, the turbulent 
flow has to be fully developed. This is not true for low Reynolds number indoor air flows, for 
which the model has been reported to overestimate the turbulent diffusivity, and its overall 
accuracy was also unsatisfactory (Liang 1994). Therefore, several modifications in the equations 
for k, ε, and µt have been made based on the standard model to improve the validity for low 
Reynolds number flows (Henkes 1990; Xu 1994). Among the modified models, the 
renormalization group (RNG) k-ε model, which was derived with the renormalization group 
methods (Yakhot 1986; Choudhury 1993), was often recommended for indoor air flow 
simulations (Chen 1995, 2001; Yuan 1999; Srebric 2002; Posner 2003; He 2005; Lai 2007; 
Zhang 2007b; Chao 2008; Qian 2009; Wan 2009). The only difference between RNG and 
standard k-ε models is in the definition of a coefficient in the transport equation for dissipation 
rate (ε). The small change improves the accuracy for low Reynolds number flows while 
remaining accurate for high Reynolds number flows (van Hooff 2012). Compared with the 
standard k-ε model, the RNG model performs better for natural, forced, and mixed convection 
flows (Chen 1995). It also performs better for re-circulating flows over an obstruction or after a 
backward-facing step (Papageorgakis 1999; Posner 2003). However, the RNG model does not 
perform as well as the standard model for jet flows (free shear flows) in both convergence and 
accuracy (Papageorgakis 1999). 
 
The shear stress transport (SST) model has also been tested frequently for indoor air flow 
simulations. The SST model utilizes k-ω model within boundary layers, and k-ε model for the far-
field. As a result, it has better accuracy within boundary layers compared to k-ε models, and is 
accurate with jet flow and prediction of the onset and the amount of flow separation under 
adverse pressure gradients (Cook 1998; Yang 2007). Since the SST model uses the standard k-ε 
model for the far-field, it has been reported to perform similarly to the standard k-ε model, and 
predict indoor air flow fields and thermal plumes less accurately than the RNG model (Cook 
1998). However, another study showed better prediction with the SST model than with either the 
standard k-ε or the RNG model for the temperature distribution in a full-scale displacement 
ventilation case (Mustakallio 2012). Since the chamber air flow may have flow transition between 
laminar and turbulent regimes, the accurate prediction of transition onset could be important for 
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the overall accuracy. In CFX 13.0, several transition models are available for the SST model. The 
full transitional model, also named the “gamma-theta” model, is based on two additional transport 
equations for the intermittency (gamma) and the transition onset criteria in terms of momentum 
thickness (theta) Reynolds number. The full transitional model has been extensively validated 
together with the SST model for a wide range of transitional flows, and is recommended for 
general-purpose applications (ANSYS 2010). 
 
In the current simulation, the RNG model, the SST model, and the SST model with the full 
transitional model were first compared in two benchmark tests, and the best one was chosen for 
the chamber simulation. 
 
7.2.2 Treatment of near-wall regions 
Due to the no-slip condition at the wall boundaries, flow is always laminar close to the wall. 
Since the standard k-ε model is valid only for fully turbulent flows, the flow near the wall 
boundaries must be solved with empirical wall functions (Tennekes 1972). Within the wall 
boundary layers, the velocity profile can be approximately described as a logarithmic function of 
distance from the wall. The wall function is thus used to describe the flow in this log-law region. 
 
In CFX 13.0, the “scalable wall function” is used for the RNG model, allowing the use of the 
logarithmic velocity profile approximation near the wall boundaries where mesh was not fine 
enough. For the SST model, the near wall region is solved using the “automatic wall function”, 
which switches between k-ω formulation and the “scalable wall function” based on the adjacent 
flow field and mesh size (ANSYS 2010). The “automatic wall function” works based on the 
dimensionless distance between the first and the second node from the wall, which is denoted as 
y+ (or y-plus). This parameter is also often used as a check for mesh quality, especially when 
boundary layer flow is important. For simulations looking for information within the boundary 
layer, low y+ is needed, meaning several nodes need to be placed inside the boundary layer. For 
the current simulation, the information inside the boundary layer is not important, so y+ does not 
need to be very small. However, it still needs to be smaller than 200 for the turbulence models 
and the wall functions to work correctly (ANSYS 2010). 
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7.2.3 CFD benchmark tests for turbulence models 
Since the selection of a proper turbulence model is critical for overall simulation accuracy, 
benchmark tests were conducted to compare the RNG k-ε model, the SST model, and the SST 
with the full transitional model. Similar flow cases were chosen as the benchmark models. A grid 
independence test was conducted by comparing the result of the original mesh and that of a fine 
mesh with the number of elements doubled. 
 
 
FIGURE 7.2.1 The two-dimensional chamber model showing main dimensions and the original mesh for 
the first benchmark test. 
 
The first benchmark test used the experimental (Liang 1994) and numerical (Xu 1994) studies in 
the same chamber as the current study. At the time when the studies were conducted, the chamber 
was empty with two linear slot openings as supply and return to create a two-dimensional flow 
field on its center plane. Despite these differences, it is still very similar to the current case, and 
could serve as a great reference. The two-dimensional simulation area was 1.95 m wide and 1.45 
m tall. The width of supply and return slots was 0.05 m. The distance between supply slot 
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centerline and right wall was the same as that between return slot centerline and left wall, and was 
0.38 m. Two meshes were created; the original mesh had 57524 nodes and 28420 hexahedra 
elements, and the fine mesh had 117458 nodes and 58240 hexahedra elements. The SST model 
was used to compare the two meshes for grid-independence. The model with the original mesh is 
shown in FIGURE 7.2.1. The simulation condition was isothermal, and the air flow velocity at 
inlet was 1.02 m/s, corresponding to a Reynolds number of 3200. The convergence criteria were 
1e-5 for the root-mean-square (RMS) residuals in momentum and mass conservation equations. 
 
 
FIGURE 7.2.2 Velocity vectors for the first benchmark test with different turbulence models and mesh 
sizes: A. SST with original mesh; B. SST with fine mesh; C. SST with transitional model and original mesh; 
D. RNG with original mesh. 
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FIGURE 7.2.3 TKE contours for the first benchmark test with different turbulence models and mesh sizes: 
A. SST with original mesh; B. SST with fine mesh; C. SST with transitional model and original mesh; D. 
RNG with original mesh. 
 
Velocity vectors and TKE contours are shown in FIGURES 7.2.2 and 7.2.3 respectively to 
compare the different turbulence models and mesh sizes. The flow field was affected by the 
Coanda effect; the main jet coming out of the supply slot attached to the right wall and moved 
around the chamber along the walls and floor before returning to the air handling unit. Low 
velocity magnitude was found in the center of the chamber, where a large eddy formed. In 
FIGURE 7.2.2, the SST model over-predicted velocity magnitude in the eddy in the upper right 
corner compared to the experiment of Liang. Adding the transitional model improved this slightly, 
but was still not as accurate as the RNG model. Otherwise all the models predicted the velocity 
field very similarly, and generally agreed well with experiment measurement. The two meshes 
with the SST model showed similar results. In FIGURE 7.2.3, high TKE was generally associated 
with the main stream going around the chamber. The SST model predicted higher TKE than the 
RNG model, especially near the inlet. Elsewhere, the SST model predicted TKE similarly with 
the RNG model, but the SST with transitional model falsely showed high TKE in the center of 
chamber. On the other hand, the RNG model generally predicted TKE well, except near the return, 
where it showed some high TKE values, which was not detected in the experiment. The two 
meshes with the SST model showed very similar TKE results as well. In summary, the RNG 
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model was slightly better than the SST model. The full transitional model did not make the 
prediction of the SST model more accurate. 
 
The second benchmark test was based on a published model in Wang 2009 and Jin 2012. In their 
studies, both the SST and RNG models agreed well with experiment for velocity profiles. 
However, the SST over-predicted TKE, while the RNG prediction was accurate. As a summary, 
the RNG model was more accurate in the recirculation zones. 
 
 
FIGURE 7.2.4 Perspective view of the three-dimensional model (left) and the original mesh (right) for the 
second benchmark test. 
 
The model for the second benchmark test featured a transitional inlet boundary condition, 
turbulent flow, and mixed convection in a room with a box. The room was cubic with each side of 
244 cm. The box was placed in the center of room, and had each side of 122 cm. The inlet slot 
was 3 cm wide, and outlet slot was 8 cm wide. The inlet velocity was 45.5 cm/s normal to the 
inlet face, and the temperature was 22.2 ˚C. The temperatures of box surface, ceiling, surrounding 
walls, and floor were 36.7 ˚C, 25.8 ˚C, 27.4 ˚C, and 26.9 ˚C, respectively as given in the 
referenced papers. The original mesh had 54630 nodes and 48960 hexahedra elements, and the 
fine mesh had 103399 nodes and 94544 hexahedra elements. The RNG model was tested for both 
meshes this time. The three-dimensional model and original mesh are shown in FIGURE 7.2.4. 
The convergence criteria were 1e-5 for the RMS residuals in the momentum, mass conservation, 
and energy transport equations. To compare with the published results, all the physics being 
studied located along the vertical line at the “position 6” in the original paper. The coordinate of 
Inlet (supply) slot 
Outlet (return) slot 
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the line based on the model’s top view was (23 cm, 122 cm), and is shown as an “X” in FIGURE 
7.2.5. 
 
 
FIGURE 7.2.5 Location of the “Line 6” denoted as an “X” at (23, 122) in the top view of the room model. 
All coordinates are shown in centimeters. 
 
From the velocity profiles along the Line 6 (FIGURE 7.2.6), the SST model over-predicted the 
velocity near the floor, and the transitional model improved the accuracy. The RNG model with 
both mesh sizes agreed well with experiment. In FIGURE 7.2.7, both SST models and the RNG 
model with either mesh size under-predicted the TKE near the floor and ceiling compared with 
experiment. In other locations, all the models predicted TKE well. For temperature profiles 
(FIGURE 7.2.8), all simulation results were greater than the experimental data, but the RNG 
model with both mesh sizes had better accuracy than the SST models. The full transitional model 
improved the prediction accuracy of the SST model. In the second benchmark test, adding the full 
transitional model slightly improved the overall prediction of the SST model, but it was still not 
as good as the RNG model. Due to the buoyancy flow in this benchmark test, the convergence 
was much slower than that of the first benchmark test. Based on the two benchmark tests as well 
as the published studies, the RNG k-ε model was chosen for the current environmental chamber 
simulation. 
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FIGURE 7.2.6 Dimensionless height from floor versus dimensionless velocity (dimensionless velocity 
profile) along “Line 6” with different turbulence models and mesh sizes. 
 
 
FIGURE 7.2.7 Dimensionless height from floor versus dimensionless TKE (dimensionless TKE profile) 
along “Line 6” with different turbulence models and mesh sizes. 
 
 
FIGURE 7.2.8 Dimensionless height from floor versus dimensionless temperature (dimensionless 
temperature profile) along “Line 6” with different turbulence models and mesh sizes. 
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7.2.4 Modeling the round supply diffuser with the momentum method 
Other than the selection of a turbulence model, the modeling of the inlet boundary at the air 
supply diffuser was also critical for simulation accuracy (Memarzadeh 2000b; Srebric 2001). One 
solution was to model the supply diffuser with full detail, but the complex geometry would 
require an impractical amount of computational power to mesh and execute the simulation. This 
could also make convergence more difficult, while still not guaranteeing better accuracy. One 
reason was the different length scales required by the diffuser and the rest of the chamber, 
causing difficulty in mesh transition. Moreover, the turbulence model and other CFD settings 
suitable for the indoor air flow might not be suitable for the flow pattern between the diffuser 
vanes (Chen 2001b; Srebric 2001). 
 
Therefore, several simplification methods for the inlet boundary condition have been developed 
for a fast and accurate simulation. These methods generally include the box method and the 
momentum method (Heikkinen 1991; Emvin 1996; Chen 2001b; Srebric 2001, 2002; He 2005). 
In short, the box method requires setting up an imaginary box containing the diffuser, and the 
assignment of velocity, temperature, and other conditions measured on the box boundaries. For 
the momentum method, on the other hand, the actual diameter of the diffuser is often used. By 
measuring volumetric flow rate and discharge velocity, an effective opening area is calculated 
and assigned to the model to decouple the momentum and mass conservation boundary 
conditions (Emvin 1996). Studies have been conducted to compare the two methods for different 
air supplies. For the round diffuser used in the current study, the momentum method is 
recommended due to its better accuracy in the jet region and fewer measurements that are 
required (Srebric 2001, 2002; He 2005). 
 
As introduced above, to model both flow rate and jet penetration accurately for the diffuser, the 
momentum method uses an effective diffuser height instead of the actual one (FIGURE 7.2.9). 
The effective diffuser height can be calculated from the discharge jet velocity at the diffuser 
perimeter, diffuser diameter, and volumetric flow rate: 
      
    
  
 
 
   
, (7.2.7) 
where Heff is the effective diffuser height, Aeff is the effective diffuser opening area, D is the 
model diameter which is usually the physical diameter of the diffuser, Q is the volumetric flow 
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rate, and U is the discharge velocity at the perimeter of the diffuser. Note that the effective 
diffuser height depends on the flow rate, thus it is not a constant; for another flow rate, the 
measurement and calculation need to be carried out again. 
 
 
FIGURE 7.2.9 Cross-section of the round supply diffuser (solid lines) and its boundaries (dashed lines) 
used for the momentum method (EQUATION 7.2.7). 
 
 
FIGURE 7.2.10 Jet velocity magnitude versus horizontal distance from the center of diffuser measured by 
the TSI VelociCheck hot wire anemometer, with “X” marking the location of the perimeter of the diffuser 
for the discharge velocity U in EQUATION 7.2.7. 
 
In the current study, as the product information was not available for the diffuser, jet velocities 
were measured along the line from the supply diffuser to the return grille at the test ventilation 
rate of 53 ft
3
/min (1500 l/min) (FIGURE 7.2.10). The measurement was taken with a hot wire 
anemometer (Model 8330 VelociCheck, TSI, Inc., Shoreview, MN) at its fast mode for the 
average velocity for the last three seconds. The discharge velocity at the perimeter of the 10 in 
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(25.4 cm) diffuser was thus found to be 248 ft/min (1.26 m/s). Using EQUATION 7.2.7, the 
effective diffuser height was calculated to be 2.4 cm. 
 
Using the air kinematic viscosity (ν) of 15.11e-6 m2/s, the Reynolds number at the model inlet 
was estimated. The characteristic length or the hydraulic diameter of the modeled channel 
geometry was twice of the channel width, and was 4.9 cm. The corresponding Reynolds number 
was found to be 4003. For flow through the actual diffuser vanes, the characteristic length was 
twice the vane width, and was 2.5 cm. The average velocity between the vanes was measured to 
be about 320 ft/min (1.63 m/s). The corresponding Reynolds number was found to be 2740. Both 
Reynolds numbers suggest a typical low Reynolds number transitional inlet boundary condition. 
To accurately calculate the turbulence intensity at the inlet was difficult, as the flow in the 
diffuser was not fully developed. For typical HVAC cases, however, a medium intensity (about 
5%) is generally recommended (ANSYS 2010), and the flow pattern was found to be very similar 
for the intensity set between 4% and 37% (Chen 2001b). 
 
For the round diffuser, the asymmetry of the inlet air flow profile caused by the turning of the 
flexible duct upstream of the diffuser should be minimized and any offset should be considered in 
the simulation. The flexible duct upstream of the diffuser in this study was kept straight for 
greater than 10 times its inside diameter which was 6 in or 15.2 cm. Measurement was done at 
four orthogonal directions at 3 in (7.6 cm) distance from the center of diffuser. The relative 
standard deviation with regard to the mean (320 ft/min or 1.63 m/s) was only 1.4%, thus the 
diffuser velocity profile can be considered symmetric. 
 
7.2.5 Flow field simulation setup 
The main dimensions of the three-dimensional chamber model are listed in TABLE 7.2.1. The 
other components, including two UV lamps, two humidifiers, and a vacuum pump were modeled 
as simple blocks with dimensions roughly containing their physical bodies to save simulation 
time and storage space. 
 
As in the benchmark tests, two meshes were created to check grid independence. The original 
mesh had 80779 nodes and 446062 tetrahedra elements, and the fine mesh had 156184 nodes and 
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873448 tetrahedra elements. Each mesh was refined at necessary locations where large gradients 
were expected or small surfaces were created. To ensure good simulation accuracy, mesh quality 
was strictly controlled according to the CFX mesh quality requirements on skewness, 
orthogonality, aspect ratio, and expansion factor (ANSYS 2010). The CFD model and the original 
mesh are shown in FIGURE 7.2.11. 
 
TABLE 7.2.1 Main dimensions of the three-dimensional CFD model. 
Item Dimensions [m] 
Chamber 1.950 (width) by 1.950 (depth) by 1.450 (height) 
Round supply diffuser 0.254 (diameter) by 0.024 (height) 
Square return grille 0.279 (side length) 
Ceiling recessed light 0.127 (diameter) 
Pump exhaust 0.024 (diameter) 
Pump make-up 0.050 (diameter) 
Aerosol injection and sampling tubes 0.013 (diameter) by 0.010 (length) 
 
 
FIGURE 7.2.11 Perspective view of the three-dimensional CFD model (left) and its original mesh (right). 
 
To be more accurate with non-isothermal flow simulation, a table of air properties at standard 
pressure was imported for interpolation. A simplified version is shown in TABLE 7.2.2. 
Absorption of radiation energy from the lamps by air was neglected. 
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TABLE 7.2.2 Air property table used for the non-isothermal simulation (cutted version). 
Temperature T [˚C] -50 0 40 80 120 160 200 
Heat capacity cp [kJ/kg/K] 1.005 1.005 1.005 1.009 1.013 1.017 1.026 
Heat conductivity k [W/m/K] 0.020 0.024 0.027 0.030 0.033 0.036 0.039 
Density ρ [kg/m3] 1.534 1.293 1.127 1.000 0.898 0.815 0.746 
Dynamic viscosity µ [kg/m/s] 1.46e-5 1.72e-5 1.91e-5 2.09e-5 2.27e-5 2.43e-5 2.58e-5 
 
TABLE 7.2.3 Boundary conditions for flow field simulation. 
Boundary location (boundary type) Conditions 
Round supply diffuser (inlet) Normal speed = 1.26 m/s 
Turbulence intensity = 5% (medium) 
Temperature = 21.7 ˚C 
Square return grille (outlet) Average static pressure = -25 Pa 
Aerosol injection (inlet) Normal speed = 1.07 m/s 
Temperature = 20.2 ˚C 
Aerosol sampling (outlet) Normal speed = 3.55 m/s 
Pump exhaust (inlet) Normal speed = 1.49 m/s 
Temperature = 73.8 ˚C 
Pump make-up (outlet) Normal speed = 0.10 m/s 
Pump surfaces (wall) Temperature = 73.8 ˚C 
Recessed light diffuser (wall) Temperature = 34.7 ˚C 
Supply diffuser side UVGI lamp (wall) Temperature = 32.0 ˚C 
Return grille side UVGI lamp (wall) Temperature = 41.4 ˚C 
Chamber walls and floor (wall) Temperature = 21.1 ˚C 
Other surfaces (wall) Adiabatic 
 
The boundary conditions in the model were the same as those used in the UVGI viral aerosol tests. 
Temperatures were measured with thermocouples and a hygrometer, and flow rates were 
measured with mass flow meters. The measuring equipment has been introduced in Chapter 2. 
The measurements were either taken by the data logging system during the tests, or conducted 
separately such as the pump surface temperature and the injection flow rate. The square return 
grille was not modeled in detail, as its effect on the flow field in the chamber could be neglected. 
The detailed boundary conditions are listed in TABLE 7.2.3. The no-slip condition was applied to 
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all wall boundaries. The chamber walls and floor temperatures were set to the same value, 
because the thermocouples at these locations showed similar readings throughout the tests. 
 
Due to flow fluctuation caused by buoyant flow, difficulty in convergence was expected using 
steady state simulation as in the second benchmark test. Therefore, a transient simulation was 
conducted instead to facilitate convergence. For time step control, the whole simulation was 
defined by two parts. The first part (flow field) used a greater time step size to make the 
simulation quickly reach steady state, and in the second part, a smaller time step was used to 
reduce residuals for convergence and for particle tracking. The time step size for the first part was 
1 second, and the total simulation time was at least 1000 s (greater than 15 min). The time step 
size for the second part was 0.5 second. In both parts, 5 coefficient iterations were performed for 
each time step. The coefficient iterations made the coefficients in the simulation equations more 
accurate before the flow field marched to the next time step, keeping the residuals low to 
facilitate convergence. 
 
The turbulence model was the RNG k-ε model, as it was proven to be more suitable for the 
current study than the standard k-ε or the SST model in both the benchmark tests and some 
previous studies. High resolution discretization scheme was used to reduce numerical diffusion 
throughout the simulation (Emvin 1996). In short, the high resolution setting is an automatic 
blend of first-order and second-order schemes to achieve the balance between performance and 
accuracy (ANSYS 2010). The high resolution setting was also used for simulating turbulence, but 
no significant difference was found between this and the first order setting. For convergence 
criteria, 1e-5 was used for the RMS residuals in momentum, continuity, and energy equations. 
Additionally, a conservation target of 1% was set for momentum, continuity, and energy 
equations to ensure global balances in the converged results. In order to further improve 
simulation accuracy, the CFX double precision solver was used to run the simulation (ANSYS 
2010). 
 
7.2.6 Flow field simulation result 
The results of the original mesh and the fine mesh were first compared to check grid-
independence. Since transient simulation was performed separately using each mesh, and the 
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results were oscillating even after convergence, the comparison should be made at different time 
steps, rather than at any specific time point. 
 
 
FIGURE 7.2.12 Comparison of the jet velocities at 0.635 m from the center of supply diffuser for the two 
meshes. 
 
 
FIGURE 7.2.13 Comparison of the return air temperatures for the two meshes. 
 
The jet velocities at 0.635 m from the center of the supply diffuser toward the return grille were 
first compared (FIGURE 7.2.12). Both meshes gave similar results, which were about 0.33 m/s, 
very close to the measurement shown as the last data point in FIGURE 7.2.10. Since the jet 
velocity primarily depended on the inlet boundary condition, the values were stable from the start 
of simulation. For the return air temperature (FIGURE 7.2.13), both meshes gave steady state 
values around 297.7 K (24.5 ˚C), which are very close to the measurement by the return air 
hygrometer during the tests. An additional transport equation, in a form similar to EQUATION 
7.2.3, was also solved for the ratio of aerosol concentration at the sampling location over that at 
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the injection location. To solve this quantity, a unit concentration was set at the injection 
boundary, and the kinematic diffusivity of 1.74e-11 m
2
/s
2
 was set for the transport equation for 
1.5 µm particles. In FIGURE 7.2.14, both meshes gave similar steady state values that were about 
0.6%, suggesting that about 0.6% of the injected 1.5 µm aerosol was present at the sampling 
location at steady state. Overall, the original and fine meshes gave similar results that agree with 
the experiment. 
 
 
FIGURE 7.2.14 Comparison of the ratios of aerosol concentration at the sampling location over that at the 
injection location for 1.5 µm particles for the two meshes. 
 
 
FIGURE 7.2.15 Decay of the diffuser jet by measurement and by simulation at different simulation times 
with the original mesh. 
 
With the original mesh, the maximum y+ was 18.7. Although not small enough to solve flows 
within boundary layers, the mesh met the requirement for the RNG k-ε turbulence model as y+ 
was much smaller than 200 (He 2005; ANSYS 2010). The flow field calculated using the original 
mesh was further verified with the diffuser jet decay profile along the jet centerline from the 
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supply diffuser toward the return grille. Due to small oscillations in the results after convergence, 
experimental data were compared with simulation results at different time steps (FIGURE 7.2.15). 
Generally, the measurements were slightly lower than the simulation results. The reason could be 
errors due to the simulation algorithm, inaccurate input of boundary conditions such as the 
volumetric flow rate, or the asymmetric velocity profile around the diffuser. 
 
 
FIGURE 7.2.16 Velocity vectors near the left wall at 1793 s (A), 1893 s (B), 1993 s (C), 2093 s (D), and 
2193 s (E) simulation times with the original mesh. 
 
Flow visualization was also conducted using a fogger to verify the flow field near the left wall, 
the other side of the diffuser with regard to the jet decay measurements. The simulation results at 
different time steps are shown in FIGURE 7.2.16. Similar to the jet decay profiles, the velocity 
vectors near the upper part of the left wall did not change significantly over time, as they were 
very close to the diffuser inlet boundary. For the visualization, the fogger generated fog by 
injecting steam onto liquid nitrogen. The visualization was focused on the top part of the left wall, 
where the fog density was the best, and the velocity was relatively high. A group of photos were 
taken at the rate of 3 frames per second (fps) (FIGURE 7.2.17). The fog could be seen while it 
was moving downward and being dissipated. Photos were also taken at 5 fps to calculate the 
velocity more accurately. The visualized flow pattern agreed well with the simulation results, and 
both velocity magnitudes were about 0.2 m/s in the region just below the UVGI lamp. 
 
 
 
 
A B 
C D E 
92 
 
 
FIGURE 7.2.17 Flow visualization near the left wall and the supply diffuser with the frame sequence from 
1 to 4 recorded at 3 frames per second. Photos were converted to negative in grayscale. 
 
The flow field results at the center plane of the chamber which includes the injection and the 
sampling points are shown in FIGURES 7.2.18-7.2.20. The results were obtained with the 
original mesh at 2193 s time step. The diffuser jet is obvious along the ceiling in the velocity 
plots, and the maximum velocity of 3.55 m/s is at the sampling location. For TKE, higher values 
were generally associated with higher velocities close to the regions of diffuser jet, return air 
grille, injection outlet, and sampling inlet. From the temperature distribution, the wall temperature 
was lower than the bulk air temperature, which was generally isothermal. Due to the 
thermophoresis effect, this temperature difference could enhance aerosol deposition onto the 
chamber walls, but the effect should not affect the relative recovery or survival of the test viruses 
as their physical losses were measured. 
 
Air flow direction 
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FIGURE 7.2.18 Velocity vectors (left) and velocity contours (right) at the chamber center plane using the 
original mesh at 2193 s time step. 
 
 
FIGURE 7.2.19 Turbulence kinetic energy contours at the chamber center plane using the original mesh at 
2193 s time step. 
 
 
FIGURE 7.2.20 Temperature contours at the chamber center plane using the original mesh at 2193 s time 
step. 
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7.3 Particle tracking 
7.3.1 Simulation parameters 
Particle trajectories were calculated in the Lagrangian framework. Since impactor stage 5 
collected the largest amount of particles (more than 40%) by mass, trajectories were calculated 
for monodispersed particles with an aerodynamic diameter of 1.5 µm, which was the geometric 
mean diameter of this impactor stage. Both gravitational settling and Brownian motion were 
neglected for this particle size (Hinds 1999; Gao 2007). By definition, the drag force (FD) on a 
spherical particle is: 
    
 
 
         
 , (7.3.1) 
where CD is the drag coefficient, ρf is the fluid density, Ap is the cross-sectional area of the 
spherical particle, and Ufp is the relative velocity between fluid and particle. In CFX, CD is 
calculated using the Schiller-Naumann model: 
    
  
  
               , (7.3.2) 
which has been reported to be accurate (<10% error) for the particle Reynolds number smaller 
than 1000 (Hinds 1999). It approaches the Stokes model (CD=24/Re) as Reynolds number 
decreases. If particle density is assumed to be the same as water density, the particle Reynolds 
number for the selected particle size is about 0.1Ufp. According to the simulated velocity field, the 
maximum particle Reynolds number was about 0.1. Thus the Schiller-Naumman model could 
give an accurate estimation of the drag coefficient. However, CFX does not include the 
Cunningham slip correction factor in the particle momentum equation. Since the factor is about 
1.10 for 1.5 µm particles, the calculated drag force is about 10% greater than the actual value. 
This offset is equivalent to simulating particles slightly larger than 1.5 µm, and was assumed not 
to significantly affect the trajectory results, as the movement of these particles was expected to 
always follow the instantaneous streamlines due to their short relaxation times (Gao 2007). 
 
Due to the small volumetric fraction of the particles present in the chamber air, their effect on 
turbulent flow patterns could be neglected. Therefore, a one-way coupling simulation was 
performed for particle tracking, which made the simulation faster and the convergence easier than 
the two-way coupling option (Memarzadeh 2000b; Wong 2010). The wall boundaries can be 
treated as sticky, not sticky, or somewhere in between for the particles contacting them. Previous 
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studies have shown that whatever selection was used did not affect the final results significantly 
(Memarzadeh 2000b). Since the particles simulated in this study were very small, the adhesive 
forces including van der Waals and electrostatic attraction forces exerted on them at the 
boundaries were considered too large to be overcome, thus the 100% sticky model was applied. 
For particles small enough (usually smaller than 20 µm), they would instantly (within 1 second) 
reduce to droplet nuclei which was about half of their original size coming out of the nebulizer 
(May 1973; Ijaz 1987; Sattar 1987; Weber 2008; Atkinson 2009). Therefore, the particles were 
assumed to be at equilibrium out of the injection inlet boundary, and thus the evaporation process 
was not simulated. Instead, a lower temperature was assigned to the nebulizer output in the CFD 
model to include the evaporation effect. Coagulation of particles was not simulated either, since 
the particle concentration in the chamber was too low to make its effect significant (Wong 2010). 
 
Since much of the flow field in the chamber was turbulent, aerosol generated from the nebulizer 
could move nearly anywhere before being collected by the impactor. This resulted in diverse 
particle trajectories and UVGI doses received. Therefore, a large number of particle trajectories 
must be calculated to reach statistical stability before further inactivation analysis could be 
carried out. In the simulation, particle material properties were assumed to be the same as water 
properties, with a density of 998 kg/m
3
 and a heat capacity of 4.18 J/g/K. After the flow field 
simulation was stabilized and converged, particles were generated uniformly on the injection 
surface at the rate of 100 particles per second for about 1000 s of simulation time to reach 
statistical stability. 
 
7.3.2 Particle tracking result 
The trajectories of some collected particles are shown in FIGURE 7.3.1. The particles coming out 
of the injection inlet boundary were firstly entrained in the diffuser jet close to the left UVGI 
lamp, and then dispersed in the turbulent flow field. Particles may travel to nearly any place in the 
chamber before being collected. However, a main path seems to exist according to the plotted 
trajectories and velocity vectors. By this path, particles could travel to the sampling inlet with a 
shorter residence time than by most other paths. 
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FIGURE 7.3.1 Trajectories of the collected particles (left) and velocity vectors on the chamber center 
plane (right) with the most likely path marked with dashed lines. 
 
 
FIGURE 7.3.2 Histogram of residence time of 350 and 990 sampled particles. 
 
The histogram of residence time from injection to sampling is shown in FIGURE 7.3.2. To test 
whether statistical stability was reached, simulation was stopped when 350 particles had been 
collected, and then the simulation was continued until the final 990 particles had been collected. 
For the first 350 particles, the geometric mean residence time was 115.6 s, and the median was 
130.7 s. For the total of 990 particles, the geometric mean residence time was 114.8 s, and the 
median was 125.8 s. The difference in the geometric mean residence time between the two groups 
of particles was smaller than 1%. These residence times were also close to the measured 
residence time which was 126+/-6 s (Appendix II). In the histogram, most particles sampled had 
the residence times shorter than 60 s, possibly related to the main path shown in FIGURE 7.3.1. 
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7.4 UVGI simulation 
7.4.1 Background 
The most frequently used methods for calculating the irradiance from a linear emitter may be the 
point-source summation (PSS) method and the line-source integration (LSI) method (Blatchley 
1997; Noakes2004b; Ducoste 2005; Sozzi 2006). Both methods are based on the inverse square 
law, by which irradiance is proportional to the inverse of square of the distance away from source. 
They also assume that irradiance is linearly additive at any point in the field and linearly 
proportional to the power of the lamp (Summer 1962; Miller 2000). The PSS method treats the 
light source as many identical points, each of which emits the same amount of energy per unit 
time. The total irradiance at any location in the field is calculated by summing the contribution of 
each source point. In order to achieve good accuracy, a large number of points are needed, but as 
the number grows, the requirement for computational power also grows. To overcome this, its 
continuous version, the LSI method was developed. However, both methods tend to over predict 
irradiance in the near field of a source, although this may not be a problem for most HVAC 
applications (Blatchley 1997; Sozzi 2006). 
 
Another method used to calculate irradiance is the Monte-Carlo method, which tracks a great 
number of energy bundles (or photon packs) through a series of events in which each bundle may 
be scattered or reflected until being absorbed or a predefined distance has been reached. The 
Monte-Carlo method makes the description of a complex problem conceptually simple, thus it is 
great for the problems which cannot be solved analytically. However, computing time for 
convergence is known to be a major drawback (Patterson 1991; Rogers 1995). Since the Monte 
Carlo method relies on random numbers and probability distribution functions, statistical stability 
must be achieved to get meaningful results. On the other hand, the accuracy of results increases 
with the number of tests (bundles or trajectories) by the Law of Large Numbers. With the 
advancement of computer technology, this obstacle has become less formidable, and the Monte 
Carlo method would become more and more popular for a wider range of applications. 
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FIGURE 7.4.1 Illustration of the parameters in EQUATION 7.4.1 for calculating the irradiance 
contributed by the linear light source on one side of the point of interest. 
 
Empirical equations based on the inverse square law have also been used to roughly simulate 
irradiation from a linear emitter (Beggs 2000; ASHRAE 2008). Because it was easy to be 
integrated into the CFD program, the current simulation used one of these equations provided in 
the ASHRAE Handbook (ASHRAE 2008): 
   
 
 
 
           
    
, (7.4.1) 
where E [W/cm
2
] is the UVC irradiance contributed by the part of lamp on one side of the point 
being calculated, Φ [W] is the emitter's output power, L [cm] is the emitter's effective length, A 
[cm] is the perpendicular distance from the point to the linear emitter, and α [rad] is the view 
angle from the point (FIGURE 7.4.1). For the UVGI lamps used in the current study, Φ was 6.9 
W, and L was 17 in (43 cm). 
 
Several assumptions were made or tested to apply EQUATION 7.4.1: 
1. The UVGI transmission was not affected by air molecules (N2, O2, CO2, and H2O) for the short 
transmission distances in the chamber. This can be proven based on the absorption spectra and 
small polarizabilities of the molecules for Rayleigh scattering (Tarafdar 1969; Huffman 1992; 
Ultraviolet radiation guide 1992). 
2. The irradiation was not weakened by fog or smoke generated by the humidifiers and vacuum 
pump (Miller 2000). By measurement with a radiometer (Solarmeter Model 8.0, Solartech, 
Inc., MD), up to 30% reduction of irradiation was found in a very small region close to the 
humidifier outlets, where most particles would travel through in a very short time if they ever 
arrived at the region. Additionally, humidifiers were not running for the most part of the UVGI 
tests. 
Φ/L 
α 
E 
A 
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3. The reflection of 253.7 nm UVC light on the chamber interior surfaces was neglected. It has 
been reported that the type of paint might be a significant factor (Thurston-Enriquez 2003). 
The paint used for the chamber interior was a semi-gloss acrylic latex white paint for exterior 
use (BEHR Premium Plus Ultra). Its main ingredients were acrylic polymer, titanium dioxide, 
and water. The reflectance of about 5% has been reported for this type of paint (Blatchley 
1997; Kowalski 2009; Uemoto 2010). In an experiment, no reflection was detected when 
pointing a radiometer in a direction away from the UVGI lamp. The UVC light hitting the 
acrylic door was considered to be 100% absorbed as well (Laube 2004). 
 
Even if the above assumptions are valid, errors could still exist due to the empirical equation 
itself or the reduced lamp output which might be caused by the actual operation hours, conditions, 
and fouling of the lamp surfaces. Therefore, a correction factor C was added to EQUATION 7.4.1 
for this study: 
        
 
 
 
           
    
. (7.4.2) 
The correction factor was determined based on measurements made at different distances from 
the lamp at the test conditions (FIGURE 7.4.2). The measurements were taken for each lamp 
individually with a radiometer after a 30 min warm-up period. Both lamps showed similar outputs 
as expected. The discrete correction factors were first obtained by comparing the irradiances 
calculated with EQUATION 7.4.1 and those experimentally measured. They were then curve 
fitted for the continuous function.  With R
2
 of 0.95, the correction factor function becomes: 
                   
 
     . (7.4.3) 
 
The irradiance curves based on the original equation (EQUATION 7.4.1), the corrected equation 
(EQUATION 7.4.2), and the experimental data are compared in FIGURE 7.4.2. From the 
comparison, it can be seen that the original equation led to overestimation for the near field 
similar to the PSS and LSI methods. The overestimation might be tolerable for common HVAC 
applications, as it was only significant within about 20 cm from the UVGI lamp. However, for the 
current study, as the aerosol could get very close to the UVGI lamps, the accuracy for the near 
field became important. 
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FIGURE 7.4.2 Correction factor C (left) and irradiance E (right) versus the distance A from a UVGI lamp. 
The original equation (EQUATION 7.4.1), corrected equation (EQUATION 7.4.2), and experimental 
measurement (error bars for standard deviation) are compared for irradiance. 
 
7.4.2 UVGI field in the chamber 
The corrected UVGI equation was integrated into the CFD simulation via additional user defined 
variables and equations to calculate the UVGI field in the chamber. The UVGI field was 
calculated as if the chamber were empty without any equipment inside even though they were 
modeled for the flow field simulations. As a result, irradiance was over predicted in the blind 
spots where the UVC light was actually blocked by the equipment. This simplification should not 
affect the final UVGI dose result significantly, since the affected regions were generally close to 
the floor, where the irradiance was already weak, and the time spent by particles was relatively 
short as can be seen from the trajectories shown in FIGURE 7.3.1. Contour plots of irradiance in 
the chamber are shown in FIGURE 7.4.3, from which, the four corners near the ceiling received 
the lowest irradiance, given that the blind spots on the floor were not considered. 
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FIGURE 7.4.3 Contour plots of UVGI irradiance on the chamber interior planes at floor (A), ceiling (B), 
front wall (C), center plane (D), and left wall (E). 
 
7.5 Dose distribution and viral aerosol inactivation 
UVGI dose received by each tracked particle was consequently obtained by integrating the UVGI 
irradiance along the particle’s trajectory. FIGURE 7.5.1 shows a histogram of the dose received 
by the collected particles. For the first 350 particles, the geometric mean was 11.5 mJ/cm
2
, and 
the median was 12.4 mJ/cm
2
. For the total of 990 particles, the geometric mean was 11.4 mJ/cm
2
, 
and the median was 11.8 mJ/cm
2
. The difference in the geometric mean dose received by the two 
groups of particles was below 1%. 
 
Virus susceptibility could now be solved with the dose histogram and an inactivation model. 
Virus inactivation by UVGI can be assumed to be exponential, similar to other microorganism 
inactivation processes (Hollander 1943; Koch 1966; Shimojo 1971; Riley 1989; Mbithi 1991; 
Beggs 2002a, 2002b; Whiting 1991; Memarzadeh 2000a, 2004; Nuanualsuwan 2002; Noakes 
2004a, 2004b, 2006; Ducoste 2005; Ko 2005; Tseng 2005b; Hijnen 2006; Sozzi 2006; McDevitt 
2010; Piercy 2010). The inactivation rate due to UVGI directly depends on the UVGI dose 
received by the microorganism: 
 
 
 
 
 
 
 
A B 
C D E 
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, (7.5.1) 
              
      , (7.5.2) 
where for the virus that received dose Di (mJ/cm
2
), CUVGI is the live virus titer with UVGI, C0 is 
the live virus titer if UVGI were not present, Ri is the proportion of collected virus that received 
dose Di, and Z (cm
2
/mJ) is the virus susceptibility to UVGI. The Z value in EQUATION 7.5.2 has 
been discussed in detail in several publications (Riley 1976; Peccia 2001a, 2004; Beggs 2002b; 
Xu 2003). It depends on several factors including virus type, strain, suspension medium, and 
humidity. The greater the Z value, the more susceptible the microorganism is. In this study, the 
live virus titers were substituted with relative recoveries to account for the differences in 
nebulizer fluid concentration and physical loss between different tests: 
 
           
              
      
      . (7.5.3) 
Because the total virus measurement was affected by UVGI as discussed in Chapter 6, the 
measured survival could not be used here. The dose (D) that a particle received can be calculated 
using the following equation: 
       , (7.5.4) 
where ∆t is the time step size, and E is the irradiance the particle received at a time step.  
 
 
FIGURE 7.5.1 Histogram of dose received by 350 and 990 sampled particles. 
 
The simple exponential (or log-linear) model has shown inaccuracy in the low and high 
inactivation regions. A more complete model contains a shoulder before the log-linear region and 
a tail after it (FIGURE 7.5.2). In most cases the shoulder is not significant, unless the dose 
received is sub-lethal and a reactivation mechanism exists (Casarett 1968; Cerf 1977; Munakata 
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1991; Pruitt 1993; Kowalski 2001; Beggs 2002a). When the regression line intercepts the y-axis 
above unity, it shows strong evidence that the shoulder effect is significant, and it could be due to 
either low irradiation levels or high resistance of the microorganism (Kowalski 2001; Thurston-
Enriquez 2003). For the most resistant virus in this study, no shoulder effect was found for 
HAdV-1 in previous studies (Nuanualsuwan 2002; Nwachuku 2005; Hijnen 2006). 
 
Dose [mJ/cm
2
]
Survival
Shoulder Log-linear Tail
1
 
FIGURE 7.5.2 A typical curve for microorganism inactivation by UVGI, including shoulder, log-linear, 
and tail regions. 
 
After the log-linear region, the inactivation rate decreases, forming the tail region (Xu 2003; 
Blatchley 2007; Memarzadeh 2010). The tail usually happens above 99% inactivation, and is 
more obvious for more susceptible microorganisms, and thus is not likely to be observed for 
resistant species like adenoviruses and MS2 (Qualls 1983; Smerage 1993; Hijnen 2006). It is 
probably due to the more resistant population of the microorganism or the shielding effect (Moats 
1971; Riley 1972; Cerf 1977; Davidovich 1991; Whiting 1991; Fujikawa 1996; Kowalski 2000, 
2001; Beggs 2002a; Pennell 2008). 
 
Not many data exist for viral aerosol inactivation by UVGI, but more data are available for 
inactivation in water (or other liquid suspensions). Virus in the airborne state is usually more 
vulnerable to UVGI than in the waterborne state, thus the susceptibility based on water tests could 
be used as conservative estimates for air disinfection purposes (Kowalski 2009). Due to test 
uncertainties and different test conditions, the differences in obtained virus susceptibilities to 
UVGI are large between studies. For MS2, the Z-values based on an aerosol test were 0.38-0.48 
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cm
2
/mJ (Walker 2007), but another study showed much greater susceptibilities up to 8.1 cm
2
/mJ 
(Tseng 2005b; Kowalski 2009). In liquid environments, they are generally 0.03-0.17 cm
2
/mJ 
(Meng 1996; Nuanualsuwan 2002; Thurston-Enriquez 2003; Ko 2005; Nwachuku 2005; Hijnen 
2006; Kowalski 2009). For HAdV-1, its Z-values were 0.39-0.68 cm
2
/mJ in aerosol form and 
0.03-0.08 cm
2
/mJ in liquid (Nwachuku 2005; Kowalski 2009). For AIV, the Z-values were 1.06-
1.19 cm
2
/mJ in aerosol and 0.48-1.38 in liquid (Kowalski 2009). 
 
Since only one inactivation rate was obtained for each virus in the experiment, the only 
inactivation model applicable was the simple log-linear model ignoring the shoulder and tail 
regions. This model should be appropriate for the viruses in this study, as their inactivation rates 
were less than 1-log, and the self-repairing or photoreactivation mechanism was not available to 
them. Using this inactivation model, the Z-value for each of the three viruses was calculated and 
is shown in TABLE 7.5.1, in which, MS2 is similar to HAdV-1, and is more resistant than AIV 
by mean value. The susceptibilities obtained in the current study are close to the published data 
for liquids, showing that as long as UVGI photons could reach the nucleic acid, their germicidal 
effect may not depend on the outside environment of the virus. 
 
TABLE 7.5.1 Z-values (susceptibilities) of MS2, HAdV-1, and AIV based on experimental inactivation 
rate, simulated dose histogram, and log-linear kinetics. 
Virus Survival [range of one standard error] Z-value [range of one standard error] [cm2/mJ] 
MS2 0.502 [0.339, 0.743] 0.057 [0.022, 0.098] 
HAdV-1 0.507 [0.403, 0.639] 0.056 [0.035, 0.079] 
AIV 0.255 [0.097, 0.669] 0.132 [0.031, 0.278] 
 
Compared with the published viral aerosol data, however, the virus susceptibilities to UVGI in 
the current study are about one order of magnitude lower. One possible reason could be the 
difference in test facility between the past and the current studies. All the referenced tests were 
conducted in tunnel-like single-pass facilities with the exposure times of only a few seconds, 
much shorter than the 2 min residence time in the current study. Another important difference is 
that the past studies directly compared live virus titers with and without UVGI, without correcting 
for different nebulization rates and physical losses of the test viruses between tests. Additionally, 
as the test data for viral aerosols are very rare, actual susceptibilities of airborne viruses have not 
been determined, and the effects of factors including RH and suspension medium have not been 
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fully tested. The difference between the current result and the published viral aerosol data could 
be due to these factors as well. 
 
For the uncertainties in the current study, one major contributor could be the uncertainty 
associated with live virus titration. Secondly, the corrected irradiance equation might still be 
inaccurate for locations very close to the UVGI lamps, since the measurement closest to the lamp 
was taken at about 13 cm, but the closest point the particles traveled to was only about 4 cm from 
the lamp. Finally, the simplification made in the UVGI field calculation by ignoring all the 
instruments in the chamber could also lead to slightly overestimated doses received by some of 
the tracked particles.  
 
For future work, tests at different UVGI dose levels are recommended to study different 
inactivation models and the effects of shoulder and tail. It would also help reduce the uncertainty 
of the calculated virus susceptibility. Tseng 2005b tested inactivation of viral aerosol by UVGI 
for the irradiance range of 0.06-0.24 mW/cm
2
, and found that irradiance did not significantly 
affect virus inactivation rate as long as the UVGI dose was constant. In this study, the range of 
irradiance in the chamber spanned two orders of magnitude from about 0.01 to 1.30 mW/cm
2
, 
which was much broader than the range tested by Tseng 2005b. This raises the question again 
whether irradiance could be a significant factor for virus inactivation by UVGI. If irradiance 
plays a significant role, the current inactivation kinetics relying only on UVGI dose received 
would be inaccurate. In order to better study all the above aspects, viral aerosol tests should be 
carried out in a specially designed facility with strictly controlled irradiance for lower uncertainty 
and higher accuracy, such as the one that has been used in Tseng 2005b. 
 
7.6 Conclusions 
In this chapter, the transient flow field in the chamber was simulated using CFX. After steady 
state and convergence were reached, particle tracking in the Lagrangian frame was conducted. To 
reach statistical stability, 990 particles were collected by the impactor in the simulation. The 
UVGI field in the chamber was calculated using an empirical equation corrected according to 
experimental data. The dose received by each particle was then calculated by integrating 
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irradiance along its trajectory. Finally, virus susceptibility was obtained by assuming a log-linear 
inactivation model. 
 
The average susceptibility of MS2 was 0.057 cm
2
/mJ with the range for one standard error of 
[0.022, 0.098] cm
2
/mJ. For HAdV-1, the susceptibility was 0.056 [0.035, 0.079] cm
2
/mJ, and for 
AIV, it was 0.132 [0.031, 0.278] cm
2
/mJ. The results are close to the published data for liquids, 
and about one order of magnitude more resistant than aerosol data. This suggests that as long as 
UVGI photons reach the nucleic acid, their germicidal effect may not depend on the outside 
environment of virus. The difference from the published aerosol data was most likely caused by 
the differences in test facility and procedure. However, measurement uncertainties and the 
simplifications made for simulation may also have affected the accuracy of the current results. 
 
Until now, virus inactivation by UVGI was mostly studied as a function of UVGI dose, but 
whether irradiance could significantly affect inactivation for the same dose is not clear yet. If 
virus inactivation is affected when irradiance is very low or very high, like what might have 
happened in the current tests, virus susceptibility to UVGI may not be determined accurately with 
dose alone. However, tests of viral aerosol inactivation by UVGI at different dose levels are also 
recommended to study the inactivation kinetics including the shoulder and tail regions. Overall, 
data for viral aerosol inactivation by UVGI are still very rare, and more tests in specially designed 
facilities with improved uncertainty and accuracy are recommended to test all the aspects 
mentioned above, and for further development of the numerical model. 
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8 Filtration of viral aerosols by HVAC filters 
8.1 Introduction 
HVAC filters are commonly used in hospitals, airplanes, animal barns, and other buildings to 
keep the internal air clean, and reduce infection (Hopkins 1971; Moser 1979; Olsen 2003; Dee 
2006; Yang 2011). HVAC filters especially with the minimum efficiency reporting value (MERV) 
smaller than 14 are significantly less efficient than the high-efficiency particulate air (HEPA) 
filters or the ultra-low penetration air (ULPA) filters, but are more economical due to lower 
pressure drops (Dee 2006; Farnsworth 2006). Their filtration efficiencies can be improved with 
ionization (Huang 2008). Germicidal capability can also be gained from chemical coatings. 
 
Particles going through fibrous filter elements may be caught by one of five mechanisms: 
interception, impaction, diffusion, gravitational settling, and electrostatic attraction. The relative 
importance of these mechanisms depends on particle size and filter face velocity. Generally, 
diffusion is important for particles smaller than 0.1 µm, while impaction and interception are 
important for particles greater than 0.5 µm. Between the two sizes, no mechanism is dominant, 
and the overall filtration efficiency tends to be lower (Hinds 1999; Verreault 2008). A filter’s 
filtration efficiency (ηi) can be calculated as: 
                   
   
   
      , (8.1.1) 
where the subscript i stands for a specific size range, P is the penetration, C is the concentration 
of the live virus, total virus, or fluorescein, and its subscript di or ui stands for downstream or 
upstream location of the filter. 
 
Air filtration has been well studied for HVAC filters using solid particles. Standards are also 
available for tests and applications. However, the filtration behavior of airborne microorganisms 
has not been thoroughly studied. Past studies have suggested that it is the physical properties 
(shape, size, density), rather than the biological properties (viability, chemical composition) that 
influence the behavior of particles in filtration process. Therefore, filtration efficiencies for 
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biological particles could be predicted with non-biological particles of similar physical properties 
(McCullough 1997). If this is true, the currently available test standards and data can be used for 
microorganisms, and the more time consuming biological aerosol tests would become 
unnecessary. It is thus the primary goal of the current tests to check whether the filtration 
efficiency for viruses can be predicted equally well with fluorescein or particle counters. 
 
8.2 Test method 
MS2, HAdV-1, and AIV were tested with two square chemical-free pleated HVAC filters 
(Accumulair brand) of MERV 8 and 13, which are commonly used in HVAC systems. The 
dimensions of the test filters were 9.50 in (24.1 cm) for side length and 1.75 in (4.4 cm) for 
thickness. To test the HVAC filters in the chamber, a test duct was attached upstream of the 
return air grille (FIGURE 8.2.1). Identical flexible Tygon tubing of 50 in (127 cm) length was 
used to connected two identical Andersen impactors with the upstream and downstream sampling 
probes (0.69 in or 1.8 cm ID, and 0.75 in or 1.9 cm OD) which were mounted horizontally, or 
perpendicular to air flow. The anisokinetic sampling efficiency of each sampling probe was 
estimated to be greater than 80% for impactor stages 3-7 (0.4-4.7 µm), greater than 90% for 
impactor stages 4-7 (0.4-3.3 µm), and greater than 95% for impactor stage 5 (1.1-2.1 µm) which 
collected the largest amount of aerosol by mass (Appendix I). Since the sampling efficiency 
depended on particle size, the anisokinetic sampling shifted the particle size distribution curve 
toward smaller sizes. However, if the upstream and downstream sampling efficiencies are 
identical, the anisokinetic sampling should not affect the filtration efficiency results. 
 
As shown in FIGURE 8.2.2, the filter duct had two sections. Each section was 6 in (15.2 cm) long, 
and was of square cross-section of 7.75 in (19.7 cm). The test filter was mounted between the two 
sections, secured with eight C-clamps. The connections between the filter and the duct were 
caulked to prevent air leaking. The upstream and downstream sampling locations were in the 
center of each section, or 3 in (7.6 cm) upstream and downstream of the test filter. The percentage 
scale shown in FIGURE 8.2.2 was used for traverse sampling locations. For viral aerosol tests, 
the sampling locations were always at 50%, or the center of the duct cross-section. For 
preliminary tests, other locations were also used. 
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FIGURE 8.2.1 Schematic drawing of the test setup for the HVAC filter tests. 
 
Because of the similarity of upstream and downstream sampling setups, their sampling 
differences were reduced. However, due to the unavoidable differences between upstream and 
downstream probes, tubing, impactors, and other components, the measured filtration efficiencies 
could still drift from their true values. Therefore, correlation tests were conducted following 
ANSI/ASHRAE 2007 without a filter installed: 
   
                                                            
                                                        
, (8.2.1) 
where R is the correlation ratio used to correct penetrations: 
                       
                    
 
. (8.2.2) 
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FIGURE 8.2.2 Filter duct schematic with main dimensions showing two identical duct sections and a 
percentage scale denoting traverse sampling locations. 
 
The HVAC filter tests were conducted at 25 ˚C, 50% RH, and about 140 ft3/min (3964 l/min) 
volumetric flow rate. The negative pressure in the chamber at the ventilation rate was about 0.36” 
water (90 Pa). Unlike viral aerosol survival, filtration efficiency is unlikely to be affected by 
humidity in the common range (30%-70% RH) (McCullough 1997; Hwang 2012). The nebulizer 
setup for aerosol generation was the same as the previous tests, and the nebulizer fluid ingredients 
for each virus were not changed. Each test was conducted for 60 min with aerosol generation at 
20 psi (138 kPa) compressed air pressure to ensure high concentrations in the downstream 
samples. Viral aerosol samples were taken from the upstream and downstream locations 
simultaneously. Tests were carried out in triplicate and in randomized order for each virus. 
Statistical analysis and ANOVA were carried out for penetration for impactor stages 3-7 as before. 
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8.3 Preliminary tests without virus 
Several preliminary tests without virus were carried out to characterize and validate the test duct 
setup before the viral aerosol tests. The preliminary tests include a pressure drop test, a velocity 
profile test, and a penetration uniformity test. The flow rate for the preliminary tests was the same 
as in the viral aerosol tests, and was about 140 ft
3
/min (3964 l/min). At this flow rate, the average 
face velocity was about 336 ft/min (1.71 m/s), lower than the filter’s designed velocity of 500 
ft/min (2.54 m/s). Operating at a lower face velocity would increase the effects of diffusion and 
electrostatic attraction, while weakening that of inertial impaction. Due to this limitation of the 
test setup, the actual performance of the test filters may not agree with those from standard test 
method. However, the filtration efficiencies for viruses, fluorescein and physical particles could 
still be compared for the primary goal of this group of tests. 
 
The pressure drop of each filter was measured with a differential pressure gauge (Magnehelic, 0-2 
cm water range, 0.05 cm water resolution) using the two aerosol sampling openings on the duct. 
The measured pressure drops were compared with the filter test reports (Blue Heaven 
Technologies, Louisville, KY) provided by the seller (www.filters-now.com). Since the filters in 
the test reports were 2 ft (61.0 cm) by 2 ft (61.0 cm), the corresponding flow rate for the same 
face velocity (336 ft/min or 1.71 m/s) was 1344 ft
3
/min (38057 l/min). For the new MERV 8 test 
filter, the reported pressure drop was about 0.25 cm water, and the measured pressure drop was 
0.30 cm water. For the new MERV 13 test filter, both of the reported pressure drop and the 
measurement were about 0.51 cm water. The agreement shows that the filters were properly 
installed. 
 
Velocity profiles were measured at both upstream and downstream locations with a hot wire 
anemometer (Model 8330 VelociCheck, TSI, Inc., Shoreview, MN) at its “fast mode”, for which 
the average velocity of the last three seconds was displayed. The measurements were taken 
through the aerosol sampling openings on the duct wall as well. Velocities were measured at the 
following traverse locations: 10%, 30%, 50%, 70%, and 90% (FIGURE 8.2.2). All measurements 
were taken with five repeats. The mean values of the measured velocities are shown in FIGURE 
8.3.1 with the standard error for each data point listed in TABLE 8.3.1. 
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FIGURE 8.3.1 Velocity profiles at upstream and downstream locations with and without filter. 
 
TABLE 8.3.1 The standard error [ft/min] for each data point in FIGURE 8.3.1. 
Location (%) 10 30 50 70 90 
Upstream with filter 3.2 3.1 3.1 2.8 8.3 
Downstream with filter 2.9 62.4 65.6 53.3 11.5 
Upstream without filter 3.7 11.8 14.0 9.4 8.1 
Downstream without filter 13.6 4.7 11.9 5.4 8.0 
 
Relative standard deviation or coefficient of variation (CV or COV) was calculated for each 
traversing measurement. With either filter installed, the upstream CV was 6.1%, and the 
downstream CV was 25.0%; without a filter, the upstream CV was 8.7%, and the downstream CV 
was 8.6%. Therefore, installing a filter did not significantly affect the upstream velocity profile. 
For the downstream velocity profile, when no filter was installed, it was similar to the upstream 
profile. When a filter was installed, however, both the maximum velocity magnitude and 
measurement fluctuation became greater. This could be due to the disturbed flow by filter pleats 
or the structural ribs on the filter frame, as the measurements were taken only 3 in (7.6 cm) 
downstream of the filter. From the velocity profiles in FIGURE 8.3.1, it appears that mass 
conservation was violated when a filter was installed. One reason could be the reduction of 
effective passage area in the filter due to pleats and ribs, causing a jet-like flow pattern. Another 
reason could be that the measured velocities were not in the main flow direction due to turbulence. 
The complex flow pattern downstream of a filter might affect the sampling efficiency, causing 
errors in filtration efficiency measurements, which could not be corrected with the correlation test, 
as it only appeared when a filter was mounted. 
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For the penetration uniformity test, aerosols were generated in the same way as the viral aerosol 
tests, except for the nebulizer fluid which used MEM instead of virus stock. Concentration was 
measured alternately between upstream and downstream locations by an optical particle counter 
(OPC) (Lasair 1002, Particle Measuring Systems, Inc., Boulder, CO) at four traverse locations of 
25%, 50%, 75%, and 87.5 % with each filter and without a filter. Each OPC measurement was an 
average of one minute sampling. At least three repeated measurements were taken at each 
location and for each filter. The OPC size channels used for this test are shown in TABLE 8.3.2. 
The 0.3-0.4 µm channel was not used as that size range for virus particles was not studied here. 
The channel for particles greater than 2 µm was not used as well, because the particle counts were 
too low. 
 
TABLE 8.3.2 The four size channels of the OPC used for the concentration uniformity test with geometric 
mean of upper and lower limits shown for each channel. 
Channel (µm) 0.4-0.5 0.5-0.7 0.7-1.0 1.0-2.0 
Geometric mean (µm) 0.447 0.592 0.837 1.414 
 
Similar to the viral aerosol tests, a correlation test was carried out without a filter mounted 
(FIGURE 8.3.2). The correlation ratios did not significantly depend on particle size (p=0.263) or 
traverse location (p=0.467) by ANOVA. Therefore, a single correlation ratio of 0.98 with a 
standard error of 0.04 was used for all particle sizes and traverse locations. The corrected 
penetrations for MERV 8 and 13 are shown in FIGURE 8.3.2. The MERV 8 filter showed higher 
penetration than the MERV 13 filter for all particle sizes. The penetration for the first two particle 
sizes for the MERV 8 filter was greater than unity, meaning that their concentrations downstream 
were higher than those upstream. This could be partly due to the error in the correlation ratio, and 
partly due to the change in downstream flow pattern when the filter was mounted. ANOVA was 
carried out for penetration to study the factors of particle size and traverse location. For the 
MERV 8 filter, particle size was significant (p<0.001), and traverse location was not (p=0.941). 
For the MERV 13 filter, particle size was significant (p<0.001), and traverse location was not 
(p=0.948) as well. In summary, filtration efficiency depended on particle size, but the same 
filtration efficiency could be obtained at different traverse locations across the duct. This result 
also suggests that the downstream turbulent flow might not significantly affect the measurement 
of the filters’ filtration efficiencies. 
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FIGURE 8.3.2 Correlation ratio (left) and Corrected penetration for each filter (right) versus particle 
aerodynamic diameter based on particle counting by OPC with error bars showing standard errors. 
 
8.4 Results and discussion 
8.4.1 Penetrations of live virus, total virus, and fluorescein 
Penetrations of live virus, total virus, and fluorescein were calculated for each filter with 
correlation ratios applied. For live virus titer, AIV and HAdV-1 had very low resolution with only 
three data points in the range of each log. For example, only 1.48, 3.16, and 6.76 were used to 
express the titers between 1 and 10, with the ratio between any two adjacent values of about 2.15. 
This resolution was much lower than that of MS2, and may cause large errors in penetration. 
Therefore, the MS2 data were processed separately from AIV and HAdV-1. For MS2 penetration 
(FIGURE 8.4.1), both filter (p<0.001) and particle size (p=0.006) were significant, but their 
interaction was not (p=0.491). For AIV and HAdV-1 (FIGURE 8.4.2), virus type was not 
significant (p=0.630). The interaction between virus type and particle size (p=0.573), and that 
between virus type and filter (p=0.588) were not significant as well. The filter was significant 
(p=0.020), but the particle size (p=0.339), and the interaction between filter and particle size 
(p=0.928) were not significant. FIGURE 8.4.2 only shows impactor stages 2-7, because most live 
virus titers for impactor stages 0 and 1 downstream of a filter were too low to be detected. For all 
three viruses, filter was significant, and penetrations were greater for the MERV 8 filter. Particle 
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size was not significant for AIV and HAdV-1 by ANOVA, possibly because of the low resolution 
problem with their live virus titers. 
 
 
FIGURE 8.4.1 Correlation ratio (left) and corrected penetration for each filter (right) versus particle 
aerodynamic diameter based on MS2 live virus with error bars showing standard errors. 
 
 
FIGURE 8.4.2 Correlation ratio (left) and corrected penetration for each filter (right) versus particle 
aerodynamic diameter based on AIV and HAdV-1 live virus with error bars showing standard errors. 
 
For fluorescein penetration (FIGURE 8.4.3), virus type was not significant (p=0.161). The 
interaction between virus type and particle size was not significant (p=0.118), as well as that 
between virus type and filter (p=0.749). Both filter (p<0.001) and particle size (p<0.001) were 
significant, as well as the interaction between them (p<0.001). This significant interaction 
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suggests that the curves of filtration efficiency as a function of particle size for the two filters 
were significantly different. 
 
 
FIGURE 8.4.3 Correlation ratio (left) and corrected penetration for each filter (right) versus particle 
aerodynamic diameter based on fluorescein with error bars showing standard errors. 
 
 
FIGURE 8.4.4 Correlation ratio (left) and corrected penetration for each filter (right) versus particle 
aerodynamic diameter based on total virus with error bars showing standard errors. 
 
For total virus penetration (FIGURE 8.4.4), virus type was not significant (p=0.238). The 
interaction between virus type and particle size was not significant (p=0.108), as well as that 
between virus type and filter (p=0.231). Particle size and filter were both significant (p<0.001), as 
well as their interaction (p<0.001), which is the same as the fluorescein results. Both penetrations 
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for total virus and fluorescein did not significantly depend on virus type or suspension medium 
(TSB or MEM) showing that the filtration efficiencies for both media were similar, although the 
particle size distributions for the two suspensions were different as found in the previous tests in 
Chapters 4 and 5. 
 
The penetrations calculated based on live virus titer, total virus concentration, and fluorescence 
intensity were converted to filtration efficiencies and compared with the OPC measurements, the 
MERV requirements (ANSI/ASHRAE 2007), and the filter test reports (Blue Heaven 
Technologies, Louisville, KY). The filter test reports provided by the seller were based on 
ANSI/ASHRAE 2007. A comparison was made for each test filter in FIGURE 8.4.5 without error 
bars shown. 
 
 
FIGURE 8.4.5 Comparison of filtration efficiencies [%] (vertical axes) as a function of particle 
aerodynamic diameter [µm] (horizontal axes) for each filter based on fluorescence intensity (FI), live virus 
(LV) titer, total virus (TV) concentration, the filter’s standard test report, MERV requirement, and the 
particle concentration measured by OPC. 
 
Compared with the references, the filtration efficiencies calculated in the current tests were 
generally lower. The main reason could be the lower face velocity. The secondary reason could 
be the disturbed flow downstream of the filter, which caused the difference between upstream and 
downstream sampling efficiencies, and this difference was not corrected by the correlation tests. 
The filtration efficiencies for MS2 live virus were higher than those for fluorescein, total virus, 
and AIV plus HAdV-1 live virus by mean value, especially at the impactor stages 5-6 (0.7-2.1 
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µm). This difference should be due to the corresponding high correlation ratios for MS2 live virus 
as shown in FIGURE 8.4.1.  
 
Compared with the filters’ standard test reports, two main differences in the measured filtration 
efficiency curves can be found. The first difference is that the filtration efficiency for impactor 
stage 7 (0.4-0.7 µm) was much higher than that of impactor stage 6 (0.7-1.1 µm). This trend is 
not present in the OPC test results, thus the reason might be associated with the impactor or the 
measurement of impactor samples. Except for this, the OPC data points are generally close to the 
fluorescein and total virus curves. The second difference is the decrease in filtration efficiency for 
particles greater than 4.7 µm (ACI stages 0-2). One reason could be the greater uncertainties and 
lower concentrations for these impactor stages. Another reason could be the flow recirculation 
downstream of the filter which actually increased the sampling efficiency for larger particles. 
Finally, the lower face velocity might have significantly reduced the impaction effect for larger 
particles, leading to the lower filtration efficiency for them. 
 
TABLE 8.4.1 P-values for comparison of penetrations with significant factors in bold. 
ANOVA model Indicator Size Filter I:S I:F S:F 
MS2 LV and TV 0.284 <0.001 <0.001 0.915 0.687 0.176 
MS2 LV and FI 0.056 <0.001 <0.001 0.154 0.368 0.051 
AIV&HAdV-1 LV and TV <0.001 0.330 <0.001 0.048 0.029 0.770 
AIV&HAdV-1 LV and FI <0.001 <0.001 <0.001 <0.001 0.003 0.010 
All-virus TV and FI 0.753 <0.001 <0.001 0.007 0.563 <0.001 
 
In order to compare the penetrations of different indicators, ANOVA models were built with the 
factors of indicator, particle size, and filter. The indicators include live virus (LV), total virus 
(TV), and fluorescein (FI). The p-values are listed in Table 8.4.1. For MS2, overall live virus 
penetration was not significantly different from overall fluorescein penetration, but the p-value 
for the indicator was very close to the threshold of significance. The interaction between indicator 
and particle size was not significant either, showing that both indicators had similar penetration 
curves, and the relative recoveries of the upstream samples were similar to those of the 
downstream samples. However, for AIV and HAdV-1, live virus was significantly different from 
fluorescein in both overall penetration and the penetration curve, which should be caused by the 
low resolution problem with the live virus titers of the two viruses. 
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Comparing total virus and live virus penetrations, both indicators were not significantly different 
for MS2 in either overall penetration or the size distribution of penetration. This means that the 
upstream survival was similar to the downstream survival, or MS2 was not significantly 
inactivated in the filtration process. This was expected as the test filters did not have any 
germicidal coating. However, for AIV and HAdV-1, the two processes were significantly 
different, and it should still be caused by the low resolution problem. 
 
Comparison of total virus and fluorescein penetrations shows that the overall penetration levels 
for fluorescein and for total virus were similar, but their size distributions were significantly 
different. From FIGURE 8.4.5, their difference at the impactor stage 6 (0.7-1.1 µm) was much 
larger than those at other stages. The reason could simply be the large test uncertainty due to lack 
of test repeats. However, it also indicates the probability that fluorescein may not accurately 
predict the filtration behavior of virus for very small particles. For any specified particle size, 
fluorescence intensity should be proportional to particle concentration, thus the filtration 
efficiencies measured with a particle counter should be equal to those measured with fluorescein, 
and could also be different from those for total virus. Further research is therefore desirable to test 
filtration behavior of viral aerosols smaller than 2 µm with a higher resolution and a lower level 
of uncertainty. 
 
8.4.2 Inactivation and concentrating in the nebulizer fluid 
Fluid evaporation and virus inactivation were studied again for the one-hour nebulization with 20 
psi (138 kPa) compressed air. The “post” fluorescence intensity was divided by the “pre” to 
calculate the concentration ratio due to water evaporation from the nebulizer during use. The 
concentration ratio significantly depended on virus type (p=0.038). By further analysis, MS2 was 
significantly different from HAdV-1 (0=0.023), while AIV was not (p=0.913). This indicates the 
suspension medium might be the significant factor. The concentration ratio for MS2 was 1.20 
with a standard error of 0.03. For AIV and HAdV-1, it was 1.38+/-0.04. In Chapter 4, the one-
hour ratio was about 1.11, and the six-hour ratio was about 1.21. It indicates that increasing the 
compressed air pressure from 10 psi (69 kPa) to 20 psi (138 kPa) significantly enhanced 
evaporation. 
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The parameter γ was calculated using EQUATION 4.4.3 to study virus inactivation during 
nebulization. Using fluorescein as the reference, γ did not significantly depend on virus type 
(p=0.289), and its mean value was calculated to be 1.34 with a 95% confidence interval of [1.06, 
1.69]. This is surprising as γ should never become greater than unity. This result literally indicates 
that fluorescein concentration was increasing at a lower rate than virus concentration during 
nebulization, or virus was generated at a lower rate than fluorescein. This was possibly because 
the smallest particles produced by the nebulizer contained fluorescein, but no virus. 
 
A similar analysis was done using total virus instead of fluorescein. For concentration ratio, virus 
type was not significant (p=0.492). The ratio of post over pre was 1.53 with a standard error of 
0.14, which was greater than that for fluorescein. This result shows the concentrating effect was 
more significant for virus than for fluorescein, supporting the conclusion in the above paragraph. 
For γ, virus was not significant either (p=0.172). Its average was 1.16 with a 95% confidence 
interval of [0.86, 1.56], showing that the viruses were not significantly inactivated during 
nebulization. It also suggests that using total virus may be more suitable than using fluorescein to 
study virus inactivation in a nebulizer, given that the damage to virus did not significantly affect 
PCR measurements. 
 
8.5 Conclusions 
MS2, HAdV-1, and AIV were tested with two HVAC filters of MERV 8 and 13. The overall 
filtration efficiencies for fluorescein and for total virus were similar, but the filtration efficiencies 
at the impactor stage 6 (0.7-1.1 µm) were significantly different by ANOVA. This result suggests 
that using fluorescein might not accurately predict the filtration behavior of viruses on the small 
particles of about 1 µm in diameter. 
 
The penetration of MS2 live virus was not significantly different from that of total virus, 
indicating negligible inactivation in the filtration process in the chemical-free filters. For AIV and 
HAdV-1, the live virus titers only used three data points per 1-log range, making the penetration 
121 
 
calculation inaccurate. It would be necessary to improve the analysis method before the animal 
viruses could be accurately tested. 
 
The filtration efficiencies calculated for the two filters could not be compared directly to their 
standard performance due to two major limitations. Firstly, the face velocity was lower than the 
standard operating value. Secondly, the downstream sampling location was close to the filter, 
where the flow pattern was greatly disturbed. The complex flow field might have affected the 
aerosol sampling efficiency of the downstream probe, which was not corrected with the 
correlation test, as the problem only existed when a filter was mounted on the test duct. 
 
At 20 psi (138 kPa) compressed air pressure, the evaporation effect of nebulizer fluid was more 
significant than that at 10 psi (69 kPa). Virus inactivation was not significant at 20 psi (138 kPa) 
for one hour nebulization based on survival. In the analysis for nebulizer fluid evaporation and 
inactivation, fluorescein and total virus gave different results. Further analysis revealed that the 
generation of fluorescein was faster than that of virus. 
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9 Key findings, recommendations, and 
limitations 
9.1 Key findings and recommendations 
In this study, viral aerosol survivability, transmission, and sampling were studied in an 
environmental chamber. Tests were first conducted to study the performance of the ACI for long-
term sampling. The six-hour sampling did not collect much more live viruses than the one-hour 
sampling, indicating significant virus inactivation on the dry impaction plates. However, the 
increase in total virus collected in the six-hour tests suggests that using a PCR technique could 
benefit from longer sampling durations usually used for field sampling. Overloading of impaction 
plates with collected particles caused a decrease in the sampling efficiencies of some impactor 
stages, which should be noted when conducting long-term sampling. For the test viruses, MS2, 
HAdV-1, and AIV had greater relative recovery and survival than SIV, TGEV and aMPV. For 
MS2, the relative recovery and survival were constant for all sampled particle sizes, but for the 
other five viruses, a decrease in relative recovery and survival was found for larger particle sizes. 
 
Based on the above results, MS2, AIV, and HAdV-1 were tested in the rest of the study. In the 
tests for different temperatures and humidities, all three viruses showed lower inactivation at 
lower temperature, but the inactivation of HAdV-1 at 30 ˚C was not significantly faster than that 
at 25 ˚C. The three viruses reacted differently to humidity changes. AH was found to be a better 
predictor of virus survival than RH. When modeling with AH, the interaction between 
temperature and humidity disappears. Therefore, documenting AH in future viral aerosol studies 
is recommended. For the three viruses used here, MS2 and HAdV-1 had the lowest inactivation 
rates at low AH, while AIV had the lowest inactivation rate at high AH for the tested AH range 
from 8.8 to 15.2 g/m
3
. Note that the virus was inactivated both in the air and in the impactor. The 
current chamber tests simulated common indoor environments. For future research, it is desirable 
to test viral aerosols under more extreme temperatures and humidities. 
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In the UVGI tests, MS2, AIV, and HAdV-1 were all significantly inactivated by UVGI, showing 
the good potential of UVGI for disinfecting indoor air. The inactivation was caused by 
photochemical reaction in nucleic acid, thus the physical loss measured by PCR was exaggerated. 
Based on relative recovery, AIV was more susceptible to UVGI than MS2 or HAdV-1, which is 
consistent with past studies. To quantify virus susceptibilities, transient numerical simulations 
were conducted in CFX using Lagrangian particle tracking and log-linear inactivation kinetics. 
By analyzing a statistically converged group of particles, the susceptibility of each virus to UV 
irradiation was calculated. The mean susceptibility of MS2 was 0.057 cm
2
/mJ with the range for 
one standard error to be [0.022, 0.098] cm
2
/mJ. For HAdV-1, the susceptibility was 0.056 [0.035, 
0.079] cm
2
/mJ, and for AIV, it was 0.132 [0.031, 0.278] cm
2
/mJ. These susceptibilities are about 
one order of magnitude lower than published viral aerosol data, but close to the water data. This 
result suggests that virus susceptibility to UVGI may not depend on the phase of the carrier fluid. 
UVGI effectiveness has been studied as a function of UVGI dose received, but whether irradiance 
may affect inactivation for the same dose is still unknown, especially when it is very low (<0.01 
mW/cm
2
) or very high (>1 mW/cm
2
). It would also be desirable to test the UVGI effect at 
different RH levels, especially those above 80% or below 20% as there is still no conclusive 
result at these conditions. Further tests are strongly recommended to be conducted in a specially 
designed facility with strictly controlled irradiance and high repeatability. 
 
In the HVAC filter tests, the overall filtration efficiencies for fluorescein and total virus were 
similar, but the filtration efficiencies at the impactor stage 6 (0.7-1.1 µm) were significantly 
different by ANOVA. This result suggests that using fluorescein may not accurately predict the 
filtration behavior of viruses on small particles. To be conclusive, however, more tests focusing 
on this size range are necessary. For MS2, no significant inactivation was found during the 
filtration process in the chemical-free filters. Since the method for the current filter tests did not 
strictly follow the existing test standard, the measured filtration efficiency curves were different 
from those provided in the standard test reports, and the results should not be used to indicate the 
performance of the test filters during normal operation. Due to the low resolution in live virus 
titer for HAdV-1 and AIV, the corresponding analysis was not useful. This issue needs to be 
resolved before these viruses should be tested again. 
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More than 95% of the collected particles by mass were smaller than 4.7 µm, and more than 40% 
were between 1.1 and 2.1 µm. Most of the particles were in the region of droplet nuclei, which 
would be the most important mode for natural viral aerosol transmission. Virus type did not 
significantly affect the particle size distribution in the samples, but the suspension medium was 
found to be a significant factor. 
 
In the nebulizer fluid, the evaporation effect was more significant for longer test duration or 
higher compressed air pressure. Virus was not significantly inactivated in the one-hour tests with 
20 psi (138 kPa) compressed air or in the six-hour tests with 10 psi (69 kPa) compressed air. 
Nebulization of fluorescein was found to be faster than that of virus. This result suggests that 
despite high repeatability, using fluorescein may not measure virus physical loss accurately for 
the whole process and may lead to different conclusions. Therefore, if virus nucleic acid was not 
significantly damaged, such as by UVGI, using total virus for physical loss would be a better 
choice. For future research, it is recommended to further compare the physical losses measured 
by both methods to determine whether the difference is only caused by different nebulization 
rates or also happens during viral aerosol transmission. For example, tests can be done by 
sampling the same aerosol at different time points during its transmission. 
 
9.2 Limitations 
Three major limitations of the current test method are summarized here for future reference. 
Firstly, despite their similarities, extrapolation of the current results based on MS2 and the five 
animal viruses to human viruses should be made carefully. Secondly, viral aerosol infectivity was 
not investigated in this study, in other words, high recovery of live viruses does not mean 
effective disease transmission. Thirdly, viral aerosols were generated from virus stocks with high 
titers in this study. On the other hand, natural viral aerosols were most likely generated from 
saliva or other bodily fluids which may have different effects on virus survivability depending on 
virus type. Studies with artificial or natural saliva, or even relying on patients or animals to 
generate viral aerosols could provide more realistic results, but also may be more difficult to 
achieve. 
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Appendix A. Sampling efficiency 
Two sampling setups were used in this study. For the filter tests, two sampling probes were 
installed in the test duct, and air was sampled perpendicular to the main flow direction. For the 
remaining tests, one sampling probe was installed facing upward when sampling the almost still 
chamber air. For the filter tests, velocity magnitudes upstream and downstream of the filter were 
also different. Overall, all sampling was performed anisokinetically, and should be evaluated 
separately for particle sampling efficiency. 
 
Impaction, turbulent deposition, and sedimentation on internal surfaces are the major mechanisms 
for particle loss in sampling inlets and tubing (Liu 1981; McFarland 1997; Kumar 2008). To 
determine their effects, velocity ratio and Stokes number are the most important parameters 
(Durham 1980; Liu 1981; Okazaki 1987a). Velocity ratio is defined as ambient velocity divided 
by sampling velocity. Stokes number (Stk) is defined as: 
      
  
  
 
      
 
   
 
  
  
, (A1) 
where τ is the relaxation time of a particle, U0 is the ambient velocity, Ds is the inside diameter of 
the sampling probe, Cc is the Cunningham correction factor, ρp is the particle density, dp is the 
particle diameter, and µ is the fluid viscosity. Sampling losses will be discussed in three parts. 
Each part corresponds to one of the three components of the total sampling efficiency: aspiration 
efficiency (Easpiration), entry efficiency (Eentry), and transport efficiency (Etransport) (Liu 1981; 
Okazaki 1987a, 1987b; Hangal 1990a): 
                                   . (A2) 
 
Aspiration efficiency 
Aspiration loss is mainly due to particles in the sampled flow that do not enter the sampling inlet, 
caused by curved streamlines near the sampling inlet for anisokinetic sampling. For misaligned 
sampling, the higher the ambient velocity or the larger the particles, the lower the aspiration 
efficiency becomes (Durham 1980; Okazaki 1987a). If the sampling-from-still-air criterion is met, 
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the aspiration loss can be neglected. The criterion is met when the ambient velocity is below the 
threshold value for a specified particle size (Hinds 1999). Assuming a particle density of 1000 
kg/m
3
 and air properties at normal conditions, the maximum allowable ambient velocities for the 
particle sizes representing the impactor stages are listed in TABLE A1. 
 
TABLE A1 Maximum ambient air velocity according to the sampling-from-still-air requirement. 
Impactor stage 0 1 2 3 4 5 6 7 
Geomean stage size [µm] 9.49 7.22 5.22 3.94 2.63 1.52 0.88 0.53 
Stokes number 0.058 0.034 0.018 0.010 0.005 0.002 <0.001 <0.001 
Max velocity ratio 0.85 1.22 1.87 2.70 4.57 9.25 18.32 33.82 
 
For the filter tests, the velocity measured at the upstream sampling location or at the downstream 
location when no filter was installed was about 425 ft/min (2.2 m/s). The average velocity 
measured downstream of a filter was about 575 ft/min (2.9 m/s). The sampling velocity through 
the sampling probe (ID=0.694 in=1.763 cm) was about 1.9 m/s. Thus the corresponding velocity 
ratios were 1.16 and 1.53, respectively. According to TABLE A1, impactor stage 0 did not meet 
the criterion for both locations, and impactor stage 1 did not meet the criterion for sampling 
downstream of a filter. 
 
TABLE A2 Aspiration efficiency [%] for each impactor stage for filter tests. 
Impactor stage 0 1 2 3 4 5 6 7 
Geomean stage size [µm] 9.49 7.22 5.22 3.94 2.63 1.52 0.88 0.53 
Filter upstream and correlation 87.8 92.7 96.0 97.6 98.9 99.6 99.8 99.9 
Filter downstream 74.1 83.1 89.9 93.5 96.5 98.5 99.3 99.7 
 
Calculation of the aspiration efficiency for each impactor stage was based on the published 
equation in Hangal 1990a and 1990b, and the result is shown in TABLE A2. The results agree 
with the sampling-from-still-air criterion in that the aspiration efficiency was generally greater 
than 90% for impactor stages 2-7 when downstream of a filter, and for impactor stages 1-7 in the 
other cases of the filter tests. Other than the filter tests, sampling velocity was 3.6 m/s, and the air 
velocity was lower than 0.5 m/s by CFD simulation (Chapter 7). The velocity ratio was therefore 
149 
 
smaller than 0.14. From TABLE A1, the sampling-from-still-air criterion was met for all 
impactor stages. No equation for calculating the aspiration efficiency in this case was found, thus 
the aspiration efficiency was assumed to be 100% for all impactor stages. 
 
Entry efficiency 
Less than 100% Eentry is due to particle impaction on the front wall of the sampling inlet. The loss 
can be neglected if the sharp-edged-inlet criterion is met (Hangal 1990a, 1990b). The criterion is 
met when the outside diameter (OD) divided by the inside diameter (ID) of the sampling probe is 
smaller than 1.1, or if the probe wall thickness divided by inside diameter is smaller than 0.5, and 
the wall taper is smaller than 15 degrees. 
 
For the filter tests, each sampling probe’s ID was 0.694 in (1.76 cm), and OD was 0.75 in (1.91 
cm), thus the ratio was 1.08, satisfying the criterion. For the other tests, the sampling probe’s ID 
was 0.5 in (1.27 cm), and OD was 0.75 in (1.91 cm), so the criterion was not met. However, as 
the ambient air velocity was very low near the sampling location, particle impaction onto the 
front wall of sampling inlet due to inertia could be neglected. Therefore, 100% entry efficiency 
was assumed for all sampling setups. 
 
Transport efficiency 
In the chamber tests, 0.5 in (1.27 cm) ID Tygon tubing was used to connect the impactor with its 
corresponding sampling probe. The Reynolds number in the Tygon tubing was about 3000 at 28.3 
l/min sampling flow rate, indicating a transitional flow regime. Particle loss equations for 
turbulent flow were therefore used for conservative estimation. Major mechanisms of transport 
loss are discussed below separately. Unless pointed out, all the equations are from Hinds 1999, 
Chapter 10, Section 3: Transport losses. 
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Bend loss 
Particle loss may happen at bends in the sampling line. Curvature ratio, Reynolds number, 
particle size, and tube flattening are important factors. Curvature ratio and Reynolds number can 
be combined as the Dean number (D), which was defined as: 
   
  
  
, (A3) 
where R is curvature ratio, which is defined as bend radius divided by tubing radius. Its effect is 
negligible when greater than 5. At large curvature ratio, the Reynolds number does not have 
significant effect either (Cheng 1975; Cheng 1981; Pui 1987; McFarland 1997; Peters 2004). For 
the chamber test setup, all curvature ratios were much larger than 5, and tube flattening due to 
bending was negligible. All sampling setups had roughly two 90 degree bends. The bend loss for 
particles collected by each impactor stage was calculated assuming turbulent flow, and is shown 
in TABLE A3. Particles collected on impactor stages 4-7 had bend losses less than 10%, with 
stage 3 slightly larger than 10%. 
 
TABLE A3 Penetration through two 90 degree bends. 
Impactor stage 0 1 2 3 4 5 6 7 
Geomean stage size [µm] 9.49 7.22 5.22 3.94 2.63 1.52 0.88 0.53 
For turbulent flow 0.701 0.813 0.897 0.939 0.972 0.990 0.996 0.999 
For two bends 0.491 0.662 0.804 0.882 0.945 0.980 0.993 0.997 
 
Contraction loss 
One contraction fitting was used for each sampling line in the filter tests. It was from the 0.694 in 
(1.76 cm) ID sampling probe to 0.5 in (1.27 cm) ID Tygon tubing. No contraction fitting was 
used for the other tests. No expansion fitting was used in any of the setups. Particle loss in a 
contraction fitting is due to flow separation, and is a function of inlet and outlet areas, contraction 
half angle, Stokes number, and Re (Muyshondt 1996). The penetration through the contraction 
fitting used in the chamber tests was estimated to be greater than 99.5% for particles collected on 
all impactor stages, thus the contraction loss was neglected. 
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Loss due to gravitational settling 
Particles moving in sampling lines may deposit on tubing walls due to gravitational settling. This 
effect depends on particle size, tube length, and tube inclination angle (Hinds 1999). In the filter 
tests, the tubing was 50 in (1.27 m) long and on a 0.611 rad inclination. In the other tests, the 
tubing was 53 in (1.35 m) long and was roughly horizontal. The results are shown in TABLE A4. 
 
TABLE A4 Penetration due to gravitational settling. 
Impactor stage 0 1 2 3 4 5 6 7 
Geomean stage size [µm] 9.49 7.22 5.22 3.94 2.63 1.52 0.88 0.53 
Filter tests 0.929 0.958 0.978 0.987 0.994 0.998 0.999 1.000 
Other tests 0.914 0.949 0.973 0.984 0.993 0.998 0.999 1.000 
 
Losses due to diffusion, interception, turbulence, thermophoresis, and 
electrostatic attraction 
Diffusion loss is greater for smaller particles, and is affected by flow regime. Calculations were 
thus based on 0.4 µm diameter particles, which was the lower limit of the impactor collection size. 
Calculations were conducted for both laminar and turbulent flows. The diffusion loss was always 
less than 0.1%. 
 
Interception loss occurs when the particle path is too close to the tubing wall. Generally, this may 
happen near the sampling inlet. Since the particles in this study were extremely small (<10 μm) 
compared to tubing ID (>1.2 cm), this effect was neglected. 
 
Turbulence may enhance particle loss in sampling lines, since larger particles with greater inertia 
may penetrate the laminar boundary layer and impact on the tubing wall (Hinds 1999). In this 
study, since the turbulence was not strong for a Reynolds number of about 3000, and the particle 
inertia was small, this effect was neglected. 
 
Particle deposition can be affected due to temperature difference, which is called thermophoresis. 
Generally, deposition is enhanced when the wall is cooler than ambient, and is reduced when the 
wall is warmer. In this study, the tubing wall temperature should be the same as the inside air 
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flow temperature due to the steady state isothermal test conditions. Therefore, thermophoretic 
losses were ignored. 
 
Particles may also deposit on tubing walls due to electrostatic attraction. This effect depends on 
tubing material. Teflon or Polyfio tubing can be easily charged by bending, but the surface 
electrical field is almost zero for Tygon or conductive metal tubing (Liu 1985). As the particles 
usually carry charge, they can also be attracted to neutral surfaces by image forces, but this effect 
is very weak, and the particles need to be very close to the tubing wall (Hinds 1999). In this study, 
the sampling tubing was mainly Tygon or metal, thus this effect was neglected. 
 
Overall sampling efficiency 
From the above discussion, the most important losses were due to aspiration, bending of the 
sampling tubing, and gravitational settling. The individual effects of the above mechanisms can 
be multiplied to calculate total penetration or sampling efficiency. The total efficiencies are 
shown in TABLE A5 for each of the three cases. 
 
TABLE A5 Total sampling efficiencies [%] for all sampling situations. 
Impactor stage 0 1 2 3 4 5 6 7 
Geomean stage size [µm] 9.49 7.22 5.22 3.94 2.63 1.52 0.88 0.53 
Stokes number 0.058 0.034 0.018 0.010 0.005 0.002 <0.001 <0.001 
Filter downstream 33.8 52.7 70.7 81.4 90.6 96.3 98.5 99.4 
Other filter tests 40.0 58.8 75.5 85.0 92.9 97.4 99.0 99.6 
Other tests 44.9 62.8 78.2 86.8 93.8 97.8 99.2 99.7 
 
In summary, for the filter tests, particles collected on impactor stages 3-7 (0.4-4.7 µm) had 
sampling efficiencies greater than 80%, and those collected on impactor stages 4-7 (0.4-3.3 µm) 
had efficiencies greater than 90%. For the other tests without the filter duct installed, particles 
collected on impactor stages 3-7 had sampling efficiencies greater than 85%, and those collected 
on impactor stages 4-7 had efficiencies greater than 90%. The sampling efficiencies were 
acceptable for this study, even though the test results may not represent the true particle size 
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distribution in the chamber. The sampling efficiency downstream of a filter was calculated based 
on the average of the measured velocities. Due to the complex flow field downstream of a filter, 
the actual sampling efficiencies might be different. The difference between the upstream and 
downstream sampling efficiencies was not corrected by the correlation tests. This might be one of 
the error sources for the filtration efficiency results. 
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Appendix B. Average residence time 
The average aerosol residence time from injection to sampling location was measured with an 
optical particle counter (OPC) (Lasair 1002, Particle Measuring Systems, Inc., Boulder, CO). The 
four OPC channels used for particle counting are listed in TABLE B1. The first channel (0.3-0.4 
µm) was not used as its range was not studied for viral aerosols. The last channel (>2 µm) was 
not used either, as its particle count was very small. 
 
TABLE B1 The four OPC channels used for the residence time measurement. 
Channel [µm] 0.4-0.5 0.5-0.7 0.7-1.0 1.0-2.0 
Geomean [µm] 0.447 0.592 0.837 1.414 
 
The residence time measured in this experiment was for a chamber ventilation rate of 15 ACH or 
53 ft
3
/min (1500 l/min), which was always used except in the HVAC filter tests. In this study, the 
chamber was always run isothermally, meaning that the temperatures of supply air and chamber 
boundaries were the same. However, operation of the vacuum pump and the two humidifiers 
might slightly affect the flow field for different thermal conditions. Measurements were thus 
taken under all five conditions (TABLE B2) used in this study. Four repeat runs were carried out 
for each condition. 
 
TABLE B2 Conditions for residence time measurement. 
Condition 1 2 3 4 5 
Temp [˚C] 25 25 25 30 30 
RH [%] 38 50 66 38 50 
AH [g/m3] 8.8 11.5 15.2 11.5 15.2 
 
The experiment was performed using the same setup as in the viral aerosol tests except for two 
differences: the nebulizer fluid did not contain any virus, and the OPC was attached to the 
sampling tubing to draw a small amount of sampled air for concentration measurement. After 
injection started, the concentration measured by the OPC first increased, and then gradually 
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leveled off, depicting a step-up response. The increasing part was used to calculate the residence 
time. Concentration measurement was taken at 0, 1, 2, 3, 5, 7, and 10 min after injection started. 0 
min measurement was the background concentration, and was used to subtract from the 
concentration at the other time points. The data points of each run were best fitted with the 
“DoseResp” (dose response) curve in Origin 8 (OriginLab Corp., Northampton, MA) with the 
form: 
      
     
              
, (B1) 
where C is the particle concentration measured by OPC, and t is the time from the start of 
measurement. A1, A2, t0, and p are the four coefficients determined by curve fitting (FIGURE B1). 
Due to subtraction of the background concentration at time 0, A1 must be 0. To calculate the 
average residence time, the step-up equation was used: 
                            
 
  
   
 
 
     
 
              
   
 
 
. (B2) 
 
Individual curve fitting in Origin 8 and numerical integration in MATLAB 7.1 (The Mathworks, 
Inc.) were performed to calculate the residence time for each run. Then, statistical analysis was 
carried out for average residence time and its standard error. ANOVA was also carried out to look 
for significant factors. 
 
Since the residence time measured by the OPC was the total time spent by aerosol in the chamber 
and in the sampling tubing, the time spent in the tubing must be subtracted from the total time to 
get the actual residence time in the chamber environment. The time spent in each section of the 
tubing could be calculated by dividing the volume of the tubing section with the corresponding 
volumetric flow rate. The total time spent in both injection and sampling tubing was about 30.5 s. 
Moreover, the OPC measured the average particle concentration of past 10 s, which was 
equivalent to a delay of 5 s in measurement. Considering both offsets, the final correction should 
be 35.5 s, which was subtracted from the numerical integration result. 
 
By ANOVA, the particle size distribution did not significantly depend on time (from 0 to 10 min) 
(channel p<0.001, time p<0.001, size*time p=0.523), thus the residence time could be considered 
independent of particle size from 0.4 to 2 µm. The average residence time of particles from the 
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injection outlet to the sampling inlet was found to be 126+/-6 s, which did not depend on 
temperature (p=0.753), RH (p=0.513), or AH (p=0.665). 
 
tAverage residence time
A1
A2
C
Midpoint: 
(LOGt0, (A1+A2)/2)
Slope at midpoint: 
C’=p*ln(10)*(A2-A1)
 
FIGURE B1 Step-up response for the calculation of average residence time of sampled particles. 
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Appendix C. Demonstration of data reduction 
for virus relative recovery and survival 
The data reduction from raw data of live virus (LV) titer, total virus (TV) concentration, and 
fluorescence intensity (FI) to relative recovery and survival was similar for all tests. As a 
demonstration, the calculation procedure for MS2 at 25 ˚C, 50% RH without UVGI is presented. 
The tests were carried out on 06/04, 06/05, and 06/08, 2012. The live virus raw data in PFU/100 
µl and normalized live virus titers are listed in TABLE C1. For the other viruses the unit used 
TCID50/100 µl instead of PFU/100 µl. In TABLE C1, the rows from “Impactor stage 0” to 
“Nebulizer post” are the raw data corresponding to stage and nebulizer samples. Geometric mean 
of “pre” and “post” nebulizer samples was first calculated for normalization of stage samples. 
The normalization was done by dividing an impactor stage value with the geometric mean of “pre” 
and “post”. As uncertainty was assumed to be symmetric about the mean on a logarithmic scale, 
the normalized live virus titers were firstly converted to a logarithmic scale, and then the mean 
and standard deviation were calculated for the three repeats as shown in TABLE C2. 
 
TABLE C1 LV raw data in [PFU/100 µl] and normalized LV (dimensionless) on the normal scale. 
Date 06/04 06/05 06/08 
Impactor stage 0 2.78E+06 7.20E+06 1.41E+03 
Impactor stage 1 3.61E+06 5.80E+06 1.92E+03 
Impactor stage 2 1.02E+07 1.72E+07 1.86E+03 
Impactor stage 3 1.08E+08 7.80E+07 2.40E+04 
Impactor stage 4 2.92E+08 2.12E+08 1.62E+04 
Impactor stage 5 3.71E+08 2.47E+08 6.00E+04 
Impactor stage 6 1.36E+08 1.18E+08 1.55E+04 
Impactor stage 7 3.02E+07 2.52E+07 2.73E+03 
Nebulizer “pre” 1.06E+10 1.07E+10 2.17E+06 
Nebulizer “post” 1.20E+10 1.27E+10 3.43E+06 
Geomean of “pre” and “post” 1.13E+10 1.17E+10 2.73E+06 
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Date 06/04 06/05 06/08 
Normalized impactor stage 0 2.46E-04 6.18E-04 5.17E-04 
Normalized impactor stage 1 3.20E-04 4.98E-04 7.04E-04 
Normalized impactor stage 2 9.04E-04 1.48E-03 6.82E-04 
Normalized impactor stage 3 9.58E-03 6.69E-03 8.80E-03 
Normalized impactor stage 4 2.58E-02 1.82E-02 5.94E-03 
Normalized impactor stage 5 3.29E-02 2.12E-02 2.20E-02 
Normalized impactor stage 6 1.21E-02 1.01E-02 5.68E-03 
Normalized impactor stage 7 2.68E-03 2.16E-03 1.00E-03 
 
TABLE C2 Mean and standard deviation of normalized LV of impactor samples on a log-scale. 
Statistic Mean Standard deviation 
Normalized impactor stage 0 -3.36804 0.21155 
Normalized impactor stage 1 -3.31683 0.17149 
Normalized impactor stage 2 -3.01369 0.16964 
Normalized impactor stage 3 -2.08299 0.08136 
Normalized impactor stage 4 -1.85141 0.33357 
Normalized impactor stage 5 -1.60483 0.10593 
Normalized impactor stage 6 -2.05299 0.17104 
Normalized impactor stage 7 -2.74571 0.22483 
 
Figures were plotted after converting the mean and uncertainty back to the normal scale. Note 
that the uncertainty converted back to the normal scale was not symmetric about the mean. 
Similar processes were performed for the total virus concentration (TABLES C3 and C4) and 
fluorescence intensity (TABLES C5 and C6). 
 
TABLE C3 TV raw data in [PFU/100 µl] and normalized TV (dimensionless) on the normal scale. 
Date 06/04 06/05 06/08 
Impactor stage 0 3.14E+07 7.50E+07 5.04E+05 
Impactor stage 1 3.53E+07 1.41E+08 6.93E+05 
Impactor stage 2 9.45E+07 1.35E+08 7.73E+05 
Impactor stage 3 4.69E+08 6.84E+08 3.95E+06 
Impactor stage 4 1.04E+09 1.83E+09 1.11E+07 
160 
 
Date 06/04 06/05 06/08 
Impactor stage 5 1.87E+09 2.98E+09 1.65E+07 
Impactor stage 6 7.73E+08 1.30E+09 1.02E+07 
Impactor stage 7 1.75E+08 2.42E+08 2.82E+06 
Nebulizer “pre” 1.92E+10 3.86E+10 2.73E+08 
Nebulizer “post” 1.66E+10 4.48E+10 4.54E+08 
Geomean of “pre” and “post” 1.78E+10 4.16E+10 3.52E+08 
Normalized impactor stage 0 1.76E-03 1.80E-03 1.43E-03 
Normalized impactor stage 1 1.98E-03 3.39E-03 1.97E-03 
Normalized impactor stage 2 5.30E-03 3.23E-03 2.19E-03 
Normalized impactor stage 3 2.63E-02 1.64E-02 1.12E-02 
Normalized impactor stage 4 5.82E-02 4.39E-02 3.14E-02 
Normalized impactor stage 5 1.05E-01 7.17E-02 4.70E-02 
Normalized impactor stage 6 4.34E-02 3.12E-02 2.88E-02 
Normalized impactor stage 7 9.82E-03 5.81E-03 7.99E-03 
 
TABLE C4 Mean and standard deviation of normalized TV of impactor samples on a log-scale. 
Statistic Mean Standard deviation 
Normalized impactor stage 0 -2.78092 0.05557 
Normalized impactor stage 1 -2.62609 0.13590 
Normalized impactor stage 2 -2.47487 0.19195 
Normalized impactor stage 3 -1.77142 0.18563 
Normalized impactor stage 4 -1.36511 0.13410 
Normalized impactor stage 5 -1.15084 0.17441 
Normalized impactor stage 6 -1.46960 0.09419 
Normalized impactor stage 7 -2.11385 0.11495 
 
TABLE C5 FI raw data (dimensionless) and normalized FI (dimensionless) on the normal scale. 
Date 06/04 06/05 06/08 
Impactor stage 0 5.15E+02 4.84E+02 2.65E+02 
Impactor stage 1 6.04E+02 6.90E+02 3.34E+02 
Impactor stage 2 1.60E+03 1.63E+03 8.20E+02 
Impactor stage 3 9.82E+03 7.87E+03 5.66E+03 
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Date 06/04 06/05 06/08 
Impactor stage 4 2.32E+04 2.15E+04 1.49E+04 
Impactor stage 5 3.74E+04 3.08E+04 2.54E+04 
Impactor stage 6 1.47E+04 1.31E+04 9.71E+03 
Impactor stage 7 2.54E+03 2.68E+03 1.68E+03 
Nebulizer “pre” 5.96E+05 5.38E+05 8.19E+05 
Nebulizer “post” 9.45E+05 9.27E+05 7.43E+05 
Geomean of “pre” and “post” 7.51E+05 7.06E+05 7.80E+05 
Normalized impactor stage 0 6.86E-04 6.86E-04 3.40E-04 
Normalized impactor stage 1 8.04E-04 9.77E-04 4.28E-04 
Normalized impactor stage 2 2.13E-03 2.31E-03 1.05E-03 
Normalized impactor stage 3 1.31E-02 1.11E-02 7.25E-03 
Normalized impactor stage 4 3.09E-02 3.05E-02 1.90E-02 
Normalized impactor stage 5 4.98E-02 4.36E-02 3.26E-02 
Normalized impactor stage 6 1.96E-02 1.86E-02 1.24E-02 
Normalized impactor stage 7 3.39E-03 3.79E-03 2.16E-03 
 
TABLE C6 Mean and standard deviation of normalized FI of impactor samples on a log-scale. 
Statistic Mean Standard deviation 
Normalized impactor stage 0 -3.26543 0.17588 
Normalized impactor stage 1 -3.15770 0.18737 
Normalized impactor stage 2 -2.76164 0.18845 
Normalized impactor stage 3 -1.99198 0.13258 
Normalized impactor stage 4 -1.58203 0.11986 
Normalized impactor stage 5 -1.38340 0.09401 
Normalized impactor stage 6 -1.78147 0.10782 
Normalized impactor stage 7 -2.51924 0.12971 
 
After the normalized LV, normalized TV, and normalized FI are calculated for these samples, 
their virus relative recovery (RR) and survival can be eventually determined using the following 
equations: 
    
 
     
         
   
 
     
         
   
 
             
             
, (C1) 
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. (C2) 
The virus relative recovery and survival results are shown in TABLES C7 and C8. The data 
respectively correspond to FIGURES 5.3.7 and 5.3.9 in Chapter 5. 
 
TABLE C7 Mean and standard deviation of virus relative recovery (dimensionless) of impactor samples. 
Statistic Mean (log scale) Mean (normal scale) Standard deviation (log scale) 
Impactor stage 0 -0.10261 0.78956 0.31703 
Impactor stage 1 -0.15912 0.69323 0.32919 
Impactor stage 2 -0.25206 0.55969 0.10449 
Impactor stage 3 -0.09102 0.81093 0.15763 
Impactor stage 4 -0.26938 0.53780 0.21747 
Impactor stage 5 -0.22143 0.60058 0.07980 
Impactor stage 6 -0.27152 0.53516 0.06513 
Impactor stage 7 -0.22648 0.59364 0.11637 
 
TABLE C8 Mean and standard deviation of virus survival (dimensionless) of impactor samples. 
Statistic Mean (log scale) Mean (normal scale) Standard deviation (log scale) 
Impactor stage 0 -0.58711 0.25875 0.23198 
Impactor stage 1 -0.69073 0.20383 0.21279 
Impactor stage 2 -0.53882 0.28919 0.21519 
Impactor stage 3 -0.31157 0.48801 0.18019 
Impactor stage 4 -0.48630 0.32636 0.20596 
Impactor stage 5 -0.45399 0.35157 0.10864 
Impactor stage 6 -0.58338 0.26098 0.11064 
Impactor stage 7 -0.63186 0.23342 0.24377 
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Appendix D. Uncertainty analysis 
Basic uncertainties 
For N samples being studied, each one is denoted by xi, and their mean is   . Standard deviation 
(Stdev) shows how dispersed the data set is about the mean: 
        
       
  
   
   
. (D1) 
Relative standard deviation (RelStdev) or coefficient of variation (CV or COV) is: 
             
     
  
     . (D2) 
Standard error (Stderr) of the mean tells how far the sample mean is from the true mean: 
        
     
  
. (D3) 
Relative standard error (RelStderr) is defined similarly as RelStdev: 
              
      
  
     . (D4) 
 
Two-sided 95% confident interval was used for γ calculation for virus inactivation in the 
nebulizer. It is defined as the interval inside which the actual value could be on a 95% probability 
(frequency), or where the true mean could be on a 95% confidence level. To calculate the 
confidence interval, variance distribution is assumed to be normal. For log normal distribution as 
in the current study, the calculation was done on a logarithmic scale. To calculate the confidence 
interval, a t-distribution table is used to get the upper and lower limits of the interval: 
                                
     
  
, (D5) 
                                
     
  
, (D6) 
where the subscript a is confidence level which is 0.95 (two-sided) for this case, and ta,N-1 is the 
value obtained from the t-table based on a and N-1 (degree of freedom). Confidence interval is 
expressed as [Lower confidence limit, Upper confidence limit]. 
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Pooled relative standard deviation 
Uncertainties from different tests can sometimes be assumed to be identical. For example, the 
uncertainty of impactor stage 5 can be assumed constant for different humidity levels. In this case, 
the different uncertainties can be pooled together to calculate a single one to represent all similar 
tests. Usually, tests with a small number of repeats benefit from this process by getting more 
accurate uncertainties for further analysis. This applies to the current study since only triplicate 
tests were conducted. 
 
Suppose a result contains three sets of data: A, B, and C. Each data set has NA, NB, and NC number 
of repeats respectively. On a logarithmic scale, their mean values are a, b, and c, and their 
standard deviations are StdevA, StdevB, and StdevC. If their uncertainties can be assumed to be 
identical, the pooled standard deviation (Stdevpool) on a logarithmic scale is: 
            
               
        
             
. (D7) 
As Stdevpool is on a logarithmic scale, converting the standard deviation back to the normal scale 
makes the uncertainty asymmetric about the mean: 
               
  
               
   
              , (D8) 
               
      
           
   
               , (D9) 
where m is the mean of any set of the samples: a, b, or c. RelStdevupper and RelStdevlower are 
relative standard deviations on the upper and lower sides of the mean respectively. 
 
Propagated uncertainty 
To calculate the uncertainty (U) associated with a derived quantity (Y) such as relative recovery 
or filtration efficiency, the uncertainties of all independent variables (X1, X2 …) in the original 
equation need to be combined as: 
      
  
   
    
   
  
   
    
   . (D10) 
Particularly, for simple cases in the form of C=A+B: 
       
    
 . (D11) 
For the relationship of C=A/B: 
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Appendix E. Measurement repeatabilities 
In this study, live virus was measured with cell-culture based titration, total virus was measured 
with PCR, and fluorescein was measured with a spectrofluorometer. In the viral aerosol results, 
the variation of fluorescence intensity was the smallest, and that of live virus titer was the largest. 
To further investigate the repeatability of each measuring method, a test was conducted. In the 
test, samples of MS2, AIV, and HAdV-1 were divided into similar aliquots, and diluted to 
different concentrations to simulate impactor and nebulizer samples. The relative standard 
deviation of 9 repeats for each case was calculated for the uncertainty associated with any single 
measurement (TABLE E1). 
 
TABLE E1 Relative standard deviations [%] of 9 repeats for live virus titer, total virus concentration, and 
fluorescence intensity. 
MS2 HAdV-1 AIV Fluorescein 
Live Total Live Total Live Total Impactor Nebulizer 
+28/-22 +29/-22 +72/-42 +27/-21 +64/-39 +36/-27 +3/-2 +45/-31 
 
The repeatabilities in TABLE E1 generally agree with the viral aerosol test results. For live virus, 
HAdV-1 and AIV had larger uncertainties than MS2, which had similar uncertainties for live 
virus and total virus. The greater uncertainties with the two animal viruses were most likely due 
to the low resolution in their raw data, where only three data points were used per 1-log range. 
For total virus, the repeatability did not seem to depend on virus or suspension, even though the 
PCR procedure for HAdV-1 was slightly different from that for MS2 and AIV. 
 
For fluorescence intensity, the uncertainty with impactor stage samples was much lower than that 
with nebulizer samples, with the latter even larger than that with the total virus concentrations. 
The reason could be that the concentration of fluorescein in the nebulizer fluid was too high for 
the spectrofluorometer to measure directly, thus requiring more diluting and transferring steps of 
tiny amounts of fluid. As a result, the normalized fluorescence intensity may not be more accurate 
or repeatable than the normalized total virus concentration in this study. 
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Note that all repeatabilities were calculated based on one sample. Thus it only included the 
factors in the sample analysis procedures. A great part of the variations in the viral aerosol test 
results could be attributed to the factors in the aerosol test procedure, including the variations of 
temperature and humidity. These factors, however, should increase the uncertainties of live virus 
titer, total virus concentration and fluorescence intensity by the same rate, thus should not affect 
the comparison results. 
 
